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Abstract 
A New Approach To Identifying Novel Effectors and Regulators of Small GTPases 
Jessica Inti Bertram 
Secretion and endocytosis are essential processes in eukaryotic cells, executed and tightly regulated by the 
cell’s endomembrane system. It is widely accepted that small GTPases of the Ras superfamily are major 
regulators of membrane trafficking and signalling, ensuring specificity and efficiency through their 
spatiotemporal regulation. 
Identifying the proteins interacting with small GTPases is vital for understanding how the small G proteins 
are regulated and where they function. With the aim of eliminating certain limitations posed by many 
traditional methods of studying protein-protein interactions, an adaptation of the recently developed in vivo 
proximity labelling technique BioID was used in this study. Here, BioID was redirected to the ectopic 
location of the surface of mitochondria (hereafter called MitoID) with the aim of restricting the non-specific 
background. Applying this method to 25 small GTPases of the Ras superfamily in their active and inactive 
states allowed for a direct and clean comparison between the putative interactomes, identifying both known 
effectors and regulators as well as putative novel interactors for most tested GTPases. Several potential 
novel interactions were validated through GST affinity chromatography and/or microscopy,  namely with 
the Rab GTPases Rab2A (ARFGEF3/BIG3, STAMBPL1), Rab5A (OSBPL9, TBCK), Rab9A (HPS3, 
NDE1), and Rab11A/B (ALS2).  
Furthermore, numerous novel interactors were identified for Rab1A and Rab1B, two mammalian 
paralogues of the yeast protein Ypt1 that are known to be key regulators in ER to Golgi trafficking and 
suggested to play a role in the regulation of autophagy. The newly identified proteins include Rabaptin5, 
which is a key player in the regulation of endosomal trafficking, PPP1R37, a protein of unknown function, 
CALCOCO1 and CLEC16A, which are potentially involved in autophagy, and several components of the 
phosphatidylinsositol-3-phospate kinase (PI3K) complex I, which is known to be a major autophagic 
regulator.  
In collaboration with the Williams group, the PI3K complex I was shown to be a bona fide Rab1A regulator. 
Furthermore, direct binding assays showed that CALCOCO1, CLEC16A, and PPP1R37 all bind to Rab1A 
and Rab1B independently of adaptor proteins or other factors. More specifically, the Rab1 binding site on 
PPP1R37 was shown to be located on the C-terminal and central regions that contain multiple leucine rich 
repeats. 
Collectively, this study has shown that MitoID is an effective and powerful tool to study protein-protein 
interactions, and has identified and confirmed several novel interactors of small GTPases which can aid in 
gaining understanding of how major processes such as vesicle trafficking and autophagy are regulated. 
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Chapter 1: General Introduction  
There and Back Again – A Tale of Secretion and Endocytosis 
 
Secretion and endocytosis are essential processes in eukaryotic cells, executed and tightly regulated by the 
cell’s endomembrane system. The secretory pathway is responsible for the production, folding, and delivery 
of membrane proteins to their correct intracellular location, as well as the export of proteins to the 
extracellular environment or the lumen of endomembrane compartments (Barlowe & Miller, 2013) The 
endocytic pathway, on the other hand, regulates the recycling or degradation of extracellular proteins or 
membrane components (Scott et al., 2014). It is the main way of obtaining nutrients and regulating the vast 
array of molecules that cells present to their environment, and is essential in fundamental processes such as 
development, immunity, and cell signalling (Elkin et al., 2016).  
 
 
1.1 The secretory pathway 
 
1.1.1 The endoplasmic reticulum: protein translation and modification 
The secretory pathway is initiated at the endoplasmic reticulum (ER), where secreted and integral 
membrane proteins, as well as a subpopulation of cytosolic proteins, are synthesised (Fig. 1.1) (Schwarz & 
Blower, 2016). Protein translation is executed by membrane-bound ribosomes lining a subsection of the 
ER surface called the rough ER. During or shortly after translation, the proteins are transported into the ER 
lumen where they are folded with the aid of chaperones and undergo modifications such as N-linked 
glycosylation and disulphide bond formation. Proteins that are terminally misfolded or unfolded will be 
transported to the cytosol and degraded by the proteasome in a process called ER-associated degradation 
(ERAD) (Ruggiano et al., 2014). Proteins that contain one or more hydrophobic stretches are incorporated 
into the lipid bilayer as integral membrane proteins, while proteins that are due to be secreted will be 
transported to the Golgi apparatus in membrane vesicles (Barlowe & Miller, 2013; Schwarz & Blower, 
2016).  
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Figure 1.1. Schematic overview of the intracellular endomembrane system. Simplified overview of a mammalian cell, showing main 
components of the endomembrane system; the plasma membrane (PM, green), Golgi apparatus (orange, cis- and trans- sides indicated), 
ERGIC (ER-Golgi intermediate compartment, purple), Endoplasmic Reticulum (ER, lilac), nuclear envelope (NE, blue) early and late 
endosomes (EE, LE, grey), endo-lysosomes (EL, grey/yellow) and lysosomes (L, yellow). Arrows indicate potential routes of vesicle 
trafficking, both towards the plasma membrane (anterograde, secretion) or towards to the cell’s interior (retrograde, endocytosis). 
Compartments not to scale. 
 
 
1.1.2 From the ER to the Golgi: budding and fusing 
 
1.1.2.1 Vesicle formation and budding 
Proteins that were correctly synthesised and modified in the ER, can now be packaged and transported to 
the Golgi apparatus by membrane vesicles regulated and shaped by the COPII coat. The transport vesicles 
leaving the ER are formed at specialised zones called ER exit sites (ERES) or transitional ER (tER) 
(Kurokawa & Nakano, 2019). The formation of COPII-coated vesicles is initiated when the protein Sec12 
activates the small GTPase Sar1 on the ER membrane (Barlowe & Miller, 2013). Small GTPases, or small 
G proteins, are a family of proteins which can be activated or inactivated by binding to GTP or GDP, 
respectively (more on small GTPases and their activation cycle in paragraph 1.3) (Wennerberg et al., 2005). 
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After Sec12 aids in the exchange of Sar1-assoiated GDP to GTP, the activated Sar1 is recruited to the 
membrane where it in turn recruits the heterodimeric complex of Sec23 and Sec24. Together, Sec23 and 
Sec24 form a stable concave complex which faces the membrane and together forms the inner layer of the 
COPII coat (Bi et al., 2002). The Sec23/Sec24 complex provides two different functions; while Sec23 
deactivates Sar1 by aiding in the hydrolysis of its associated GTP, Sec24 allows cargo-binding by 
interacting with several sorting signals and ER export motifs, enriching cargo at the pre-budding site 
(Barlowe & Miller, 2013; Miller & Barlowe, 2010). Next, the heterotetrameric Sec13/Sec31 complex is 
recruited, which further stimulates the deactivation of Sar1 and comprises the outer layer of the COPII coat 
(Bi et al., 2007). Interestingly, Sec13 and Sec31 were shown to inherently self-assemble into a cage-like 
structure, independently of the presence of Sec23 and Sec24 (Stagg et al., 2006).  However, later research 
by Stagg and colleagues indicated that Sec23/Sec24 complexes first oligomerise into clusters which define 
the site for Sec13/Sec31 cage formation, suggesting that Sec13/Sec31 might not be solely responsible for 
the structural roles of the COPII coat (Stagg et al., 2008). 
 
After the planar ER membrane is transformed into a curved vesicle containing cargo ready for ER export, 
the budding vesicle will be released through scission. It is thought that COPII vesicle scission is driven by 
Sar1, but the exact mechanism behind this remains elusive; while certain studies suggests that Sar1 
hydrolysis leads to fission by deforming the membrane, other studies have shown that a high concentration 
of Sar1 on the vesicle causes scission regardless of its activity state (Adolf et al., 2013; Hariri et al., 2014; 
M. C. S. Lee et al., 2005). 
 
1.1.2.2 Vesicle tethering and fusion with the Golgi apparatus 
The budded vesicles quickly encounter the first downstream sorting compartment, the ER-Golgi 
intermediate compartment (ERGIC) (Lord et al., 2013). The ERGIC is often found adjacent to ER exit sites, 
and mediates vesicle sorting both forwards to the Golgi and back to the ER (Ben-Tekaya et al., 2005). The 
COPII-coated vesicles can also fuse directly with the Golgi apparatus, specifically the ER-facing side called 
the cis-Golgi (Fig. 1.1). While a study in S. cerevisiae showed that the cis-Golgi can approach and contact 
the ERES to ensure efficient cargo transport, in general, the budded vesicles traverse the cytoplasm along 
cytoskeletal filaments and are guided to the cis-Golgi by certain tethering proteins (Kurokawa et al., 2014). 
Tethering proteins are categorised into two main groups, the multi-subunit tethering complexes and long 
coiled-coil proteins (Gillingham & Munro, 2019). Furthermore, tethers are generally only present on a 
specific membrane compartments where they recognise incoming vesicles, aiding towards the specificity 
of vesicle trafficking. Capture and tethering of ER-derived vesicles directed to the Golgi membrane arises 
through an interplay between COPII coat proteins, the small GTPase Rab1, the Rab1 activating protein 
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complex TRAPPIII, and the Rab1 effector and coiled-coil protein USO1/p115 (Lord et al., 2013). Small 
GTPase effectors are proteins that bind specifically to the activated form of the GTPase, thereby often 
setting in motion a cascade of events. After the TRAPPIII complex activates Rab1, the small GTPase 
becomes associated to the cis-Golgi membrane, where it recruits the long coiled-coil protein p115 (Lord et 
al., 2013). While the yeast ortholog of p115 (Uso1p) has been shown to be required for docking of ER-
derived COPII vesicles at the Golgi, the exact mechanism through which p115 carries out this function is 
not yet fully understood (Cao et al., 1998). Several studies point towards p115 working together with the 
coiled-coil proteins GM130 and giantin, others indicate that p115 binds to monomeric SNARE proteins 
(Alvarez et al., 2001; Short et al., 2005; T. Wang et al., 2015). SNARE proteins (soluble N- ethylmaleimide-
sensitive factor attachment protein receptors) are a group of proteins which aid membrane fusion by 
bringing two opposing membranes together through the interaction between SNAREs on vesicles (v-
SNAREs) and SNAREs on the target membrane (t-SNAREs). Observing that p115 binds the v-SNARE 
sec22b and the t-SNARE rbet1, Wang and colleagues suggest a model in which p115 catalyses SNARE-
SNARE interactions to mediate fusion (T. Wang et al., 2015). Further research is necessary to fully 
elucidate the mechanism of ER-derived vesicle docking and fusion at the cis-Golgi. 
 
1.1.3 The Golgi apparatus 
The Golgi apparatus is the main sorting station of the cell; central to both the secretory and endocytic 
pathways, it orchestrates the sorting and distribution of cargo originating from the ER and endocytic 
vesicles (Pantazopoulou & Glick, 2019). Consisting of stacks of distinct and polarised cisternae, the Golgi 
is organised from cis- to trans-, with the cis-side facing the ER and the trans-side facing outwards towards 
the cytoplasm and the plasma membrane (Fig. 1.2). Transport within the Golgi apparatus can occur from 
cis- to trans- (anterograde), as well as from the trans- to cis- (retrograde).  
 
How intracellular membrane compartments maintain their identity, and how vesicle trafficking between 
these compartments and the plasma membrane is regulated, are topics of great interest and debate. One 
popular model that describes how this compartmentation could potentially be developed, is the cisternal 
maturation model, in which the cis-Golgi cisternae are formed de novo and then mature into trans-Golgi 
cisternae by undergoing certain biochemical changes. This model postulates cargo remains in a 
compartment and the arrival of certain enzymes converts cis cisternae into medial cisternae, and medial 
into trans cisternae. As the cisternae mature, they carry forward secretory cargoes and are remodelled into 
transport carriers at the trans-Golgi network (TGN), which means that each Golgi compartment would be 
viewed as a certain stage in the maturation process (Glick & Luini, 2011; Papanikou & Glick, 2014). 
However, while some studies point towards increased concentration of Golgi enzymes in transport vesicles 
 11 
compared to the donor membrane, others observe that these vesicles are actually depleted of Golgi enzymes, 
which brings doubt to this model (Kweon et al., 2004; Lanoix et al., 1999). 
 
 
Figure 1.2. Schematic overview of the Golgi apparatus – a cross-section. A schematic representation of a cross-section of the 
mammalian Golgi apparatus. Cisternae are organised from cis- to trans-, terminating in a tubular structure called the trans-Golgi network 
(TGN). Cisternae are connected through continuous anterograde transport of cargo vesicles towards the TGN, while a retrograde flow of 
resident Golgi enzymes ensures that the cisternae retain their distinct organisation and function.  
 
 
Another model suggests that the cisternae remain relatively stable and the cargo is transported between 
Golgi compartments by transport vesicles and/or tubules (Glick & Luini, 2011). While this model supports 
many aspects of observed Golgi morphology and function, the speed of vesicular transport that would be 
necessary to account for fast traffic of small cargoes also suggests that this model does not fully describe 
intra-Golgi transport. 
 
In both the cisternal maturation and the vesicular transport models, the vesicles which transport either the 
Golgi enzymes or the cargo are coated by COPI. The COPI coat consists of seven components (αCOP, 
βCOP, β’COP, γCOP, δCOP, εCOP, ζCOP) forming a stable heteroheptameric complex called the coatomer 
(Popoff et al., 2011). Similar to the COPII coat, the assembly of the coatomer on vesicles is driven by a 
small GTPase of the Ras superfamily – Arf1. After Arf1 activation, most commonly by the protein GBF1, 
the GTP-bound Arf1 will anchor itself into the Golgi membrane and recruit the coatomer there (Beck et al., 
2009). While Arf1 activation drives vesicle formation and budding, Arf1 hydrolysis by ArfGAPs leads to 
the shedding of the coat and allows the vesicle to fuse with the target membrane. Whether COPI-coated 
vesicles travel mostly anterograde or retrograde, and whether they largely carry protein cargo or Golgi 
enzymes remains disputed (Rabouille & Klumperman, 2005). A recent proteomic profiling study has found 
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numerous Golgi resident proteins, but hardly any anterograde cargo proteins, to be present in the proteomes 
of COPI vesicles, suggesting that COPI is mainly involved in retrograde traffic (Adolf et al., 2019). Further 
research toward COPI vesicle function could elucidate the potential roles of the cisternal maturation and 
the vesicle transport models. 
 
Finally, the latest major model aimed at explaining intra-Golgi transport, the so-called cisternal progenitor 
model, is based on the observation that Rab GTPases can form distinct domains in endosomes (Sönnichsen 
et al., 2000). Furthermore, the previously described Rab cascades can drive a process called Rab conversion 
on endosomes, in which Rab cascades lead to the conversion of early to late endosomes (Rink et al., 2005). 
The cisternal progenitor model proposes that the Golgi is made up of stable compartments which are defined 
by distinct Rab GTPase domains (Pfeffer, 2010). These Rab domains can convert into a downstream Rab 
domain, after which the newly converted domain can fuse with the matching downstream Rab domain, 
creating a passageway for cargo to travel regardless of their size. While an intriguing proposition, this model 
provides no specific function for observed COPI vesicles and is also less appropriate for non-animal Golgi, 
which are generally observed in separate ministacks (Glick & Luini, 2011). 
 
Even though the exact mechanism of developing and maintaining the cis- to trans-Golgi organisation 
remains elusive, it widely accepted that tight regulation of this process is necessary for proper Golgi 
function. One of the main reasons behind this is how anterograde traffic through the Golgi correlates with 
the sequential nature of glycan modifications on cargo proteins. In the secretory pathway, ER-derived 
vesicles dock at the cis-Golgi and traverse through the medial cisternae, where they may receive certain 
post-translational modifications (Jackson, 2009). While N-linked glycosylation mainly occurs in the ER, 
the Golgi apparatus is the main site of glycan processing, trimming, and addition, and is thus abundant with 
glycan modifying enzymes such as glycosyltransferases and glycosidases (Stanley, 2011; Welch & Munro, 
2019). While glycosyltransferases catalyse the transfer of sugar groups onto proteins or lipids containing 
glycan acceptors, glycosidases may remove sugars to trim the glycan groups. Since the glycan 
modifications occur sequentially as the protein travels through the Golgi, the localisation of the enzymes 
relative to one another is key for providing the correct final modifications. It is thought that (specific) 
retrograde cisternal transport of resident Golgi enzymes ensures cisternal organisation and functionality 
while the Golgi is undergoing a continuous anterograde flow of cargo proteins (Fig 1.2) (Welch & Munro, 
2019).  
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It is likely that multiple mechanisms are in place to facilitate the sorting and retention of Golgi enzymes, 
with a combination of factors contributing to maintaining proper Golgi organisation (Schoberer & Strasser, 
2011; Welch & Munro, 2019). Firstly, an extensive comparison of transmembrane proteins has shown that 
the length of their transmembrane domains (TMDs) differs depending on which organelle the protein 
resides on – TMDs appeared to be shorter in the early secretory pathway and longer in the late secretory 
pathway (Sharpe et al., 2010). In line with these observations, it is thought that organelle membranes 
become increasingly thicker as they progress through the secretory pathway, possibly due to differing lipid 
compositions (Welch & Munro, 2019). It has previously been shown that increasing the length of the TMD 
decreases the efficiency of Golgi enzyme retention, which suggests that the Golgi enzymes are retained in 
the Golgi because their shorter TMDs favour the relatively thinner Golgi membranes (Munro, 1995). More 
recently, it has been shown that the cisternal membranes gradually increase in thickness from the cis- to 
trans-Golgi, suggesting that the thickness of membranes could not only be responsible for Golgi enzyme 
retention but also the sorting and organisation within cisternae (Bykov et al., 2017).  
 
The rapid partitioning model, on the other hand, proposes that transport vesicles are sorted spatially due to 
self-organising lipid domains (Patterson et al., 2008). The variance of lipid composition and formation of 
distinct domains is suggested to be generated by the flux of proteins and lipids by intra-Golgi transport, as 
well as certain individual membrane properties. However, the mechanism described by Patterson and 
colleagues was disputed by Nilsson and colleagues, who suggest that the membrane proteins order the lipids 
surrounding them, rather than the other way around (Nilsson et al., 2009). Further research is necessary to 
elucidate the role of lipid composition in the sorting of glycan processing enzymes. 
 
Another mechanism through which the Golgi enzymes can be organised and sorted to certain cisternae is 
through sorting motifs on the enzymes themselves. The main proteins identified to interact with certain well 
conserved motifs on glycosyltransferases are GOLPH3 and GOLPH3L (Tu et al., 2008). Furthermore, 
GOLPH3 and GOLPH3L have been found to bind directly to components of the COPI coat and interact 
with phosphatidylinositol-4-phosphate (PI4P), indicating that GOLPH3 and GOLPH3L could function as 
adaptor proteins to promote glycosyltransferase incorporation into COPI coated vesicles and transport them 
back to previous cisternae (Eckert et al., 2014; Tu et al., 2012; Welch & Munro, 2019). 
 
Finally, the kin recognition mechanism postulates that Golgi enzymes resident to the cis- and medial 
cisternae oligomerise and form higher order complexes which prevents them from entering budding vesicles 
(Nilsson et al., 1993). Although the oligomerisation of medial Golgi enzymes (but not trans-Golgi enzymes) 
has been observed, a study using fluorescence recovery after photobleaching (FRAP) has shown that the 
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Golgi membrane composition recovers rapidly after photobleaching, indicating that the resident Golgi 
enzymes are not hindered in their mobility (Brandizzi et al., 2002; Opat et al., 2000). Further research 
towards this mechanism is crucial in understanding how the several proposed mechanisms could work 
together to generate and maintain Golgi enzyme sorting. 
 
1.1.4 The journey after the Golgi 
After navigating through the Golgi, the synthesised proteins reach the TGN where they will be sorted and 
packaged into transport carriers. The cargo sorting is a meticulous process involving coat proteins, adaptor 
proteins of the AP and GGA families, phosphatidylinositols, and the small GTPase Arf1 (Gadila & Kim, 
2016). The general consensus of this process is as follows; active Arf1 can recruit phosphatidylinositol-4-
kinase (PI4K) to the TGN membrane, which aids in the production of phosphatidylinositol-4-phosphate 
(PI4P). The presence of PI4P promotes the recruitment of the GGA adaptor proteins to the TGN by Arf1, 
which in turn recruits additional PI4K to the membrane, providing a positive feedback loop. When sufficient 
levels of PI4P are reached at the TGN, Arf1 will recruit and activate AP-1. AP-1 can then interact with 
sorting motifs present on cargos destined for endosomes and lysosomes, as well as recruit the clathrin coat 
on the budding vesicle (Gadila & Kim, 2016; Guo et al., 2014). 
 
Besides transport to endosomes and lysosomes, proteins arrived at the Golgi can also be trafficked back to 
the ER. Retrograde Golgi-to-ER trafficking occurs generally to allow protein quality control in the ER, or 
to return trafficking machinery or ER-resident proteins, and is mediated by the COPI coat (Duden, 2009; 
Spang, 2013).  
 
While clathrin-coated vesicles are the main carriers for endosome/lysosome-directed transport, and COPI-
coated vesicles mediate the retrograde Golgi-to-ER trafficking, the main route of transport to the plasma 
membrane is through ‘pleomorphic tubular-vesicular carriers’ – lipid tubules and vesicles which are 
heterogenous in size and remain uncoated (Stalder & Gershlick, 2020). Bard and Malhotra suggest a model 
in which the transport carriers bud off from the membrane and grow in size, potentially through pulling by 
motor proteins, hereby forming tubules. Certain feedback loops and signalling cascades generate lipid 
domains on the TGN membrane, which lead to fission of the tubules and create the transport carriers (Bard 
& Malhotra, 2006). 
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1.2 The endocytic pathway 
 
1.2.1 Internalisation via the plasma membrane 
In the endocytic pathway, small membrane vesicles are generated that transport cargo from the plasma 
membrane into the interior of the cell. The cargo consist mainly of transmembrane proteins and their 
ligands, nutrients, and growth factors, although pathogens often exploit the endocytic pathway to mediate 
their internalisation (Doherty & McMahon, 2009).  
 
1.2.1.1 Clathrin-mediated endocytosis 
Most commonly, endocytosis is known to occur through the generation of clathrin-coated vesicles at the 
plasma membrane. Briefly, the proteins that make up the coat concentrate at the site of invagination, 
promoting membrane bending and resulting in a ‘clathrin-coated pit’ (Kaksonen & Roux, 2018). Certain 
protein components of the clathrin coat bind to cytosolic parts of different transmembrane cargo molecules, 
which mediates recruitment of cargo molecules to the prospective vesicle. Vesicle scission is generally 
catalysed by the GTPase dynamin, which forms a collar around the neck of the clathrin-coated pit, and 
snips it. The formation of the vesicle ends with the disassembly of the protein coat, after which the uncoated 
vesicle can fuse with early endosomes (Kaksonen & Roux, 2018). 
 
1.2.1.2 Clathrin-independent endocytosis 
Endocytosis can also occur via several clathrin-independent routes, of which the best characterised involves 
clathrin-independent carriers (CLICs) that can mature into glycosylphosphatidylinositol-anchored protein-
enriched early endocytic compartments (GEECs). CLIC/GEEC endocytosis is regulated by the small 
GTPases Arf1 and Cdc42 and several other proteins including GTPase activating proteins, actin nucleation 
factors, and BAR-domain proteins (Shafaq-Zadah et al., 2020). It is thought that clathrin-independent routes 
of endocytosis are associated with cell polarity, since cargoes internalised via these routes are often found 
to be localised and internalised in a polarised manner. Furthermore, the clathrin-independent uptake 
machinery can show a polarised distribution itself; CLIC structures are preferentially found at the leading 
edge of migrating cells, as is the occurrence of clathrin-independent fast-endophilin-mediated endocytosis 
(FEME) (Casamento & Boucrot, 2020; Shafaq-Zadah et al., 2020). 
 
1.2.2 endosomes: from early to late 
Upon internalisation, endocytic vesicles fuse with early endosomes (EE), also known, appropriately, as 
sorting endosomes. Here, cargo is sorted into a variety of different endocytic pathways, including 
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degradation via endo-lysosomes, recycling either via recycling endosomes or directly back to the plasma 
membrane, or cargo redistribution via the Golgi apparatus, namely the trans-Golgi network (Fig. 1.1) 
(Huotari & Helenius, 2011).  
 
Recycling of membrane components back to the plasma membrane is key in acquiring membrane 
homeostasis; an estimated 50-180% of plasma membrane surface area is cycled in and out of the cell every 
hour, highlighting the need for an efficient system of membrane recycling (Steinman et al., 1983). The 
recycling of plasma membrane components can occur directly via EE, allowing rapid turnover, or via 
recycling endosomes (RE). RE are often tubular in shape and are localised in the perinuclear region called 
the endocytic recycling complex (ERC) (Naslavsky & Caplan, 2018).  
 
1.2.3 lysosomes and autophagosomes: degradation and recycling 
If endocytosed proteins are targeted for degradation, the EE carrying the proteins will transport to late 
endosomes (LE) and fuse with lysosomes, forming endo-lysosomes (Fig. 1.1) (Scott et al., 2014). 
Lysosomes are membranous organelles that contain acid hydrolases and enzyme activators which can 
degrade different substrates (Ballabio & Bonifacino, 2020). The endo-lysosomal pathway is key in 
maintaining cell health, breaking down molecules to inactivate pathogens or clear up protein aggregates. 
Besides via the endocytic pathway, proteins and other macro-molecules can reach the lysosomes through 
the secretory, phagocytic, and autophagic pathways. 
 
Autophagy is a key process in the cell and is induced upon cellular stress such as nutrient starvation, 
hypoxia, and infection. The main function of autophagy is to degrade cellular components and recycle them, 
mostly to meet energy requirements under starvation, but also to aid in the removal of misfolded proteins 
(K. H. Kim & Lee, 2014). It is a highly controlled and regulated process, and the key steps are largely 
homologous between mammalian cells and yeast.  
 
Since the lysosomes are vital in mediating cellular catabolism, they are ideal hubs to sense the cell’s 
nutritional status and health. One of the main signalling pathways related to nutrient starvation starts with 
the mTOR complex; mTORC1 is generally localised on lysosomes where it activates a signalling cascade 
that functions in cell survival (Ballabio & Bonifacino, 2020). Upon starvation or other autophagic cues, 
mTORC1 becomes inhibited which causes the dissociation of the ULK1 complex (ULK1, ATG13, 
ATG101, and FIP200) from mTORC1. ULK1 is then able to phosphorylate ATG13 and FIP200, hereby 
activating the ULK1 complex. The active ULK1 complex phosphorylates the protein AMBRA1, which 
then recruits the VPS34/VPS15/Beclin1 complex (specifically complex I, which additionally contains 
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ATG14L and NRBF2) to membranes. Notably, several other factors such as AKT and EGFR can also 
phosphorylate Beclin1 independently of mTORC1. The VPS34 complex functions by phosphorylating the 
lipid phosphatidylinositol to form phosphatidylinositol-3-phosphate (PI3P). Hence, the VPS34 complex is 
also called the PI3-kinase complex, or PI3K. PI3P then recruits numerous other proteins which together 
initiate the membrane formation that will ultimately form the phagophore (Fig. 1.3) (K. H. Kim & Lee, 
2014; Ravanan et al., 2017). Besides in PI3K complex I, the VPS34/VPS15/Beclin1 components also exists 
in a separate but related complex – the class III PI3K complex II additionally contains UVRAG and 
Rubicon, and is mostly present on endosomal membranes (Ohashi et al., 2018).  
 
 
Figure 1.3. Schematic overview of signalling pathways involved in autophagy initiation. Schematic and simplified representation of 
initial molecular interaction and signalling pathways set in motion after detection of an autophagy inducer such as nutrient starvation. 
 
 
 
After the initial phagophore membrane is formed, numerous autophagy-related proteins aid in the 
elongation, and eventually closure, of the phagophore (Fig. 1.4). The proteins ATG5, ATG12, and 
ATG16L1 form a complex that assists in forming the correct curvature of the double membrane structure. 
 18 
Furthermore, ATG4B, ATG7, and ATG3 work together to lipidate LC3B, fully named MAP1LC3B 
(microtubule-associated protein 1A/1B light chain 3B) for its association with microtubules, but now 
mostly regarded as an autophagosome marker. The ATG5/ATG12/ATG16L1 complex then recruits the 
lipidated LC3B (LC3B-II) to the inner and outer membranes of the autophagosomes. Finally, 
autophagosomes fuse with lysosomes to form autolysosomes, this can happen either directly or by first 
fusing with endosomes to form amphisomes (K. H. Kim & Lee, 2014; Ravanan et al., 2017). Fusion with 
lysosomes allows the degradation of autophagosomal cargo by acidic lysosomal components, after which 
they can be recycled to help fulfil the cell’s requirements for energy and amino acids.  
 
 
 
 
Figure 1.4. Schematic overview of autophagy initiation and progression. Schematic representation of initiation and progression of 
autophagy, starting at phagophore formation (grey), elongation of the phagophore to enclose cellular components (blue), closure of 
phagophore and autophagosome formation, fusion with the lysosome (pink), and ultimately degradation and recycling of degraded 
components. 
 
 
 
Besides the aforementioned proteins, numerous other proteins are involved with the initiation, maturation, 
or regulation of autophagy. Several Rab GTPases have been found to show links to the regulation of 
autophagy, one of which is the previously mentioned Rab1. The yeast homologue of Rab1, Ypt1, has been 
shown to play an important role in autophagy, starting several decades ago when Ypt1 was shown to be 
necessary for the onset of autophagy and cell survival under starvation (Segev & Botstein, 1987). Since 
then, numerous studies have identified different ATG proteins as Ypt1 effectors, more specifically showing 
that Ypt1 is required for the recruitment of some of these proteins to the pre-autophagosomal structure, 
where the phagophore will be formed in yeast (Lipatova et al., 2012; Segev & Botstein, 1987; Juan Wang 
et al., 2013). 
 
 19 
1.3 Small G proteins – a closer look 
 
It is widely accepted that Arf and Rab GTPases from the Ras superfamily are key contributors to the 
regulation of membrane trafficking, which is vital for maintaining cell health. The Ras superfamily consists 
of the Ran, Ras, Rab, Rho, and Arf families, which all tend to have their own areas of expertise; while Rab 
and Arf proteins regulate membrane traffic, Ran is involved in nuclear trafficking, Ras family members are 
key cell cycle regulators, and members of the Rho family are mostly known to regulate actin formation 
(Donaldson & Jackson, 2011; Hall, 2012; Macaluso et al., 2002; Matchett et al., 2014).  
 
Even though they affect various processes, all G-proteins in the Ras superfamily function in a similar way 
– they are all GTPases that act as molecular switches and set downstream effects in motion through their 
effectors. In their active state, the GTPases are GTP-bound, whereas inactive GTPases are associated with 
GDP. The activity cycle of GTPases is regulated by two groups of enzymes which catalyse the reactions; 
guanine nucleotide-exchange factors (GEFs) allow for GTP-association by opening up nucleotide 
interaction interface, while GTPase-activating proteins (GAPs) catalyse GTP hydrolysis by providing an 
extra residue to the active site (Hennig et al., 2015) (Fig. 1.5). 
 
 
Figure 1.5. Schematic representation of the small GTPase activity cycle. Schematic representation of the activity cycle of small 
GTPases, in which the GTPases are activated by GTP association and inactivated by GTP hydrolysis. Guanine nucleotide-exchange factors 
(GEFs) exchange GDP for GTP, while GTPase activating proteins (GAPs) aid in the GTP hydrolysis. In its activated state, the small 
GTPase is membrane bound and can recruit effector proteins, while in its inactivate state, the GTPase becomes disassociated from the 
membrane aided by the GDP-dissociation inhibitors (GDIs) which protect the hydrophobic hypervariable domains (HVD) from the cytosol. 
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Most GTPases are incorporated into their target membrane through the prenylation of their C-terminal 
cysteines; enzymes called geranylgeranyl transferases catalyse the addition of a 20-carbon isoprenoid chain 
to cysteine residues which enables membrane association (Gutkowska & Swiezewska, 2012). Other small 
GTPases, such as members of the Arf family, receive their membrane-anchoring modifications at the N-
terminus, while the GTPase Ran lacks the membrane targeting domain altogether (D’Souza-Schorey & 
Chavrier, 2006, Boudhraa, 2020). While active Rab GTPases generally remain associated with their distinct 
membrane compartments, inactive GTPases are solubilised by GDP-dissociation inhibitors (GDIs) (Fig. 
1.5). GDIs specifically bind prenylated and inactive GDP-bound Rab proteins, ensuring extraction of the 
Rab proteins only after inactivation (Müller & Goody, 2017). 
 
Small GTPases are generally allocated to specific intracellular membrane compartments and organelles. 
How the GTPases are targeted to specific membrane compartments remains a topic of great discussion, 
however more recent studies points towards GEFs being key players in GTPase targeting. In a literature 
review, Francis Barr proposes a model based on the continuous cycling of Rab GTPases membrane 
association state and the localisation of GEFs. Rab GTPases cycle between being soluble through GDI-
association, and being incorporated in membranes they come across. Barr proposes that, once they 
encounter a membrane surface hosting its associated GEF, the Rab GTPases are activated and become 
resistant to GDI extraction, remaining in this membrane compartment (Barr, 2013). 
 
This, importantly, means that the cycle of the GTPase’s activity state is linked to its association to specific 
membrane compartments. Because GTPases predominantly interact with their effector proteins in their 
active, GTP-bound state, effectors are essentially recruited to specific intracellular membrane 
compartments where they are able to activate signalling pathways or set interaction cascades in motion 
(Zerial & McBride, 2001). One thoroughly investigated example shows how activated Rab5 recruits its 
effectors EEA1 and Rabaptin5 to early endosomes, where they have been shown to drive endosome fusion 
(Mills, et al., 1999). Active GTPases can also recruit motor proteins or motor protein adaptors, regulating 
the directed transport of organelles. For example, activated Rab7 on lysosomes and endosomes is able to 
recruit RILP (Rab-interacting lysosomal protein) and ORP1L (oxysterol-binding protein-related protein 
1L), which together bind to the p150glued subunit of dynactin and the dynein light intermediate chain. This 
complex recruits the dynein-dynactin complex to the Rab7-positive vesicles for minus end-directed 
transport (Johansson et al., 2007). 
 
Interestingly, certain effector proteins are able to bind multiple GTPases using distinct binding sites. For 
example, the aforementioned Rab5 effector Rabaptin5 was found to also bind to Rab4, thereby essentially 
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functioning as a molecular link between the two Rab GTPases (Vitale et al., 1998). This process is called a 
GTPase cascade, which can play essential roles in establishing membrane flow between intra-organelle 
compartments, such as endosome maturation or cis- to trans-Golgi flow (Pfeffer, 2017). 
 
Another route through which GTPase cascades can be established is through the effector recruitment of 
regulators for downstream or upstream GTPases. A well-established example occurs in the conversion 
between Rab5- and Rab7-positive endosomes with the Mon1-Ccz1 complex, which is both a Rab5 effector 
and a Rab7 GEF. Upon Rab5 activation, the Mon1-Ccz1 complex is recruited to Rab5-positive early 
endosomes where they can recruit and activate Rab7, hereby driving the transition and maturation to Rab7-
positive late endosomes and lysosomes (Langemeyer et al., 2020).  
On the other hand, activated GTPases can also recruit GAPs of upstream GTPases. This leads to a cascade 
in which the activation of the second GTPase leads to inactivation of the first GTPase, hereby further 
allowing a proper GTPase transition. Continuing on with the previously mentioned example regarding 
endosome maturation, a study in yeast has identified that active Ypt7 (Rab7 homologue) recruits the BLOC-
1 complex and the GAP Msb3, which together drive the inactivation of Vps21 (Rab5 homologue) (Rana et 
al., 2015). Together, this shows a sophisticated mechanism which drives endosome maturation.  
 
 
1.4. Expanding the set of known Rab GTPase effectors 
 
As previously discussed, membrane trafficking requires a high degree of regulation. Defects or alterations 
in these processes are known to be associated with numerous pathological conditions such as Parkinson’s 
disease, Alzheimer’s disease, and cancer (Goldenring, 2013; Rajendran & Annaert, 2012; Vidyadhara et 
al., 2019). However, since a multitude of diseases and conditions arise when the endocytic or secretory 
pathways are affected, these pathways in turn are possible therapeutic targets (Goldenring, 2013; Wright, 
2008). Furthermore, bacteria and viruses target and hijack the host membrane machinery, which is essential 
for both the survival and pathogenesis of these infectious pathogens, further underscoring the importance 
of these processes in maintaining cell health (Armas-Rillo et al., 2016; Asrat et al., 2014).  
 
Strict regulation of membrane trafficking is necessary to maintain cell health; a multitude of factors 
contribute to this regulation, with Rab GTPases being the largest protein family known to play key roles in 
membrane trafficking. With 66 members, the Rab GTPases are the largest family of small GTPases in 
humans, coordinating events such as the tethering and fusion of vesicles with their target membranes and 
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recruiting motor proteins necessary for intracellular transport (Mizuno-Yamasaki et al., 2012). It is 
therefore essential to maximise our understanding of their localisation, regulation, and downstream 
effectors, in order to better understand how vesicle trafficking is regulated and maintained. In order to 
investigate whether interacting proteins are Rab effectors or regulators, binding experiments are often 
preformed with the Rab GTPases in their active vs inactive states, since effectors and GAPs generally 
associate with GTPases in their active state, whereas GEFs interact mainly with inactive GTPases (Zerial 
& McBride, 2001). This can be achieved either by loading the GTPases with GDP and non-hydrolysable 
GTP, or by using mutations to lock the GTPases in GTP- or GDP-bound conformational states (Feig, 1999; 
G. Li & Stahl, 1993; Shirataki et al., 1992). 
 
1.4.1 Traditional methods used to identify protein-protein interactions  
The two main experimental approaches that are generally used to identify novel protein interactors are 
affinity chromatography and yeast two-hybrid screens. Affinity chromatography makes use of an affinity 
column which has the ability to selectively and reversibly bind to a target in the sample (Hage & Matsuda, 
2015). One such (larger-scale) affinity chromatography study on Rab GTPases has previously been 
performed in the Munro lab (Gillingham et al., 2014). In that study, GST-based affinity chromatography 
experiments using Drosophila melanogaster Rab GTPases were performed, followed by mass spectrometry 
to identify their interactors. Their study resulted in the identification of a multitude of putative Rab 
interactors, a number of which were validated as novel effectors (Gillingham et al., 2014).  
 
In addition to affinity chromatography, yeast two-hybrid is another traditional and widely-used method of 
studying binding interactions, and has previously been used to identify Rab GTPase interactors (Fukuda et 
al., 2008). Yeast two-hybrid uses a downstream reporter gene as output, splitting a transcription factor of 
the reporter gene in two and fusing these domains to two proteins of interest; if the proteins bind to each 
other, the two domains come into close contact and are able to activate the downstream reporter gene 
(Paiano et al., 2018). While yeast two-hybrid is generally used to study the interaction between one bait 
with one prey, the technique can also be used to screen for interaction partners (Simonsen et al., 1998). 
 
These two approaches have had many successes in the past, but also come with limitations. Yeast two-
hybrid requires the correct folding of both the GTPase and the potential effector in yeast, and does not allow 
for detection of protein complexes because single genes are tested. Even though affinity chromatography 
is able to detect protein complexes, it not only requires correct GTPase folding but also will have great 
difficulty detecting transient or weaker interactions due to repeated column washing in which the interactors 
might be lost. 
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1.4.2 In vivo proximity labelling 
The continuous growth of novel experimental techniques and the increasing capacity for large-scale data 
analysis will greatly aid the journey towards maximising the set of known Rab GTPase effectors. One 
ground breaking method to study protein-protein interactions is by in vivo proximity labelling. By studying 
protein interactions in vivo, the endogenous environment remains mostly intact, ensuring correct protein 
folding.  
 
The two most widely used proximity labelling methods, BioID (proximity-dependent biotin identification) 
and APEX (ascorbate peroxidase proximity labelling), both utilise biotin derivatives which can label 
proximal proteins through diffusion from the enzyme’s active site (Trinkle-Mulcahy, 2019). Using 
biotinylation as a labelling method of choice, is largely due its strong interaction with streptavidin; since 
streptavidin-based affinity chromatography is used to isolate biotinylated proteins, and the interaction 
between biotin and streptavidin is tremendously strong and selective, the loss of interactions due to column 
washing is minimal (Dundas et al., 2013). Previously in the Munro lab, both APEX and BioID were 
compared for the identification of Rab GTPase interactors. The use of APEX resulted in much higher 
amounts of cytosolic background, compared to when BioID was used (personal communication). Hence, 
for this study, our focus lies on the BioID technique and the adaptions thereof. 
 
BioID (proximity-dependent biotin identification) was developed by Roux and colleagues as a novel 
proximity-labelling technique (Roux et al., 2012). The BioID approach makes use of a promiscuous mutant 
of the biotin ligase BirA (R118G, hereafter named BirA*). Whereas wildtype BirA specifically biotinylates 
lysine residues in the biotin acceptor tag, BirA* prematurely releases biotinoyl-5’-AMP (bioAMP) after 
which it can be attached to available lysine residues within a ~10 nm radius (Roux et al., 2012). The BioID 
approach is a valuable addition to the repertoire of protein-protein interaction methods, firstly because 
proximity labelling allows for the identification of transient or less stable interactions. Secondly, the method 
is performed in vivo and in the native cell type, unlike the traditionally bacterially-expressed affinity 
chromatography and yeast two-hybrid. And thirdly, since biotin is used as a labelling agent, the extremely 
selective and stable interaction between biotin and streptavidin can be used to isolate biotinylated proteins 
from the sample (Dundas et al., 2013). 
 
In practice, the BioID approach can be used to identify potential interaction partners by fusing a protein of 
interest to BirA*. After expressing the fusion protein in cells and allowing biotinylation to occur after 
addition of exogenous biotin, the biotinylated proteins are isolated using streptavidin-based affinity 
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chromatography and identified using mass spectrometry and/or SDS-PAGE followed by Western blotting 
(Fig. 1.6). 
Like every experimental approach, BioID comes with a few internal drawbacks. Mainly, the nature of the 
promiscuous BirA* biotin ligase means that all proximal proteins with accessible lysines are biotinylated, 
meaning that proximal non-interacting proteins will be identified but are in fact background proteins. 
Distinguishing this non-specific background from true interactors is challenging – something we aimed to  
 
 
Figure 1.6 Schematic overview of the BioID method. The promiscuous mutant of the biotin ligase BirA (BirA*) is fused to a protein of 
interest and expressed in cells. Upon addition of biotin, proteins with available lysine residues and within the radius of biotinylation (~10 
nm) are biotinylated. Biotinylated proteins are isolated using affinity chromatography and identified through mass spectrometry or SDS-
PAGE resolution. Proteins, BirA*, biotin, and the radius of biotinylation are not to scale. 
 
 
improve by adapting the BioID approach. By redirecting the BirA*-fused proteins to a stable, ectopic 
location, the mitochondria, we were able to develop a system in which the interactomes of many GTPases, 
in their distinct activity states, can be directly compared to one another. Performing these large-scale 
comparisons, we were able to more clearly distinguish true interactors from the background. In this study, 
the development and large-scale use of the adapted BioID (MitoID) approach was described. Numerous 
novel Rab GTPase interactors were validated and further examined, with a particularly in-depth look at the 
interactome of Rab1A and Rab1B. 
 
 
1.5 Thesis lay-out 
 
In Chapter 2, the use of BioID in combination with stable ectopic localisation will be examined, directing 
the BioID-tagged proteins to the outer mitochondrial membrane (MitoID) to considerably equalise the 
background landscape and aid in the identification of true interactors. In order to test the MitoID approach, 
the well-characterised Rab GTPase Rab5A was used and several potential Rab5A interactors were 
identified, two of which (TBCK and OSBPL9) were confirmed to be novel interactors. 
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In Chapter 3, this system will be used for a screen with a whole panel of Rab GTPases and various small 
GTPases of the Rho and Ras families, resulting in the identification of a multitude of putative novel 
effectors. Several putative effectors are studied further and validated as novel Rab GTPase effectors, 
namely ARFGEF3/BIG3 and STAMBPL1 for Rab2A, NDE1 and HPS3 for Rab9A and ALS2/Alsin for 
Rab11A and Rab11B. 
 
In Chapter 4, several adaptations to the MitoID approach are examined, namely use of BioID2 and TurboID 
and how these compare to the original BioID, and whether MitoID can be used to study the effect of post-
translational modifications on protein interactions. 
 
In Chapter 5, the MitoID approach is applied to Rab1A and Rab1B, aiming to maximise the set of effectors. 
Numerous putative effectors are identified and several (GCC88, CALCOCO1, AKAP10, PPP1R37, and 
CLEC16A) are validated to be true novel Rab1 interactors. 
 
In Chapter 6, Rab1 and its novel effectors are studied further to examine their role in vesicle trafficking and 
autophagy. In collaboration with the Roger Williams group (MRC LMB), Rab1 is identified as a specific 
activator of the class III phosphatidylinositol-3-kinase complex I, and its binding site is studied through 
mutagenesis. CLEC16A, CALCOCO1, and PPP1R37 are identified as direct binders Rab1A and Rab1B, 
of which CALCOCO1 and PPP1R37 are associated with autophagosomes and CLEC16A and PPP1R37 
appear to play a role in maintaining Golgi morphology. 
 
Note: a portion of the work done in Chapter 2 was done before the official start of my PhD. The screen was 
set up and started, and certain Rab GTPases were tested in duplicates (Rab1A, Rab2A, Rab5A, Rab6A, 
Rab8A, Rab11A, Rab18, Rab19B, Rab30B, Rab33B, Rab39B, Rab43). During my PhD, this was extended 
to add more Rab GTPases (Rab1B, Rab7A, Rab9A, Rab10, Rab11B, Rab21, Rab29), other small GTPases 
(Cdc42, Rac1, RhoA, RalB, Rheb, and N-Ras), and the whole screen was extended to triplicates. In addition, 
the bulk of the mass spec analysis and all the interactor validations were performed during my PhD. This 
study was done together with Alison Gillingham from the Munro Lab, and we contributed in equal 
measures. Experiments/analysis performed solely by Alison Gillingham or Sean Munro are credited where 
appropriate. 
 26 
Chapter 2: Developing a novel mitochondrially-redirected 
proximity labelling approach 
 
2.1 Introduction 
 
In this study, we set out to use and adapt the proximity labelling technique BioID and perform this across 
a subset of small GTPases (Gillingham et al., 2014, 2019). Maximising the set of known Rab GTPases 
interactors will increase our knowledge on how they regulate membrane traffic. 
 
As previously mentioned, different Rab GTPases can act on different membranes in their GTP-bound 
forms, ranging from early endosomes to the Golgi apparatus and recycling endosomes. Furthermore, in 
their GDP-bound forms, Rab GTPases are generally cytosolic. When comparing several baits to each other, 
the non-specific background can be identified by determining which proteins are present regardless of 
which bait is used and the bait’s activity state. However, since active Rab GTPases are localised to a wide 
range of different cell compartments, and are largely cytosolic in their inactive states, their interactomes 
cannot be directly compared in order to identify the general background. 
 
In order to overcome this, we have established a system which allows relocation of the BirA*-fusion 
proteins to a standard and consistent location – the mitochondrial outer membrane. In our adapted BioID 
(MitoID) assay, we have used a subset of the Ras superfamily that comprises 25 small GTPases, each 
containing point mutations which essentially lock the GTPases in permanently active or inactive states 
(Feig, 1999; G. Li & Stahl, 1993). Although these mutations have mostly been studied in Ras GTPases, it 
is thought that these mutations have similar effects on other small GTPases. Comparing the MitoID data of 
a large subset of small GTPases in their different activity states, will aid in the identification of true GTPase 
interactors and can significantly increase our knowledge on GTPase effectors and regulators.  
 
2.2 Results 
 
2.2.1 GTPase-BirA* chimeras can be stably re-localised to mitochondria  
Re-localising GTPase-BirA* fusion proteins to a stable and ectopic location allows for a cleaner and more 
direct comparison between a large set of different baits and their mutations. Since mitochondria have been 
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proven useful for ectopic relocation of cytosolic proteins, we have replaced the C-terminal cysteines of the 
GTPases that receive lipid modifications, with the mitochondrial targeting sequence of monoamine oxidase 
(MAO) (Hoogenraad et al., 2003). Together, this results in a chimera schematically shown in Figure 2.1A, 
with the GTPase C-terminally fused with BirA*, an HA tag to allow for close examination of expression 
and localisation of the chimera, and finally the MAO targeting sequence to anchor the chimera into the 
mitochondrial membrane (Fig. 2.1A, right panel). Our aim is that these chimeras will allow recruitment of 
specific GTPase effectors and regulators to the mitochondria (Fig 2.1A, left panel), where they can be 
biotinylated and later identified. This technique is hereafter called MitoID (Gillingham et al., 2019).   
 
 
Figure legend on next page. 
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Figure 2.1. BirA*-tagged GTPases are re-localised and functional at the mitochondrial surface. (A) Schematic overview of the 
MitoID approach, in which the chimeras are anchored to the mitochondrial outer membrane, where they are able to recruit and biotinylate 
GTPase effectors. The right panel shows the MitoID chimera in which the C-terminal cysteines of a GTPase are replaced by the biotin 
ligase BirA*, an HA-tag and the mitochondrial targeting sequence MAO. (B) Confocal images of HeLa cells expressing Rab5A chimeras 
in either the GTP-form (QL) or the GDP-form (SN), and stained for the HA tag in the chimera as well as markers for the mitochondria 
(COXIV) and Golgi (giantin). (C) Confocal images of HeLa cells either un-transfected or expressing active Rab5A chimeras. Cells were 
stained for the chimera using HA-antibodies, in addition to the Golgi marker golgin-84 and the use of the biotin-binding neutravidin-488. 
(D) As (C) except that the cells were incubated with fluorescent transferrin prior to fixation to label endosomes, and then also stained for 
cation-independent mannose 6-phosphate receptor (CI-MPR) that recycles through endosomes (top panel). Lower panel shows confocal 
images of HeLa cells co-transfected with GTP-locked Rab5A chimera and GFP-PX (PI(3)P binding domain) and stained for the Golgi 
apparatus (ZFPL1). Data generated and collected by Alison Gillingham. (E) Confocal micrographs of HeLa cells expressing Rab2A 
chimeras in either the GTP-form (QL) or the GDP-form (SN) and stained for the chimera itself (HA), mitochondria (COXIV), and the 
Golgi (giantin). (F) Confocal images of HeLa cells expressing active Rab2A chimera (QL), stained for the chimera itself (HA), the Golgi 
(golgin-84), and using neutravidin-488 to stain biotinylated proteins.  
 
 
To test the localisation and activity of these GTPase-chimeras, we transiently expressed both GTP- and 
GDP-locked mutants of the endosomal GTPase Rab5A in HeLa cells and found that both are efficiently 
ectopically localised to the mitochondria (Fig. 2.1B). Importantly, co-staining of the Golgi marker giantin 
shows that the presence of Rab5A on mitochondria does not result in disruption or fragmentation of the 
Golgi apparatus. Furthermore, the presence of biotinylated proteins on the mitochondria indicates that the 
BirA* has remained active and is able to biotinylate proximal proteins (Fig. 2.1C). Moreover, the 
mitochondrial localisation of the endosomal Rab5A does not result in the disruption or relocation of entire 
endosomes – the endosomal lipid PI(3)P is observed on endosomal vesicles and not at the mitochondria, as 
are the endosomal cargoes transferrin and CI-MPR (cation-independent mannose 6-phosphate receptor) 
(Fig. 2.1D, data generated by Alison Gillingham). This indicates that any potential Rab5A interactors we 
detect, are not biotinylated simply for being a part of the endosomal landscape but are true potential 
interactors.  
 
The well-characterised Golgi GTPase, Rab2A, was also tested for the use of MitoID. Similar to Rab5A, 
chimeras in both activity states are efficiently re-localised to mitochondria, while retaining biotin ligase 
activity at the mitochondria and keeping the Golgi apparatus intact (Fig. 2.1E, F). 
 
Finally, we tested whether transiently expressed mitochondrial chimeras induced mitochondrial stress by 
observing whether the ubiquitin ligase Parkin is accumulated there – a commonly used marker for 
mitochondrial stress (Lazarou et al., 2015). We observed clear Parkin accumulation when stress was 
induced by CCCP (a mitochondrial uncoupling agent), but no such Parkin accumulation after expression of 
 29 
Rab2A or Rab5A chimeras, indicating that mitochondria remain functional and healthy (Fig. 2.2) 
(Georgakopoulos et al., 2017). Interestingly, a recent study has shown that Rab5A and its effector 
Alsin/ALS2 are recruited to mitochondria after induction of oxidative stress (Hsu et al., 2018). Even though 
we have shown that a major mitochondrial stress marker Parkin is not accumulated at the mitochondria, the 
relevance of these new potential stress markers to our study will be further examined in the discussion of 
this chapter. 
 
 
 
Figure 2.2. Expression of mitochondrial GTPase-chimeras does not induce mitochondrial stress. Confocal micrographs of HeLa cells 
stably expressing mCherry-parkin, either un-transfected or transfected with Rab2A- or Rab5A mitochondrial chimeras for 48 hours. As a 
positive control, un-transfected cells were treated with 10 μM CCCP (carbonyl cyanide m-chlorophenyl hydrazone, a mitochondrial 
uncoupling agent) for three hours prior to fixation. Scalebars: 10 μm. 
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Together, these data indicate that transiently expressing the GTPase chimeras results in efficient ectopic 
localisation of the small G protein, while retaining the chimera’s biotin ligase activity and showing no 
disruption to the organelle of residence nor inducing mitochondrial stress. 
 
2.2.2 Rab5A-BirA* chimeras biotinylate interacting proteins at the mitochondria 
To determine whether the chimeras are able to biotinylate interacting proteins, we expressed Rab5A 
chimeras in wildtype HEK293T cells, added exogenous biotin, and isolated biotinylated proteins by 
streptavidin affinity chromatography. The MitoID experiments were performed according to the BioID 
protocol set out by Roux and colleagues, supplying 50μM biotin for 18-24 hours and performing the affinity 
chromatography protocol with the same buffers (Roux et al., 2012, detailed in the Materials and Methods). 
Next, we identified the proteins using tandem mass spectrometry, using the total number of spectra that 
match peptides from a certain protein (further referred to as spectral counts) as a semi-quantitative analysis 
method. We tested chimeras of both GTP- and GDP-locked Rab5, and performed these MitoID experiments 
in biological triplicates. 
 
In order to visualise the identified proteins, the mean of the total spectral counts obtained from GTP-locked 
Rab5A triplicates was plotted against the mean of the GDP-locked Rab5 triplicates (Fig. 2.3A,B). As 
expected, the chimera itself (identified as Rab5A) is found in high and roughly equal amounts between the 
two forms. Other proteins that are high on the list and found in roughly equal amounts are endogenously 
biotinylated proteins such as Acetyl-CoA carboxylase 1 (ACACA) and Pyruvate carboxylase (PC) (Tong, 
2012). Importantly, the fact that both the bait and several endogenously biotinylated proteins are found in 
roughly equal amounts is a good indicator that similar input levels were used (Fig. 2.3A). 
 
Amongst the proteins specific for the GTP form of Rab5A were several proteins that are known to bind to 
active Rab5, such as EEA1, HTT/Huntingtin, APPL1/2 and RABEP1/Rabaptin-5 (Miaczynska et al., 2004; 
Pal et al., 2006; Simonsen et al., 1998; Stenmark et al., 1995). Furthermore, multiple subunits of the 
CORVET complex (VPS8, VPS18, VPS11) and the class III PI3-kinase complex (PIK3R4/VPS15, 
PIK3C3/VPS34, NRBF2, UVRAG, RUBCN/Rubicon) were identified (Fig. 2.3B) (Beek et al., 2019; 
Ohashi et al., 2018). 
 
Furthermore, we were able to identify three known Rab5 GEFs, of which two (GAPVD1 and ALS2/Alsin) 
are predominantly present in the GDP-locked form (Hunker et al., 2006; Topp et al., 2004).  The third 
known and identified Rab5 GEF, RABGEF1/Rabex-5, was found in similar levels in both mutants, which 
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can be explained by its ability to form a complex with the Rab5 effector Rabaptin-5 (Horiuchi et al., 1997; 
Z. Zhang et al., 2014). When examining the separate triplicate runs, we find that almost all of the identified  
 
 
Figure 2.3. Mitochondrial Rab5A-BirA* chimeras are able to biotinylate Rab5 effectors and regulators. (A) Plot of spectral counts 
obtained by tandem mass spectrometry using streptavidin affinity chromatography samples from cells expressing Rab5A-BirA*-HA-MAO 
chimeras. These Rab5A chimeras were either GTP-locked (Q79L) or GDP-locked (S34N), and the counts represent means of triplicate 
biological repeats. (B) As (A) except only the region in the dashed box in (A) is shown. Known Rab5A effectors (red) and exchange factors 
(orange) are labelled as indicated by their gene names. (C) Spectral counts for known Rab5A interactors identified using the mitochondrial 
Rab5A chimeras in both GDP-locked (S34N) and GTP-locked (Q79L) mutants, as well as BirA*-HA-MAO as a control. Values from 
three biological replicates are shown, with the area of the circle proportional to the number of counts. Plots were generated by Sean Munro. 
 
 
effectors and regulators were found across all three replicates, indicating that the approach is robust and 
reproducible. This is visualised by a so-called ‘bubble plot’, in which the area of the circles corresponds to 
the number of spectral counts (Fig. 2.3C). 
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Taken together, these results indicate that the Rab5A chimeras are able to recruit effectors and regulators 
to the mitochondria in a nucleotide-specific manner, where they can be biotinylated and identified. 
 
2.2.3 Expanding the method: chimeras of a range of GTPases are efficiently expressed and re-localised  
The results so far suggest that mitochondrial GTPase-BirA* chimeras are expressed well in mammalian 
cultured cells, are efficiently anchored at the mitochondria, are able to recruit nucleotide-specific effectors 
and regulators to the mitochondria, and are biotinylated there by the BirA* within the chimeras. Having 
examined the efficiency of the MitoID approach using the well-characterised Rab5A, we next aimed to 
expand this approach to a subset of 25 small GTPases from the Ras superfamily. Our studies are mainly 
focused on the family of Rab GTPases, investigating a number of Rabs from several intracellular membrane 
compartments.  
 
The full set of Rab GTPases examined in this study are Rab1A, Rab1B, Rab2A, Rab6A, Rab8A, Rab10, 
Rab19B, Rab29/Rab7L1, Rab30, Rab33B, Rab39B, and Rab43 from the Golgi apparatus, Rab11A and 
Rab11B from recycling endosomes, Rab5A and Rab21 from early endosomes, and Rab7A and Rab9A from 
late endosomes (Hutagalung & Novick, 2011) (Huber et al., 1993). Rab18 can be found on lipid droplets 
as well as the Golgi (Hutagalung & Novick, 2011). In addition to Rab GTPases, we have also included the 
small GTPases Cdc42, RhoA, and Rac1 from the Rho family (known to regulate the actin cytoskeleton and 
cellular polarity and migration), and N-Ras, Rheb, and RalB from the Ras family (mainly involved in 
signalling cascades and cell proliferation) (Hall, 2012; Macaluso et al., 2002; Wennerberg et al., 2005). It 
should be noted that most small GTPases don’t have just one resident organelle and their stated localisation 
might not be as distinct as originally thought. This will be further discussed later in this thesis, as we gain 
more knowledge on the interaction partners of the GTPases. 
 
Notably, the Arf family of GTPases was not included in this study since, unlike the other small GTPases 
investigated here, Arf GTPases receive their membrane-tethering modifications on their N-terminus instead 
of the C-terminus (D’Souza-Schorey & Chavrier, 2006). This seemingly small distinction would force a 
change in the chimera’s structure; switching from the C-terminal MAO-tag to an N-terminal mitochondrial 
localisation tag such as TOM70. Unfortunately, the N-terminal TOM70 tag has proven to be less efficient 
for the use of MitoID by several researchers in the Munro group (data not shown, personal communication). 
Since this would not allow a fair and equal comparison between the samples, we have decided to exclude 
Arf GTPases from this study. 
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All 25 small GTPases were expressed as chimeras (as in Figure 2.1A) either as wildtype proteins or with 
their known or predicted GTP-locked and GDP-locked mutations (Sup. Table 1). Wildtype Rab GTPases 
were used to examine the behaviour and stability of the mutants, but were not used for any further 
comparisons or investigations – all direct comparisons and further validations were performed with GTP- 
and GDP-locked mutants.   
 
Immunoblotting showed that all chimeras were expressed at comparable levels, except for GDP-locked 
Rab7A, Rab18 and RhoA, which appear to be less stable (Sup. Fig. 2.1). This phenomenon has previously 
been reported for Rab27A and will be further examined in the discussion (Ramalho et al., 2002). 
Furthermore, all used chimeras were efficiently redirected to the mitochondria, with the Golgi apparatus 
remaining intact (several representative images shown in Sup. Fig. 2.2). 
 
Taken together, this data indicates that the chimeras were expressed and localised as intended, with no 
noticeable negative effects on the Golgi apparatus. Next, MitoID experiments were performed across the 
whole panel of small GTPases, in both their locked activity states and in biological triplicates, as was done 
for Rab5A in Figure 2.3.  
 
The appropriate scale with which to perform the MitoID experiments was investigated by testing the 
approach with either 1, 2, or 3 confluent T175 flasks of HEK293T cells expressing Rab2A-chimeras 
(equivalent to approximately 20-25 million cells per flask) (Fig. 2.4). Using our set-up, we found that using 
1 flask of HEK cells leads to several true Rab2A hits being left out (such as BICD1 and OATL1/TBC1D25) 
and various others to be present in only very low amounts (such as BICD2, CCDC186, and 
GOLGA2/GM130) (data not shown). Bubble plots showing the top hits of these three scales also highlight 
an increase of non-Rab2A associated proteins/background proteins when using 1 T175 flask (Fig. 2.4A). 
We did not observe an absence of known hits or an increase in non-specific background proteins when 
comparing the use of 2 T175 flasks to 3 flasks (Fig. 2.4B,C). However, in the dataset of 3 T175 flasks, 
several background proteins are falsely annotated to be GTP-locked specific proteins such as Acetyl CoA 
Carboxylase 2 (ACACB) (Fig. 2.4C). It is likely that in using 3 T175 flasks, other proteins that are not as 
obviously background will also falsely be identified as interactors, making it a trade-off between more non-
specific background versus more false positives. Hence, we have decided to perform all MitoID 
experiments in this study using 2 confluent HEK293T T175 flasks.  
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Figure 2.4. The use of approximately 50 million HEK293T cells per MitoID experiment is efficient and effective. (A-C). Bubble 
plots of MitoID experiments on GTP- and GDP-locked Rab2A chimeras, using either 1 confluent T175 flask/20-25M cells (A), 2 confluent 
T175 flasks/40-50M cells (B), or 3 confluent T175 flasks/80-100M cells (C) per sample. Circle area corresponds to WD-score of GTP-
locked Rab2A compared to GDP-locked Rab2A within each sample. Top 35 hits are shown. All bubble plots are aligned for their GTP-
locked Rab2A samples (yellow columns).  
 
 
 
2.2.4. Analysing the MitoID data 
Comparing the identified interactors across multiple baits can aid in the identification of true and specific 
interactors – for instance, proteins that are present in a nucleotide-independent manner across all baits will  
likely be proximal background and not putative interactors, whereas proteins interacting with one bait in a 
nucleotide-dependent manner are very likely to be true interactors. In this study, we applied a scoring 
system to aid in distinguishing background from interactors. 
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The analytic method is based on spectral count data obtained from mass-spectrometric analysis, and 
involves applying a scoring system from the CompPASS platform (Sowa et al., 2009). The scoring system 
we used on our data set is the WD-score: 
 
where i is the bait number, j is the interactor, Xi,j is the total number of spectral counts for interactor j with 
bait i, k is the total number of baits in the dataset, f is the frequency that prey i interacts with the set of baits, 
p is the number of replicates in which the interactor is present, ω is a weighting factor, and σ is the standard 
deviation of X. 
 
Applying this formula to our entire dataset, each datapoint will be assigned a score that takes into account 
how many times a protein is identified across a set of baits, how many times a protein is identified in the 
replicates of that certain bait, and the number of spectral counts of the protein in that certain bait. In our 
study we have decided to use the WD-score and not the original D-score, because the latter would assign 
lower than fair scores to proteins that are interactors for multiple small GTPases. The WD-score, however, 
gives an extra weight factor (ω) to proteins found in multiple baits with higher spectral counts than average 
for that protein, more accurately reflecting effectors that interact with multiple small GTPases. Thus, 
proteins that are enriched in all replicates of a certain bait but not in many (or any) other baits, will have 
the highest WD-scores. 
 
After performing MitoID experiments on the entire panel of small GTPases, we analysed the mass 
spectrometry data using the WD-scoring system. To demonstrate the application, we will first examine the 
results of GTP-locked Rab5A.  
 
2.2.5 MitoID analysis efficiently identifies both known and putative novel Rab5 effectors 
Aligning the entire list of raw spectral count data to GTP-locked Rab5A, shows that many proteins that are 
found at the top of the list are also present in multiple other GTPases (Fig. 2.5A). These non-specific 
interactors include abundant cytosolic proteins and some mitochondrial proteins. After applying the WD-
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scoring method on the spectral counts data, we observe a clear differentiation of specific protein interactors 
versus background (Fig. 2.5B). By applying the WD-scoring system, the known Rab5A interactors (red) 
become strongly enriched in the top hits, some of which were discussed in paragraph 2.2.2. 
 
Though this data is analysed by comparing GTP-locked Rab5A against all other small GTPases, the 
visualisation in Figures 2.5A,B only shows Rab5A and the negative control in order to clearly observe 
which proteins are enriched in GTP-Rab5A in comparison to GDP-Rab5A. However, when we want to get 
a clear overview of which other small GTPases bind to a certain protein, we can observe the WD-score data 
of the entire panel of GTPases at once (Fig. 2.5C, Sup. Table 3 for separate triplicate runs). This overview 
not only allows for identification of overlap in the GTPase interactomes, but again clearly highlights the 
efficiency of this WD-score analysis to separate specific interactors from the background. 
 
In addition to previously known Rab5A effectors, we were also able to identify a number of novel putative 
Rab5A effectors. These proteins include the TSC1 and TSC2 subunits of the Rheb GAP and the V-ATPase 
regulator WDR7, as well as the two subunits of the Rab3 GTPase activating protein RAB3GAP, which has 
also been shown to play a role in nuclear envelope formation at the ERGIC, as well as function as a Rab18 
GEF (Gerondopoulos et al., 2014; Hantan et al., 2014; Manning & Cantley, 2003; Sethi et al., 2010) (Fig. 
2.5B). 
 
Other notable putative interactors include OSBPL9 and its closely related paralog OSBPL11 (Fig. 2.5B). 
These members of the oxysterol-binding protein (OSBP) family are known to regulate lipid transport and 
triglyceride stage, and have also been shown to heterodimerise and localise to the Golgi/late endosome 
interface (You Zhou et al., 2012). The protein KIAA1468/RELCH was also identified as a putative novel 
Rab5A interactor. Interestingly, RELCH was recently found to bind to Rab11 and OSBP proteins and we 
find both RELCH and OSBPL9/11 to specifically interact with Rab11 as well as Rab5A (Fig. 2.5C) 
(Sobajima et al., 2018). Another novel putative Rab5A effector is TBC1 domain-containing kinase (TBCK). 
Only limited knowledge exists on TBCK, though it is suggested to play possible roles in mTOR signalling, 
actin organisation and cell proliferation (Y. Liu et al., 2013). Interestingly, the presence of the TBC domain 
may indicate that TBCK could potentially function as a Rab GAP, however TBCK has been suggested to 
be inactive due to lack of catalytic domains (Y. Liu et al., 2013; Pan et al., 2006). 
 
Next, we set out to validate the binding of OSBPL9 to Rab5A (novel interactor) and Rab11A (known 
interactor). We performed affinity chromatography with bacterially expressed GTP- and GDP-locked 
mutants of GST-Rab5A and GST-Rab11A and used wildtype HEK293T lysate as input.  
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Figure 2.5. Analysis of Rab5A MitoID experiments highlights specific interactors. (A, B) Bubble plot of MitoID experiments of both 
the BirA* control and both Rab5A chimeras, aligned for GTP-locked Rab5A (second replicate). Circle area corresponds to total spectral 
counts (A) or WD-score (B). BirA* is a non-GTPase control at the mitochondria (BirA*-HA-MAO). Top 35 hits of all three biological 
replicates are shown. Known effectors are shown in red. (C) Bubble pot of MitoID experiments of the whole panel of studied GTPases, 
aligned for GTP-locked Rab5A. Circle area corresponds to average WD-score (average of the biological triplicates). T: GTP-locked mutant, 
D: GDP-locked mutant. Top 40 hits are shown. Yellow columns indicate alignment. 
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OSBPL9 is observed clearly binding to GTP-locked Rab5A and to a lesser extent to GTP-locked Rab11A, 
while not binding to their GDP-locked forms (Fig. 2.6A, data generated by Alison Gillingham). 
Interestingly, the affinity chromatography experiments suggest that the interaction with OSBPL9 is much 
stronger with Rab5A than with Rab11A, while similar levels of spectral counts are acquired by mass 
spectrometry (Fig. 2.5C, Fig. 2.6A). One possible reason for this disparity could be the difficulty of in vitro 
affinity chromatography to detect weaker and transient interactions, which can be identified through in vivo 
proximity labelling, suggesting that OSBPL9 binds more strongly or stably to Rab5A compared to Rab11A. 
 
Finally, we probed the abovementioned blots with an antibody against TBCK, and found it to bind 
specifically to GTP-locked Rab5A and not to its GDP-locked form or to Rab11A (Fig. 2.6B, data generated 
by Alison Gillingham). To visualise this interaction, we co-expressed GFP-TBCK and the mitochondrial 
GTP-locked Rab5A chimera in wildtype HeLa cells. While expression of GFP-TBCK alone leads to 
dispersion throughout the cell, we observed a strong co-localisation of Rab5A and TBCK when the Rab5A 
chimera was co-expressed (Fig. 2.6C, data generated by Alison Gillingham). 
 
 
 
Figure 2.6. Analysis of Rab5A MitoID data identifies OSBPL9 and TBCK as novel Rab5A effectors. (A,B) Affinity chromatography 
of GST-tagged baits (indicated), probed with OSBPL9 (A) and TBCK (B) antibodies. Input: wildtype HEK293T lysate. Data obtained and 
analysed by Alison Gillingham. (C) Confocal micrographs of HeLa cells expressing GFP-TBCK (upper panel) or GFP-TBCK and 
Rab5QL-BirA*-HA-MAO (lower panel). Both panels are additionally probed for the Golgi marker ZFPL1. Data obtained and analysed by 
Alison Gillingham.  
 
 
Taken together, this data shows that WD-score bubble plots illuminate which proteins are likely to be 
specific interactors and whether proteins bind to multiple GTPases, giving a clear overview of the entire 
panel of GTPases. We were able to identify both known and novel putative Rab5A effectors, two of which 
(OSBPL9 and TBCK) were validated using affinity chromatography and immunofluorescence. Together, 
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this shows that the MitoID approach can effectively and accurately identify both known and novel GTPase 
interactors.  
 
 
2.3 Discussion 
 
Rab GTPases are key regulators of vesicle trafficking and endomembrane organisation; in their active state 
they recruit effectors to specific intracellular membrane compartments where they can recruit further 
proteins and activate signalling pathways. Gaining more knowledge of the effectors and regulators of Rab 
GTPases will aid in better understanding the strictly regulated vesicle trafficking pathways and could 
ultimately result in the generation of treatments for pathologies ranging from cancer to neurodegenerative 
diseases. 
 
In this study, we have adapted the in vivo proximity-labelling technique BioID by redirecting the chimeras 
containing BirA* to the mitochondria. The mitochondria were chosen as the ectopic location to which the 
small GTPase chimeras are re-localised, since previous studies have shown that mitochondria are useful for 
this purpose; they are ubiquitous membranous structures that are thought to not interfere with the studied 
trafficking pathways (Hoogenraad et al., 2003).   
 
Importantly, overexpressing the mitochondrial chimeras does not appear to induce stress – our MitoID set-
up does not lead to mitochondrial accumulation of the stress marker Parkin. Interestingly, a recent study 
has found that Rab5A and its effector Alsin/ALS2 are recruited to mitochondria when the cells are under 
stress (Hsu et al., 2018). In our study, Rab5A and Alsin are not found throughout the dataset, which suggests 
that they are not detected due to stress induced by overexpressing and ectopically localising the chimeras. 
If the presence of Rab5A and/or Alsin would indicate induction of mitochondrial stress, we would expect 
to observe this with the overexpression of every (or at least multiple) chimera(s), irrespective of nucleotide 
state. This suggests that where these proteins are identified, they are potential true interactors and not 
indicators of mitochondrial stress.  
 
Stably re-localising the chimeras to the mitochondrial outer membrane is one of the methods we used to 
equalise – and ultimately reduce – the background in our BioID experiments. Since proximity-labelling 
techniques inherently have more non-specific background proteins, we aimed to minimise the presence of 
background proteins in the resulting data set through a combination of different factors. By stably re-
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localising the chimeras to the same ectopic location, comparing the biotinylated proteins across a large 
panel of GTPases, internally comparing a GTPase between its GTP- and GDP-locked forms, performing 
biological triplicates, and applying a scoring systems to the resulting data, several possible novel Rab5A 
interactors stood out from the background. These proteins include TBCK and OSBPL9, both of which were 
subsequently validated to be true Rab5A effectors. 
The mutations used to lock the GTPases in their GTP- or GDP-bound conformations, were based on many 
years of research done on members of the Ras superfamily (Feig, 1999; G. Li & Stahl, 1993). A number of 
these mutations were previously established, and these locations were used to generate mutations for less 
well studied GTPases. However, the use of some of these mutants has proven to be challenging for certain 
GTPases, especially the GDP-locked forms. When immunoblotting the MitoID samples for the chimeras, 
the GDP-locked mutants were sometimes found to be expressed at lower levels than their GTP-locked 
counterparts (Sup. Fig. 2.1). For most GTPases, this expression level difference was negligible, however 
for Rab7A, Rab18 and RhoA in particular this discrepancy was significantly larger. Interestingly, in these 
samples, the tubulin levels are extremely similar, as are the levels of the non-specific background band 
from the HA antibody (Sup. Fig. 2.1). This indicates that cells expressing the GDP-locked forms are not 
dying, but rather it is more likely that they break down the chimeras to protect the health of the cell. This 
phenomenon has previously been reported in in vivo mouse studies with Rab27, where the rapid degradation 
of the GDP-locked GTPase was observed using pulse-chase experiments (Ramalho et al., 2002).  
 
The variation between the GTP- and GDP-locked forms of the same GTPase, can lead to challenges for the 
analysis of the data and conclusions drawn. Normalisation of spectral counts against background proteins 
such as Acetyl CoA carboxylase (ACACA) was considered, since this is a endogenously biotinylated 
protein and could work as a sample size control (normalising the number of cells used in each experiment). 
Alternatively, taking the amount of abundant background proteins such as fatty acid synthase (FASN) or 
filamin-A (FLNA) could be used to normalise for the amount of BioID-dependent biotinylation. However, 
neither of these normalisation methods would solve the problem of potentially missing proteins (even with 
normalisation, a zero remains zero). In this study, we have decided to examine the results for the GTPases 
described above on a case-by-case basis. The post-experimental analyses we have chosen are semi-
quantitative, which means that we use the numbers obtained as a guideline only. When investigating the 
MitoID results, we are mainly interested in the ratios of the hits between the GTP- and GDP-locked mutants, 
in which case the expression levels of the GTPases as well as indicators such as ACACA, FASN, or FLNA 
can be taken into account to assess whether it is a potential interactor. This will be further discussed in the 
next chapter, where the datasets are thoroughly examined to identify GTPase interactors  
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Using different inactive mutations could potentially overcome the issue of degradation. In addition to the 
mutation that locks the protein’s conformation in a GDP-bound state, there are known point mutations that 
mimic the nucleotide-free state, described in Rab3D as N135I (as opposed to the T36N GDP-locked 
mutation corresponding to the mutations used in this study) (X. Chen et al., 2003). Interestingly, the GDP-
locked mutations used throughout this study function by perturbing binding of Mg2+ to the GTPase, which 
leads to the reduced binding affinity to guanine nucleotides. However, the protein’s affinity for GDP is the 
deciding factor whether this ‘GDP-locked’ mutation functions as a GDP-bound GTPase, or a GTPase in a 
nucleotide-free state (Macia et al., 2004; Y.-C. Shin et al., 2016). This was underscored in a study on the 
GTPase Arf6, in which the ‘GDP-locked’ mutant T27N was found to be nucleotide-free, causing the 
GTPase to aggregate in vivo (Macia et al., 2004). Macia and colleagues developed a novel dominant 
negative mutant, T44N, which only affected GTP-binding and not GDP-binding, hereby functioning as a 
true GDP-locked mutant. In addition, a study on Rab11 has shown similar findings; the traditionally used 
‘GDP-locked’ mutant of Rab11A functioned as a nucleotide-free mutant because of low GDP affinity, 
causing the mutant to be unstable (Y.-C. Shin et al., 2016). It appears that the stability and affinity for GDP 
is GTPase-dependent, leading us to speculate that the expression level variations of the GDP-locked 
mutants could be due to instability caused by these specific mutations. The study performed by Macia and 
colleagues indicate that similar point mutations in other GTPases could be found that do give the desired 
outcome; a mutation that only affects GTP- binding, but not GDP-binding affinity (Macia et al., 2004). 
Testing various mutations of residues in switch 1 that interact with GTP, could potentially improve the 
instability of dominant-negative mutants. 
 
While an increased background is a major inherent BioID pitfall that we were able to strongly improve by 
redirecting to a stable, ectopic location and several internal controls, there remain several pitfalls to the 
BioID approach that we were unable to address with this adaptation. One main problem is the availability 
of free lysines; proximal proteins are biotinylated on their available lysines, if there are no available lysines 
on an interacting protein it will not be biotinylated and thus not identified as a potential interactor. This can 
be taken into account when confirming a certain interaction, but when searching for novel interactors this 
could become problematic. Second, the semi-quantitative mass spectrometry analysis is built upon the 
number of spectral counts (how many times a certain protein fragment belonging to that protein is identified 
in the mass spectrometer), but this number will be skewed highly towards larger proteins. Larger proteins 
can be fragmented in more peptides, each of which would count as a spectral count in the spectrometer. 
Thus, larger proteins would (sometimes misleadingly) be detected as being present in higher amounts than 
smaller proteins would. Since this is an intrinsic mass spectrometry challenge, perhaps the best way to 
overcome this would be to normalise the spectral counts against the size of the protein. We have not 
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performed this analysis here, since addressing this issue would leave other related issues unaddressed, such 
as protein abundancy in the cell.  
 
Finally, a note on another family of vesicle trafficking regulators – Arf GTPases. As previously mentioned, 
Arf and Rab GTPases both play key roles in regulating intracellular membrane trafficking, however, 
throughout this study, our main focus has been on the Rab family of GTPases (Donaldson & Jackson, 2011; 
Stenmark, 2009). Arf GTPases differ from other small GTPases in their main structure; instead of being 
membrane-anchored through a C-terminal modification such as geranylgeranylation, the Arf GTPases 
associate with the membrane through myristoylation of an N-terminal amphipathic helix (Nawrotek et al., 
2016). This seemingly straightforward reversal means that the GTPase needs to be fused to a mitochondrial 
targeting sequence on its N-terminus instead of its C-terminus, which lends better to the use of a N-terminal 
TOM70 sequence than a C-terminal MAO sequence (Backes et al., 2018; Iacovino et al., 2018). Previous 
work in our group has indicated that TOM70-HA-BirA*-Arf chimeras are not as effective as the MAO 
sequence tagged GTPases in MitoID experiments (personal communication, Munro Lab). Whether this 
discrepancy is due to the TOM70 targeting sequence (and why) remains unknown. However, the inability 
to accurately compare the Arf GTPases to the other small GTPases, has led us to exclude the Arf GTPases 
from the MitoID study. 
 
All in all, our MitoID adaptation of the BioID approach appears promising; we are able to identify both 
previously known and putative novel interactors for the well-characterised Rab5A. Next, we will examine 
several datasets generated by MitoID experiments and study whether this approach remains effective and 
accurate with other small GTPases of the Ras superfamily.  
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Chapter 3: Identifying small GTPase interactors by 
applying the MitoID approach 
 
3.1 Introduction 
 
The previous chapter has shown that the MitoID approach is an effective and accurate method to identify 
Rab5A effectors and regulators. By comparing triplicate runs of the GTP- and GDP-locked forms of 25 
different small GTPases, we were able to distinguish putative Rab5A interactors from non-specific 
background. Here, several of the other tested small GTPases are examined, with the aim of identifying 
novel effectors or regulators. 
 
 
3.2 Results 
 
In addition to Rab5A, we have performed MitoID experiments on 18 other Rab GTPases, and 6 other small 
GTPases – 3 from the Ras family, and 3 from the Rho family – all in their known or suspected GTP- and 
GDP-locked forms. Here, the results of Rab2A, Rab9A, Rab11A, and Rab11B will be thoroughly 
examined, in addition to the results of the small GTPases of the Ras and Rho families. The full datasets – 
both the raw Mass Spectrometry data, and the analysed data – are available in Supplementary Tables 2 and 
3. Furthermore, bubble plots of all GTP-locked GTPases not discussed below are available in 
Supplementary Figures 3.1 – 3.3, with the exception of Rab1A/B which will be discussed in detail in 
Chapter 5. 
 
 
3.2.1 Rab2A 
Rab2A is a highly conserved Rab GTPase which is mainly localised on the Golgi membrane, where it is 
proposed to be a key regulator of ER-to-Golgi trafficking. More recent studies have suggested that Rab2 is 
also involved in late endosomal and lysosomal pathways (Ailion et al., 2014; Lund et al., 2018).  
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Examining the bubble plot when aligned to GTP-locked Rab2A, several known interactors were present, 
including the golgins GOLGA2/GM130 and golgin-45, the coiled-coil protein CCDC186 and the dynein 
adapter Bicaudal D (BICD) (Fig. 3.1A) (Ailion et al., 2014; Ding et al., 2019; Gillingham et al., 2014). In 
addition, several high-scoring proteins are suspected to be involved in membrane trafficking, such as GBF1, 
RUFY1, USO1/p115 and ARFGEF3/BIG3 (Cormont et al., 2001; Grabski et al., 2012; Richter et al., 2014; 
X. Zhao et al., 2006).  Furthermore, the Rab GAP TBC1D25 is also identified as interacting with Rab2A, 
which aligns with a previous report that TBC1D25, in addition to Rab33B, also has GAP activity on Rab2A 
(Itoh et al., 2006). Finally, in addition to a number of proteins involved with centrosomes and cilia (such as 
CEP250 and centrobin), we identified several proteins of unknown function (including STAMBPL1 and 
FAM184A) (Ambuj Kumar et al., 2013; Ogungbenro et al., 2018). The argininosuccinate synthetase 
enzyme (ASS1) seems unlikely to be valid, though it is interesting that it appears to bind specifically and 
consistently to GTP-locked Rab2A. 
 
Interestingly, even though a study initially identified p115 as a potential Rab2 binding partner, direct yeast 
two-hybrid studies revealed that they do not directly interact (Short et al., 2001). Short and colleagues 
suggest that p115 was initially found to bind to Rab2 since both are known to bind to GM130, and it can 
thus act a bridge between the proteins (N. Nakamura et al., 1997). This highlights the importance of 
performing further validations after identifying potential binding partners, in particular when using 
techniques such as proximity labelling or other large-scale indirect binding experiments. 
 
Further validations were performed for ARFGEF3, a member of the Sec7-domain family of Arf GEFs 
without GEF activity, and STAMBPL1, a deubiquitinase that localises to early endosomes (Y.-A. Chen et 
al., 2014; M. Nakamura et al., 2006). Firstly, we validated the interaction with ARFGEF3 by applying 
wildtype HEK293T lysate to beads coated with bacterially expressed Rab2A, and observing clear binding 
in the GTP-locked samples (Fig. 3.1B, data obtained by Alison Gillingham). For STAMBPL1, the mass 
spectrometry data was confirmed by Western blotting the MitoID samples, where the protein was found to 
be enriched in GTP-locked Rab2A samples (Fig 3.1C). Next, this interaction was validated by applying 
wildtype HEK293T lysate to bacterially expressed Rab2A, in a similar manner as was done for ARFGEF3 
above (Fig. 3.1D, data obtained by Alison Gillingham). Furthermore, after expressing and isolating GFP-
STAMBPL1 and GST-Rab from E. coli, we observed direct binding between STAMBPL1 and GTP-locked 
Rab2A, but not with GDP-locked Rab2A or Rab5A (Fig. 3.1E, data obtained by Alison Gillingham). In 
addition, confocal imaging of GFP-tagged ARFGEF3 and STAMBPL1 co-expressed with GTP-locked 
Rab2A chimera, showed distinct re-localisation of the interactors to the mitochondria (Fig. 3.1F, G, data 
obtained by Alison Gillingham). 
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Figure 3.1. Rab2A MitoID analysis has identified ARFGEF3 and STAMBPL1 as novel Rab2A effectors. (A) Bubble plot aligned for 
the third replicate of GTP-locked Rab2A. Shown here are all three biological replicates of BirA* (BirA-HA-MAO control) and both Rab2A 
chimeras, though GTP-locked Rab2A was compared against all other GTPases in the full data list to generate this plot. Circle area 
corresponds to WD-score. The top 35 hits are shown. Yellow column indicates alignment. (B) Affinity chromatography in which HEK293T 
lysate was washed over GST-tagged Rab2A-coated beads. Resulting eluates were probed against ARFGEF3, the Coomassie staining shows 
expression levels of the baits. Wildtype HEK293T lysate is used as input. Data obtained by Alison Gillingham. (C) Western blots of MitoID 
samples of GTP- and GDP-locked Rab2A and Rab9A. Blots were probed with STAMBPL1 and HA (internal chimera epitope tag) 
antibodies. Asterisk (*) indicates non-specific background band of the HA antibody. Input: HEK293T lysate expressing GTP-locked 
Rab2A chimera. (D) Affinity chromatography of GST-tagged Rab2A and Rab6A with wildtype HEK293T lysate, resulting samples probed 
for STAMBPL1. Input: wildtype HEK293T lysate. Coomassie stained gels show bait expression levels. Data obtained by Alison 
Gillingham. (E) Coomassie stained gel of a direct binding experiment of bacterially-expressed GST-Rab2/5 with purified GFP-
STAMBPL1. Indicated are GFP-STAMBPL1 and GST-Rab bands. Data obtained by Alison Gillingham. (F,G) Confocal micrographs of 
HeLa cells expressing GFP-ARFGEF3 (F) or GFP-STAMBPL1 (G), either co-expressed with GTP-locked Rab2A chimeras (lower panels) 
or co-stained with a Golgi marker (ZFPL1). Data obtained and analysed by Alison Gillingham. (H) Affinity chromatography of GST-
tagged Rab2A and Rab6A with wildtype HEK293T lysate, probed with anti-GBF1. Input: wildtype HEK293T lysate. Data obtained by 
Alison Gillingham. 
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In addition to ARFGEF3 and STAMBPL1, we further examined the high scoring hit GBF1, a Sec7 domain 
containing Arf GEF that mainly functions at the Golgi and TGN (Bhatt et al., 2019). However, this 
interaction could not be validated by GST affinity chromatography (Fig. 3.1H, data obtained by Alison 
Gillingham).  While this could mean that the interaction identified by MitoID is not a true interaction, this 
is not necessarily the case. Drawbacks to validating MitoID-identified interactions by GST-affinity 
chromatography will be examined in the discussion of this chapter.  
It should be noted though, that although GBF1 is mainly known for its role in the secretory pathway, it has 
recently been reported to have a role in mitochondrial positioning and reorganisation (Walch et al., 2018). 
Even though this mitochondrial function of GBF1 might seem to indicate that this protein is simply 
mitochondrial background, this is not likely since the protein is not found consistently throughout all 
mitochondrially localised baits (Sup. Tables 2 and 3). 
 
Together, these findings confirm that analysing MitoID experiments across large panel of small GTPases, 
allows us to identify of both previously known and novel putative Rab2A interactors. Furthermore, two 
relatively uncharacterised proteins – ARFGEF3 and STAMBPL1 – were validated to be true novel Rab2A 
effectors, highlighting the efficiency and large potential of this MitoID screen. 
 
3.2.2 Rab9A 
Active Rab9A is mainly associated to endosomes, entering the endosomal pathway at the stage between 
early Rab5-positive and late Rab7-positive endosomes (Kucera et al., 2016). In addition to the known 
Rab9A effector GCC2/golgin-185, we were able to identify numerous proteins known to be involved with 
the endocytic pathway. These proteins include the coiled-coil scaffolding protein GRIPAP1/GRASP1, the 
endosomal and lysosomal sorting nexins SNX13 and SNX14, and the A-kinase anchoring proteins and Arf 
GEFs BIG1/ARFGEF1 and BIG2/ARFGEF2 (Fig. 3.2A) (Akizu et al., 2015; Boal & Stephens, 2010; 
Henne et al., 2015; Hoogenraad et al., 2010; Hoogenraad & Sluijs, 2010; STINTON et al., 2005). 
Interestingly, while BLOC-3 (Biogenesis of Lysosome-related Organelles Complex-3) is reported to 
interact with Rab9A, we find GTP-locked Rab9A to interact with HPS3, a subunit to the related BLOC-2 
(Fig. 3.2A) (Gautam et al., 2004; Kloer et al., 2010). 
 
The dynein interactor NDE1/NudE is also identified as a putative Rab9A interactor (Fig. 3.2A). 
Interestingly, although NDE1 has previously been recorded to interact with Rab9B by yeast two-hybrid, 
co-precipitation did not result in nucleotide-specific binding (Bradshaw & Hayashi, 2016).  
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Figure 3.2. Analysis of Rab9A MitoID experiments have identified NDE1 and HPS3 as novel effectors. (A) Bubble plot aligned for 
the second replicate of GTP-locked Rab9A. Shown here are all three biological replicates of BirA* (BirA-HA-MAO control) and both 
Rab9A chimeras, though GTP-locked Rab9A was compared against all other GTPases in the full data list to generate this plot. Circle area 
corresponds to WD-score. The top 35 hits are shown. Yellow column indicates alignment. (B) Western blots of MitoID samples from 
Rab9A-chimeras, probed with antibodies against NDE1 and HA. Asterisk (*) indicates HA antibody background band. Input: HEK293T 
lysate expressing GTP-locked Rab9A chimera. (C) Affinity chromatography Coomassie-stained gel of GST-Rab9A with wildtype 
HEK293T lysate, showing both GST-Rab9A levels and His6-tagged NDE1. The lower panel shows a Western blot of this sample probed 
with anti-His. Data obtained by Alison Gillingham. (D) Affinity chromatography of GST-tagged Rab9A, using HEK293T lysate expressing 
FLAG-HPS3 cell lysate. Blot probed for FLAG to show FLAG-HPS3, Coomassie gel showing GST-Rab levels in lower panel. Data 
obtained by Alison Gillingham. (E) Confocal micrographs of HeLa cells co-expressing GDP- or GTP-locked Rab9A-chimeras and FLAG-
HPS3, and stained for giantin (Golgi). Data obtained and analysed by Alison Gillingham. (F) Western blot of MitoID samples using Rab9A 
chimeras, probed against SIPA1L2. Input: HEK293T lysate expressing GTP-locked Rab9A chimera (G) Affinity chromatography of 
bacterially purified GST-tagged Rab9A with wildtype HEK293T lysate, probed against SIPA1L2. Input: wildtype HEK293T lysate. Data 
obtained by Alison Gillingham. 
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Finally, the Rap GAP SIPA1L2 is consistently in the top 3 highest WD-scoring proteins (Fig. 3.2A). A 
recent study showed SIPA1L2 to be involved in neuronal retrograde trafficking of autophagosomal 
organelles called amphisomes, and several studies link variations in the SIPA1L2 gene to Parkinson’s 
disease or Charcot-Marie-Tooth disease type 1A, though the function of SIPA1L2 in non-neuronal cells is 
unknown (Andres-Alonso et al., 2019; Tao et al., 2019). 
 
Putative effectors SIPA1L2, HPS3, and NDE1 were chosen for further validation. Firstly, a Western blot 
of the Rab9A MitoID samples confirmed the presence of NDE1 in the GTP-locked Rab9A sample, thereby 
validating the mass spectrometry data (Fig. 3.2B). Next, GST-Rab9A was purified from E. coli and mixed 
with E. coli lysate expressing His6-tagged NDE1. NDE1 was found to bind to purified GTP-locked Rab9A, 
indicating a direct interaction between the two proteins (Fig. 3.2C, data obtained by Alison Gillingham). 
Next, the interaction with HPS3 was examined by performing a similar affinity chromatography 
experiment, but this time using lysate of HEK293T cells expressing epitope-tagged HPS3 since no effective 
HPS3 antibodies were available. A clear enrichment of HPS3 was observed with the GTP-locked Rab9A 
compared to GDP-locked Rab9A, validating the interaction of the novel effector with Rab9A (Fig. 3.2D, 
data obtained by Alison Gillingham). Finally, this interaction was corroborated by the recruitment of 
epitope-tagged HPS3 to GTP-locked mitochondrial Rab9 chimeras (Fig. 3.2E, data obtained by Alison 
Gillingham).  
 
The presence of the putative interactor SIPA1L2 in MitoID samples was confirmed by Western blot, 
showing a clear band near the expected size of 190kDa (Fig. 3.2F). This interaction was examined further 
in vitro by mixing wildtype HEK293T lysate with bacterially expressed and purified GST-Rab9A and 
performing a Western blot (Fig. 3.2G, data obtained by Alison Gillingham). However, even though the 
Western blot shows a clear band that is present only in GTP-locked Rab9A and not in GDP-locked Rab9A, 
it is not of the expected size but rather much smaller (approximately 45 kDa). Conversely, no SIPA1L2 
bands are present at the expected size of 190 kDa. Further research needs to be performed to investigate 
whether this is a true interaction, for instance by repeating this experiment with overexpressed epitope-
tagged SIPA1L2 in the HEK293T lysate. 
 
Taken together, this data shows that MitoID can effectively identify new interactors for a Rab GTPase that 
previously had few known effectors, in this case Rab9A. 
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3.2.3 Rab11A/B 
Rab11 is a conserved and relatively well-characterised Rab GTPase, mostly known to regulate membrane 
trafficking at recycling endosomes and the TGN (Wandinger-Ness & Zerial, 2014). It has two main 
paralogues, Rab11A, Rab11B, as well as the more distantly related Rab11C/Rab25 which we will not focus 
on in this study. While Rab11A is ubiquitously expressed, Rab11B is mostly expressed in the brain, testes 
and heart (Lai et al., 1994). Previous studies have shown that, despite having 89% amino acid sequence 
homology, Rab11A and B not only reside in different vesicular compartments, but are also able to 
differentially regulate endosomal sorting (Grimsey et al., 2015; Lapierre et al., 2003). Furthermore, a recent 
study found that deletion of Rab11A led to distinct morphological and functional defects of the endo-
lysosomal system, whereas Rab11B did to a lesser extent (Zulkefli et al., 2019). To further examine the 
overlap and/or distinction of the two main Rab11 paralogs, we have included both proteins in our MitoID 
screen. 
 
Among the top hits for Rab11A are numerous known Rab11 effectors, such as Rab3IP/Rabin8, 
Rab3IL1/GRAB, TBC1D12, AKAP10/D-AKAP2, and several subunits of the exocyst complex (namely 
EXOC3/Sec6 and EXOC5/Sec10) (Eggers et al., 2009; Horgan et al., 2013; Oguchi et al., 2017; Vetter et 
al., 2015; Welz et al., 2014) (Fig. 3.3A,B). Furthermore, WDR44 and RELCH/KIAA1468, two known 
Rab11 interactors with unknown function, and two known Rab11 GAPs, Evi5 and RABGAP1, are also 
identified (Fuchs et al., 2007; Häsler et al., 2020; Sobajima et al., 2018; C J Westlake et al., 2007). 
Interestingly, oxysterol binding protein 1 (OSBP) was recently identified as a RELCH-interactor, with 
RELCH mediating the interaction between OSBP and Rab11A (Sobajima et al., 2018). While we do not 
detect OSBP in our dataset, we do detect OSBP-like proteins OSBPL9 and OSBPL11 as high-scoring hits 
in GTP-locked Rab11A samples (Fig. 3.3A,B). 
 
In addition to previously known Rab11A effectors, we were able to identify a number of proteins known to 
be involved with endosomal trafficking but not previously known to interact with Rab11A. These include 
the Rab4 and Rab14 effector RUFY1, the CORVET subunit VPS8, and the Syntaxin 6 binding partner 
UHRF1BP1L, as well as the previously discussed Rab5 interactors RABEP1 and RABGEF1 (Kunita et al., 
2007; Markgraf et al., 2009; Otto et al., 2010; Yamamoto et al., 2010). Furthermore, we find 
ARFGEF1/BIG1 to bind to GTP-locked, but not GDP-locked, Rab11A. Even though this interaction hasn’t 
yet been reported in mammalian cells, the yeast homologue of ARFGEF1, Sec7, is a known effector of the 
yeast Rab11 homologue, Ypt31/32 (McDonold & Fromme, 2014) (Fig. 3.3A,B). 
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Figure 3.3. The MitoID approach highlights interactome differences and similarities between Rab11 paralogues. (A) Bubble pot of 
MitoID experiments of the whole panel of studied GTPases, aligned for GTP-locked Rab11A. Circle area corresponds to average WD-
score (average of the biological triplicates). T: GTP-locked mutant, D: GDP-locked mutant. BirA* is an empty mitochondrial control. Top 
40 hits are shown. Yellow column indicates alignment. (B) Bubble plot aligned for the third replicate of GTP-locked Rab11A. Shown here  
 
          Legend continued on next page. 
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are all three biological replicates of BirA* (BirA-HA-MAO control) and both Rab11A chimeras, though GTP-locked Rab11A was 
compared against all other GTPases in the full data list to generate this plot. Circle area corresponds to WD-score. The top 35 hits are 
shown. Yellow column indicates alignment (C) Affinity chromatography of bacterially expressed and purified GST-tagged Rab5A and 
Rab11A with wildtype HEK293T lysate, probed with ALS2 antibody. (D) As (B) but with Rab11B chimeras and aligned for GTP-locked 
Rab11B. 
 
 
 
Interestingly, although the protein UHRF1BP1L remains largely uncharacterised, it is found to interact with 
several small GTPases in their GTP-locked forms (mainly Rab1B, Rab5A, Rab6A, Rab10, Rab11A and 
Rab11B) (Fig. 3.3A). Similarly to UHRF1BP1L, Rabaptin5 is also detected in multiple GTP-locked Rab 
GTPases, as is RABGAP1 and several other interactors such as RABGAP1L and AKAP10, indicating 
overlap of function between these Rab GTPases (Fig. 3.3A). 
 
Furthermore, one of the highest scoring hits in GTP-locked Rab11A samples is the Rab5 GEF and Rac1 
effector ALS2/Alsin (Fig. 3.3A,B). Although Alsin has been found to play a role in the regulation of the 
mitochondrial stress response (Hsu et al., 2018), it is highly unlikely that this is the reason that it is present 
in our dataset, since the protein is solely present in GTP-locked Rab11A and GDP-locked Rab5A and not 
across the whole panel, and we have formerly shown that our experimental set up does not induce 
mitochondrial stress, as was examined in the discussion of the previous chapter (Sup. Table 2 and 3, Fig. 
2.2). The interaction between ALS2 and Rab11A was validated by affinity chromatography using 
bacterially expressed and purified GST-tagged Rab11A and wildtype HEK293T cell lysate (Fig. 3.3C, 
performed by Alison Gillingham). 
 
Examining the top hits for Rab11B, we again identify many of the previously mentioned Rab11A 
interactors, such as RELCH, UHRF1BP1L, RABGAP1/1L, VPS8, ARFGEF1, and the exocyst components 
(Fig. 3.3D). However, when comparing the two Rab11 paralogues, we find that almost all effectors seem 
to have higher spectral counts for Rab11A than Rab11B (Fig. 3.3A). In particular Rab3IL1, AKAP10, Alsin 
and RABGEF1 stand out for being almost exclusively present in the Rab11A samples. Exceptions to this 
are RELCH, ARFGEF1, and RABEP1, which appear to interact with similar strengths to both paralogues, 
and ARFGEF2/BIG2, which is present in higher amounts in Rab11B samples than in Rab11A (Fig. 3.3A, 
Fig. 3.4A). Finally, RABEP1 and RABGEF1 are known to interact and form a protein complex, yet they 
do not seem to follow the same binding patterns to the Rab11 paralogues; Rab11A appears to interact with 
both RABEP1 and RABGEF1 at similar strengths, whereas Rab11B appears to interact only with RABEP1 
(Fig. 3.3A). This suggests separate and additional functions for both proteins, besides the known Rab4-
Rab5 activation bridge (Horiuchi et al., 1997; Kälin et al., 2015).  
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When comparing the top hits for Rab11A and B, we also identified several proteins that appear to bind to 
Rab11B alone, such as alpha-II spectrin (SPTAN1), which is involved in numerous neurological conditions, 
and DNAJC13/RME-8, an endocytic protein involved in Parkinson’s disease and recently found to function 
as an autophagy regulator (Besemer et al., 2020; Girard et al., 2005; Roosen et al., 2019; Syrbe et al., 2017) 
(Fig. 3.3D, Fig. 3.4A). Carbonyl reductase 1 (CBR1) is unlikely to be a true Rab11B interactor due to its 
cellular function and the fact that it binds to both the GTP- and GDP-locked mutants, though it is interesting 
that it binds almost exclusively and consistently to Rab11B, Rac1, and Rheb (Sup. Tables 2 and 3). 
 
Furthermore, Rab11B, but not Rab11A, interacts with Rab5A, Rab8A and Rab10 (Fig. 3.3D, Fig. 3.4A). 
Interestingly, Rab11A and Rab8A are coupled by Rabin8/RAB3IP –Rabin8 is a Rab11A effector and a 
Rab8A GEF, and thus mediates the Rab11A-Rab8A cascade (Vetter et al., 2015). Even though a 
biochemical interaction between Rab11B and Rabin8 has not yet been reported, and the MitoID data 
suggests a very reduced interaction affinity compared to Rab11A, Rab11B has shown some with degree of 
co-localisation with Rabin8 (Christopher J Westlake et al., 2011). Moreover, Rabin8 also activates Rab10, 
which, similarly to Rab8A, is very enriched in GTP-locked Rab11B samples compared to Rab11A and thus 
shows opposing interaction patterns (Fig. 3.4A) (Homma & Fukuda, 2016).  
 
Even though Rab11A and Rabin8 are known to be in a complex with the Rab11-interacting protein 
Rab11FIP3 (FIP3), this latter protein is not detected in our study (Vetter et al., 2015). The absence of FIP3 
in our dataset could be due to several reasons. One, FIP3 is simply too far away from the BirA* in our 
Rab11 chimeras, which prevents the protein from being biotinylated by the free biotin released by the 
BirA*. Two, the lysines of FIP3 are almost exclusively localised at the C-terminal domain, which is also 
the Rab11A binding region (Vetter et al., 2015). It is possible that the lysines are not available for 
biotinylation because they are blocked by the binding of Rab11. And finally, perhaps an intrinsic mass 
spectrometry fault has obstructed the identification of FIP3. In this specific case the latter seems most likely, 
since a recent study also failed to detect FIP3 by performing mass spectrometry on immunoprecipitated 
Rab11A (Walia et al., 2019). Notably, the same study observed that the interaction between FIP3 and 
Rab11A increases the binding affinity of Rabin8 fourfold, which makes the likelihood of FIP3 being present 
in this sample likely.  
 
Interestingly, WDR44 is found to compete with FIP3 for the canonical binding site on Rab11, suggesting 
that WDR44 could interfere with the interaction between Rabin8 and Rab11A. In our study, WDR44 is 
found in similar amounts in both Rab11A and B, suggesting it has a similar role for both Rab11 paralogues 
(Fig. 3.3A) (Walia et al., 2019). 
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While Rab11B and Rab5A are occasionally found to function in similar pathways, an interaction between 
the two GTPases has as of yet remained unreported (Anand et al., 2020; Pavlos & Jahn, 2011). One 
possibility is that the two GTPases are involved in a Rab cascade with the Rab5A GEF ALS2. However, it 
would be more likely for this potential cascade to include Rab11A than Rab11B, since our data suggests 
that ALS2 preferentially interacts with Rab11A. Further research is necessary to uncover this interaction 
further.  
 
 
Figure 3.4. Different detection methods lead to discrepancies between identified Rab11A and Rab11B interactomes. (A) Plot of 
WD-scores of potential interactors of GTP-locked Rab11A and Rab11B. The WD-scores shown represent means of triplicate biological 
repeats. Several potential or known interactors that have higher WD-scores in one of the paralogues are highlighted in orange and labelled, 
as is RELCH which has high scores for both paralogues. (B) Western blots of MitoID samples of GTP- and GDP-locked Rab11A and 
Rab11B, probed with RELCH, OSBPL9, BIG2, ALS2 and HA antibodies, as indicated. 
 
 
With the aim to validate the differences and similarities between the binding patterns of Rab11A and 
Rab11B, Western blots were performed on the MitoID samples and probed against RELCH, OSBPL9, 
BIG2, and ALS2 (Fig. 3.4B). While the mass spectrometry data shows OSBPL9 and ALS2 to be strongly 
enriched in Rab11A samples as opposed to Rab11B, the Western blots of the same samples show minimal 
differences in binding patterns (Fig. 3.4A,B). The very slight enrichment of OSBPL9 and ALS2 in Rab11A 
samples is likely due to the slightly higher expression levels of Rab11A chimeras as opposed to Rab11B 
(Fig. 3.4B, HA panel). This is corroborated by a similar level of RELCH enrichment in the Rab11A samples 
which mass spectrometry data have suggested are present in similar amounts in both paralogues (Fig. 3.4B). 
Contrarily, even though mass spectrometry detects higher levels of ARFGEF2/BIG2 in Rab11B samples 
compared to Rab11A, probing a Western blot for BIG2 again shows a slight enrichment in Rab11A samples 
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in line with chimera expression levels (Fig. 3.4A,B). Potential causes of the discrepancy between mass 
spectrometry output and biochemical analysis of the same samples will be examined in the Discussion of 
this chapter.  
 
Together, this shows that the MitoID approach and subsequent analyses can highlight both similarities and 
differences between the interactomes of paralogues. However, we report discrepancies between mass 
spectrometry output and Western blotting of the same samples, which remains unexplained. Differences 
between detection methods highlight the necessity of validating the interactions through different 
approaches. 
 
3.2.4 Rho family GTPases 
Rab GTPases are one of five families of the Ras GTPase superfamily, the four other families being Ras, 
Rho, Ran and Arf GTPases (Wennerberg et al., 2005). To examine whether the MitoID approach is 
applicable to other small GTPases, we have tested the approach with three Rho family GTPases and three 
Ras family GTPases. 
 
The Rho family of GTPases act mainly in the organisation and regulation of the actin cytoskeleton, which 
drive processes such as cell migration and morphogenesis (Hall, 2012). The MitoID approach was tested 
on three of the best characterised family members RhoA, Rac1, and Cdc42, using their known or predicted 
GTP- and GDP-locked mutants. 
 
Cdc42 plays a large role in the regulation of actin dynamics and cell polarity, and thus affecting large scale 
processes like morphogenesis (Farhan & Hsu, 2015; Pichaud et al., 2019; Watson et al., 2016). The top hits 
for GTP-locked Cdc42 contains many known Cdc42 effectors, such as kinases (TNK2/ACK1, PAK2/4, 
and CDC42BPB/MRCKB), actin regulators (WASL and CDC42EP1/2/4 (BORG5/1/4), and scaffolding/ 
adaptor proteins (IQGAP1/2 and BAIAP2/IRSp53) (Fig. 3.5A) (Carlier et al., 1999; Farrugia & Calvo, 
2016; Ha & Boggon, 2018; Hedman et al., 2015; Jung & Traugh, 2005; Lim et al., 2008; Moncrieff et al., 
1999; Yokoyama & Miller, 2003). Known Cdc42 GAPs ARHGAP31/CDGAP and ARHGAP32/RICS are 
also high scoring hits for GTP-locked Cdc42 (Lamarche-Vane & Hall, 1998; Okabe et al., 2003). The motor 
protein myosin18A is also identified to be a potential Cdc42 effector, and, although this specific interaction 
has not been reported yet, myosin18A is reported to interact with the known Cdc42 effector MRCKB (Z. 
Zhao & Manser, 2015). Furthermore, KCTD3, mostly reported for its role in neurocognitive disease and 
selecting proteins for ubiquitination by cullin-RING ligases, is strongly enriched in GTP-locked Cdc42 
samples (Teng et al., 2019). Interestingly, another KCTD family member, SHKBP1, is also found to interact 
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with active Cdc42 (Teng et al., 2019). Finally, several known regulators of other members of the Rho family 
are high scoring hits for Cdc42, such as ARHGEF11, ARHGEF12, and PLEKHG4 (Gupta et al., 2013; 
Kourlas et al., 2000; Rümenapp et al., 1999) (Fig. 3.5A). For instance, the RhoA GEF ARHGEF11 is 
enriched in both GTP- and GDP-locked Cdc42 samples. Interestingly, ARHGEF11 has been shown to 
interact with PAK4, though PAK4 only interacts with GTP-locked Cdc42; together this could suggest 
distinct roles of ARHGEF11 on both activity states of Cdc42 (Barac et al., 2003).  
 
 
 
Figure 3.5. Identification of known and putative interactors of  GTPases from the Rho family. (A) Bubble plot aligned for the second 
replicates of GTP-locked Cdc42. Shown here are all three biological replicates of BirA* (BirA-HA-MAO control) and both chimeras of 
Cdc42, though GTP-locked Cdc42 was compared against all other GTPases in the full data list to generate this plot. Circle area corresponds 
to WD-score. The top 35 hits are shown. Yellow column indicates alignment. (B) as (A) but showing RhoA chimeras and aligned for the 
second replicate of GTP-locked RhoA. (C) as (A) but showing Rac1ΔC chimeras and aligned for the second replicate of GTP-locked 
Rac1ΔC. 
 
 
Similar to the other Rho family GTPases, RhoA functions by regulating the actin cytoskeleton (Nguyen et 
al., 2016). Numerous previously known effectors are detected in GTP-locked RhoA samples, which include 
kinases (PKN1, PKN3/PKNbeta and CIT/Citron), scaffolding/adaptor proteins (RTKN/Rhotekin, 
RTKN2/Rhotekin-2, and ANLN/Anillin), and phosphatases (INPPL1/SHIP2) (Fig. 3.5B) (Collier et al., 
2004; Ito et al., 2018; Kato et al., 2012; Madaule et al., 1995; Reyes et al., 2014; Shibata et al., 2001; F. 
Wang et al., 2017). Moreover, the known Rho GAPs ABR, ARHGAP32/GRIT, GMIP, and both isoforms 
of p190RhoGAP (ARHGAP5 and ARHGAP35), are identified to be present in either GTP-locked or both 
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GTP- and GDP-locked RhoA samples (ARESTA et al., 2002; T. H. Chuang et al., 1995; Héraud et al., 
2019; T. Nakamura et al., 2002). As for potential novel RhoA interactors, the Rac1 and Cdc42 effector 
IQGAP2 is strongly enriched in GTP-locked RhoA, which has so far remained unreported (Ozdemir et al., 
2018). Finally, other high scoring hits that are as of yet unreported to interact with RhoA include the Cdc42 
GEF DNMBP/Tuba, the sorting nexin SNX4, and several DNA or RNA binding proteins which are likely 
to be unspecific background (Fig. 3.5B) (Salazar et al., 2003).  
 
Rac1 also plays a role in actin polymerisation and cell migration (Nguyen et al., 2016), however, after initial 
application of the MitoID approach to Rac1 chimeras, a multitude of DNA or RNA binding proteins were 
detected independently of their nucleotide-state (Fig. 3.6A). For this analysis we used peak intensity data 
obtained from mass spectrometry and analysed this with the Perseus platform (Keilhauer et al., 2014). Here, 
intensities of the peptide spectra within the replicates of GTP-locked Rac1 are compared to the intensities 
of that peptide for all tested GDP-locked GTPases, which results in a fold enrichment and a statistical 
confidence for that enrichment. Plotting fold enrichment and statistical confidence against each other results 
in so called ‘volcano plots’, which highlight proteins that sit high on both axes and are thus proteins that 
are likely to be specific interactors. In this analysis, GTP-locked Rac1 was compared against all GDP-
locked baits with the aim of reducing the chance of incorrectly assigning proteins as background due to 
them being true interactors to multiple baits. This is based on the grounds that effectors generally bind only 
to the active/GTP-locked form and not to the inactive/GDP-locked form (Zerial & McBride, 2001). The 
GDP-locked baits were also compared to the other GDP-locked baits, because it is very unlikely that GEFs 
regulate multiple Rab GTPases due to the fact that several factors together contribute to GEF specificity 
(Pylypenko et al., 2017). 
 
Several small GTPases in the Rho and Ras families have a C-terminal polybasic region, which promotes 
the association with membranes and can also serve as a nuclear localisation signal (Williams, 2003). Rac1 
contains such a polybasic region, and is now brought to the ectopic and less acidic location of the outer 
mitochondrial membrane, which could lead the polybasic stretch to associate with nucleic acids. To test 
this, we repeated the MitoID approach with Rac1 lacking the C-terminal basic region (Rac1ΔC). Comparing 
these two MitoID experiments, we indeed detected fewer nucleic acid binding proteins with the Rac1ΔC 
version, without affecting the effector interactions, and thus this version was used for further analysis (Fig. 
3.6B).  
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Figure 3.6. Deletion of Rac1 C-terminal polybasic stretch reduces the number of detected DNA/RNA binding proteins. (A,B) 
Volcano plots of GTP-locked Rac1 (A) and GTP-locked Rac1ΔC (Rac1 from which six basic residues have been deleted (Δ183-188)) 
plotted against all tested GDP-locked GTPases. Data was generated by MitoID proximity labelling and consecutive streptavidin affinity 
chromatography experiments, after which the peak intensity data was obtained through mass spectrometry. Red: known effectors, blue: 
known GAPs, green: DNA/RNA binding proteins. Data analysed by Alison Gillingham, plots generated by Sean Munro. 
 
 
The top hits of GTP-locked Rac1ΔC contain numerous previously known Rac1 effectors, including kinases 
(PAK2, CDC42BP/MRCK), scaffolding/adaptor proteins (IQGAP1/2) and actin regulators 
(WAVE1/WASF2, WAVE2/WASF2, ABI1/2, CYFIP1/Sra1, and CYFIP2/PIR121)(B. Chen et al., 2017; 
Dubielecka et al., 2010; Flaiz et al., 2009; Hedman et al., 2015; Ozdemir et al., 2018; Z. Zhao & Manser, 
2015) (Fig. 3.5C). Furthermore, all the components of the GIT/PIX complex (GIT1, GIT2, 
ARHGEF6/PIXA, and ARHGEF7, PIXB) are specifically enriched in GTP-locked Rac1ΔC(W. Zhou et al., 
2016) (Fig. 3.5C). Besides numerous previously identified RhoA effectors such as Anillin and 
INPPL1/SHIP2, the Nance-Horan syndrome (NHS) protein family member, NHSL1, was identified as one 
of the putative novel Rac1 effectors. Interestingly, the NHS family proteins contain a WAVE homology 
domain, and function in actin remodelling and cell morphology (Brooks et al., 2010). 
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3.2.5 Ras family GTPases 
The Ras family of GTPases function mainly in the regulation of signalling cascades, cell proliferation and 
differentiation, and we have selected three of the well characterised members for further analysis; N-Ras, 
RalB, and Rheb (Wennerberg et al., 2005). 
 
The Ras family proteins are quite extensively studied due to their activity as oncogenes, and we are able to 
identify a number of known Ras effectors in our GTP-locked N-Ras samples (Hobbs et al., 2016). Among 
the highest scoring hits are the kinases RAF1/c-RAF and BRAF1, the Ras GAP neurofibromin/NF1, and 
Rap GEFs RAPGEF2/CNrasGEF and RAPGEF6/RA-GEF-2 (Fig. 3.7A) (Gao et al., 2001; G. A. Martin et 
al., 1990; Pham et al., 2000; Weber et al., 2001). Furthermore, the tumour suppressor RASSF5/NORE1A 
has been reported to bind to N-Ras in a GTP-dependent manner, which we can confirm by RASSF5 
enrichment in two out of three GTP-locked N-Ras samples (Zinatizadeh et al., 2019) (Fig. 3.7A). UniProt 
has annotated CBARP/C19orf26 as a voltage-dependent calcium channel beta subunit-associated 
regulatory protein, although no reports have been published on the exact function of CBARP or how it 
could relate to N-Ras signalling. In addition, two centrosomal proteins are enriched in N-Ras samples; 
CEP104, involved in ciliogenesis, is specifically present in GTP-locked N-Ras, whereas CEP192, involved 
in centrosome maturation and spindle assembly, is enriched in both GTP- and GDP-locked samples (Fig. 
3.7A) (Gomez-Ferreria & Sharp, 2008; Tammana et al., 2013). 
 
The Ral family of GTPases regulate several key cellular processes such as exosome secretion, cell 
migration, and gene expression (Gentry et al., 2014; Hyenne et al., 2016). Since RalB is known to interact 
with the exocyst, the high degree of enrichment of several subunits (EXOC6, 7, and 8) and presence of 
many others (EXOC1, 2, 3, 4, 5) in our GTP-locked RalB samples is no surprise (Fig. 3.7B, Sup. Tables 2 
and 3) (Fenwick et al., 2010; Moskalenko et al., 2003; Rossé et al., 2006). Other high scoring hits are the 
known effector RLIP76/RalBP1, its binding partner REPS1, and two known Ral GAPs (RALGAPA1/2 and 
RALGAPB) (Fenwick et al., 2010; Shirakawa et al., 2009; Yamaguchi et al., 1997). Interestingly, we detect 
high amounts of N-Ras in GTP-locked RalB samples but not in GDP-locked samples, and, contrarily, we 
do not observe any RalB in the N-Ras samples (Fig. 3.7A,B). It has been reported that Ras and Ral are 
involved in a GTPase cascade, in which active Ras binds to the Ral GEFs RGL1 and 2 which activate RalB 
(Zago et al., 2018). However, intriguingly, the aforementioned Ral GEFs are not identified in our dataset. 
It is unclear whether RGL1 and 2 are not detected by mass spectrometry, or if there is another link between 
Ras and Ral that is as of yet unidentified. Finally, several other significant hits are DNA- and RNA-binding 
proteins, which are unlikely to be true interactors.  
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Figure 3.7. Identification of known and putative interactors of GTPases from the Ras family. (A) Bubble plot aligned for the second 
replicate of GTP-locked N-Ras. Shown here are all three biological replicates of BirA* (BirA-HA-MAO control) and both chimeras of N-
Ras, though GTP-locked N-Ras was compared against all other GTPases in the full data list to generate this plot. Circle area corresponds 
to WD-score. The top 35 hits are shown. (B) as (A) but showing RalB chimeras and aligned for the second replicate of GTP-locked RalB. 
(C) as (A) but showing Rheb chimeras and aligned for the third replicate of GTP-locked Rheb. (D) Bubble pot of MitoID experiments of 
the whole panel of studied GTPases, aligned for GTP-locked Rheb. Circle area corresponds to average WD-score (average of the biological 
triplicates). T: GTP-locked mutant, D: GDP-locked mutant. BirA* is an empty mitochondrial control. Top 40 hits are shown. Yellow 
columns indicate alignment. 
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Rheb is an activator of mTORC, controlling protein synthesis and cell growth, and thus it is reassuring that 
one of the highest scoring proteins we detect in the GTP-locked Rheb samples is the mTORC1 subunit 
Raptor/RPTOR (Fig. 3.7C) (Heard et al., 2014). Moreover, we find the tumour suppressor gene encoded 
subunits of the Rheb GAP complex, TSC1 and TSC2, as very significant hits (Manning & Cantley, 2003). 
Interestingly, a third subunit of this complex, TBC1D7, is not detected in our study. Perhaps, since TBC1D7 
is found to interact with the complex through TSC1, the protein is not proximal enough to the BirA* in our 
Rheb chimera to be biotinylated (Dibble et al., 2012). This is corroborated by TSC2 containing the active 
GAP domain, and TSC2 having significantly more spectral counts than TSC1 in our GTP-locked Rheb 
samples (Sup. Table 2, Fig. 3.7D shows scores) (Huang & Manning, 2008). Finally, one of the top scoring 
hits is Rab3C (Fig. 3.7C). Although it is only detected by 4 spectral counts, Rab3C is consistently present 
throughout the three replicates in GTP-locked and not in GDP-locked Rheb samples. It is not consistently 
detected with other baits, which suggests it could be a true interactor (Fig. 3.7D). There is no known link 
between active Rheb and Rab3C, with Rab3C mostly functioning on synaptic and secretory vesicles, and 
more research needs to be done to investigate this putative interaction further (Schlüter et al., 2002). Finally, 
even though Ral and Rheb proteins have been shown to both work on mTOR signalling and the TSC1/TSC2 
complex, there is no clear overlap between their MitoID results (T. D. Martin et al., 2014). 
 
Taken together, we are able to identify both known and novel potential interaction partners for all the tested 
Rho and Ras family members. In addition, we have detected both numerous GTPase-specific interactors as 
well as certain overlapping interactors between the members of each GTPase family. This shows that the 
MitoID approach is successful in identifying effectors of different families of small GTPases. 
 
3.2.6 The MitoID approach allows for identification of small GTPase GEFs  
As previously mentioned, there are two broad categories of GTPase regulators: the GTP bound to small 
GTPases is hydrolysed by GAPs (GTPase activating proteins), whereas GEFs (guanine nucleotide exchange 
factors) reactivate the GTPase by catalysing the dissociation of GDP and the association of a free GTP 
molecule. GEFs have been shown to interact more strongly with the nucleotide-free or GDP-associated 
form than with the GTP form, which means that mutations that interfere with GTP-binding should show an 
increase of exchange factor binding (Koch et al., 2016; Langemeyer et al., 2014; Müller & Goody, 2017). 
Since the conserved P-loop is necessary for GTP-binding, we have used mutations where the serine or 
threonine is replaced by an asparagine. Similar mutations have shown to both prevent GTP-binding as well 
as reduce affinity for GDP, which makes these mutations a hybrid between GDP-bound and nucleotide-
free forms (John et al., 1993; Koch et al., 2016). Performing the entire MitoID screen on mitochondrially-
localised chimeras with these mutations, we aimed to identify known GEFs and perhaps identify new 
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candidates. Contrary to our successful GTP-locked Rab results, it appeared to be more challenging to 
identify GEFs using the GDP-locked Rab GTPases, with more candidates identified with the GDP-locked 
GTPases of the Rho and Ras family. Bubble plots of GDP-locked GTPases not discussed below are 
available in Supplementary Figures 3.4 - 3.6, with the exception of Rab1A/B which will be discussed in 
detail in Chapter 5. 
 
Focusing on the Rab GTPases discussed above for their GTP-locked forms, GDP-locked Rab2A showed 
specific enrichment of the autophagy regulator CLEC16A, which has previously been reported with the C. 
elegans homologue (GOP-1) activating Rab2A homologue UNC-108 (Fig. 3.8A) (Tam et al., 2017; Yin et 
al., 2017). 
 
 
 
Figure 3.8. Analysis of GDP-locked Rab GTPases illuminates putative novel Rab regulators. (A) Bubble plot aligned for the third 
replicate of GDP-locked Rab2A. Shown here are all three biological replicates of BirA* (BirA-HA-MAO control) and both chimeras of 
Rab2A, though GDP-locked Rab2A was compared against all other GTPases in the full data list to generate this plot. Circle area 
corresponds to WD-score. The top 35 hits are shown. Yellow column indicates alignment. (B) as (A) but showing Rab5A chimeras and 
aligned for the second replicate of GDP-locked Rab5A. (C) as (A) but showing Rab9A chimeras and aligned for the second replicate of 
GDP-locked Rab9A. 
 
 
The previously mentioned Rab5A GEFs (Alsin/ALS2, GAPVD1, and the RABEP1-RABGEF1 complex) 
are all high scoring hits for the GDP-form of Rab5A (Fig. 3.8B) (Horiuchi et al., 1997; Hunker et al., 2006; 
Topp et al., 2004; Z. Zhang et al., 2014). Furthermore, the unconventional myosin MYO19 and the kinesin-
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adaptor protein TRAK1/Milton are both enriched in GDP-locked Rab5A samples, however, upon closer 
inspection both proteins appear to be related to mitochondrial trafficking and are thus possible contaminants 
(Shneyer et al., 2015; van Spronsen et al., 2013). Finally, the myotubularin-related protein MTMR3 is 
specifically present in GDP-locked Rab5A samples, though it is mostly known to play a role in autophagy 
regulation and there are no reports that this protein might function as an exchange factor (Fig. 3.8B) (Hao 
et al., 2015). 
 
Rab9A results did not show any potential GEF candidates – GDP-locked Rab9A samples contained specific 
enrichment of mitochondrial factors such as tRNA ligases, NADH dehydrogenases, and proteases, as well 
as COIL/coilin which is a main component of nuclear bodies and the zinc transporter SLC30A9 (Fig. 3.8C).  
 
Two known Rab11A GEFs are very strong hits in GDP-locked Rab11A samples; SH3BP5/SH3BP5L and 
the C9 and C10 subunits of the TRAPPII complex (Fig. 3.9A) (Riedel et al., 2017; Sato et al., 2016). 
Intriguingly, we detect high levels of Rab43 in our GDP-locked Rab11A samples, which could potentially 
be explained by two possibilities – it is possible that both Rab11A and Rab43 are a part of a Rab cascade, 
but it is more likely that they are in close contact with each other due to them both being activated by the 
same regulator. This latter explanation is corroborated by the presence of TRAPPC8 and TRAPPC9 as high 
scoring hits for GDP-locked Rab43. (Sup. Fig. 3.6D). Interestingly, while Rab11A is technically present in 
Rab43 samples, it is not specifically enriched when compared to background levels. 
 
A number of these high-scoring Rab11A hits are not detected in GDP-locked Rab11B samples, including 
Rab43, TRAPPC10 and RalGAPA2 (Fig. 3.9B). However, since the TRAPPII complex subunit TRAPPC9 
is present in Rab11B (although in significantly lower amounts than in Rab11A) it is possible that the 
TRAPPII complex is in fact a GEF for both Rab11 paralogues but has a lower affinity to Rab11B (Fig. 
3.9C). The other known Rab11 GEFs, SH3BP5 and SH3BP5L, are detected in GDP-locked Rab11B 
samples in similar amounts as for Rab11A (Fig. 3.9C). Other high-scoring GDP-locked Rab11B hits include 
many proteins that are likely to be unspecific background, such as transcription factors BTF3 and TAF7 
and protein modifier enzymes NMT1 and PPID. 
 
The binding patterns of SH3BP5L and TRAPPC10 to the Rab11 paralogues were further examined, first 
by performing Western blots on the MitoID samples which confirmed SH3BP5L to be enriched in both 
GDP-locked Rab11A and B (Fig. 3.9D). Since a sufficient TRAPPC10 antibody was lacking, MitoID 
experiments were then performed in HEK293T cells transiently expressing FLAG-tagged SH3BP5L or 
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Figure 3.9. Differences and similarities between regulators of Rab11 paralogues. (A) Bubble plot aligned for the second replicate of 
GDP-locked Rab11A. Shown here are all three biological replicates of BirA* (BirA-HA-MAO control) and both chimeras of Rab11A, 
though GDP-locked Rab11A was compared against all other GTPases in the full data list to generate this plot. Circle area corresponds to 
WD-score. The top 35 hits are shown. Yellow column indicates alignment. (B) as (A) but showing Rab11B chimeras and aligned for the 
second replicate of GDP-locked Rab11B. (C) Bubble plot of MitoID experiments with Rab11 paralogues. Circle area corresponds with 
WD-score, generated by comparing against the full list of tested GTPases. T: GTP-locked form, D: GDP-locked form, BirA*: empty 
mitochondrial control. Yellow column indicates alignment. (D) Western blots of MitoID experiments on Rab11 paralogues, probed with 
SH3BP5L and HA (bait) antibodies. Input: wildtype HEK293T lysate. (E) Western blots of MitoID experiments on Rab11 paralogues, 
performed in HEK293T cells transiently expressing FLAG-TRAPPC10 (upper panel) or FLAG-SH3BP5L (lower panel). Blots are probed 
with FLAG antibody. Input: lysate of HEK293T cells overexpressing indicated FLAG-tagged protein. (F) Affinity chromatography of 
bacterially expressed and purified GST-Rab11 paralogues with HEK293T lysate transiently expressing FLAG-TRAPPC10 (upper panel) 
or FLAG-SH3BP5L (lower panel). Blots are probed with FLAG antibody. Input: lysate of HEK293T cells overexpressing indicated FLAG-
tagged proteins. Performed by Alison Gillingham. 
 
 
TRAPPC10. Western blots of these samples again confirmed the presence of SH3BP5L in the GDP-locked 
Rab11 paralogues, while, surprisingly, TRAPPC10 appeared to be enriched only in GTP-locked Rab11A 
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(Fig. 3.9E). While the mass spectrometry analysis indeed suggests that TRAPPII interacts with Rab11A 
and not (or much less) with Rab11B, it is expected to interact with the inactive, GDP-locked form. Affinity 
chromatography experiments were performed to investigate this further; bacterially expressed GST-Rab11 
paralogues were purified and mixed with HEK293T lysate expressing FLAG-tagged SH3BP5L or 
TRAPPC10 (performed by Alison Gillingham). Western blotting of these samples validated the interactions 
described above; SH3BP5L interacts with both Rab11A and B and is enriched in their GDP-locked forms, 
whereas TRAPPC10 interacts with GTP-locked Rab11A (Fig. 3.9F). Even though TRAPPII was shown to 
activate Drosophila melanogaster Rab11, the study by Riedel and colleagues does not include binding or 
interaction comparisons between GTP- or GDP-bound forms of Rab11 (Riedel et al., 2017). Furthermore, 
since D. melanogaster Rab11 does not exist in multiple paralogues, a comparison between the fly orthologs 
of Rab11A and Rab11B could not be made (Riedel et al., 2017).  
It is possible that TRAPPII interacts with GTP-bound Rab11A as well as being a Rab11A GEF, essentially 
forming a positive feedback loop, similar to Rabex-5/RABGEF1 with Rab5A. Such an interaction could 
involve another Rab11A effector, just like Rabex-5 binds to active Rab5A through Rabaptin5. Further 
research is necessary to elucidate the potential interaction pattern of the TRAPPII complex with Rab11A. 
 
As mentioned above, identifying proteins specifically interacting with inactive GTPases was a lot more 
effective for small GTPases of the Rho and Ras families compared to those of the Rab families, with the 
exception of RalB and Rheb. GDP-locked N-Ras showed enrichment of SOS1 (son of sevenless homologue 
1), a well-characterised Ras GEF, in 2 out of 3 replicates (Fig. 3.10A) (Tian & Feig, 2001). Furthermore, 
the previously mentioned Rho and Ras family GEF RAP1GDS1/smgGDS is present in both GDP- and 
GTP-locked N-Ras samples, although, interestingly, previous reports have been unable to detect GEF 
activity towards N-Ras in vitro  (Vikis et al., 2002). 
 
A subset of DOCK family members are well-characterised GEFs for several small GTPases. Cdc42 is 
known to be activated by DOCK-D (DOCK9, 10, and 11), and DOCK-C (DOCK6, 7, and 8) is thought to 
have dual specificity for both Rac1 and Cdc42 (Gadea & Blangy, 2014; Kang et al., 2019; Kukimoto-Niino 
et al., 2019; Lin et al., 2006; Miyamoto et al., 2007; Shiraishi et al., 2016; Yeyun Zhou et al., 2013). With 
the exception of DOCK10, we are able to detect all of these DOCK proteins with high numbers of spectral 
counts (Fig. 3.10B) (Gadea & Blangy, 2014; Kang et al., 2019; Lin et al., 2006; Miyamoto et al., 2007; 
Shiraishi et al., 2016; Yeyun Zhou et al., 2013). In addition, certain members of the DOCK family have 
recently been found to interact with LRCH proteins, of which we found two (LRCH2 and LRCH3) very 
specifically enriched in inactive Cdc42 samples (O’Loughlin et al., 2018). The scaffolding protein 
DNMBP/Tuba is also a known Cdc42 GEF, though, interestingly, we detect DNMBP in GTP-locked, but 
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not in GDP-locked, Cdc42 samples (Fig. 3.10B) (Salazar et al., 2003). This can be explained by the complex 
formation of DNMBP and Cdc42 with the adaptor protein PAR6; PAR6 is known to bind solely to active 
Cdc42, so this could explain why DNMBP is also present in GTP-locked Cdc42 samples (Noda et al., 
2001). To corroborate this, we detect the PAR6 subunit PAR6G/PARD6G enriched in 2 out of 3 GTP-
locked Cdc42 samples (Fig. 3.10B). The known Cdc42 GEF AKAP13/Brx is also detected in GDP-locked 
Cdc42 samples (Rubino et al., 1998). Finally, the Rho GEFs ARHGEF11/LARG and ARHGEF12/PDZ-
RhoGEF bind to Cdc42 in a nucleotide independent manner, while, interestingly, the Rho famly GAP 
ARHGAP35/p190RhoGAP appears to bind specifically to inactive Cdc42 (Fig. 3.10B) (Kourlas et al., 
2000; Lévay et al., 2013; Rümenapp et al., 1999). 
 
The known Rho GEFs ARHGEF11 and ARHGEF12 are high scoring hits for RhoA (Fig. 3.10C) (Kourlas 
et al., 2000; Rümenapp et al., 1999). Similarly to Rho GEFs ARHGEF18 and ARHGEF2, ARHGEF11 and 
ARHGEF12 appear to bind RhoA in a nucleotide independent manner, which suggests that they are also 
effectors that can act in a positive feedback loop (Medina et al., 2013; Niu et al., 2003; Pathak & 
Dermardirossian, 2013). The Cdc42 effector Cdc42BPA/MRCKA appears to interact with GDP-locked 
RhoA, suggesting this could be a novel RhoA GEF and potentially function as a link in a RhoA and Cdc42 
cascade. 
 
The DOCK protein family has been previously mentioned as GEFs for Cdc42, but are also known to be 
Rac1 activators. More specifically, DOCK-A (DOCK1, 2, and 5) and DOCK-B (DOCK 3 and 4) are Rac1 
activators, while DOCK-C (DOCK6, 7, and 8) is suspected of having dual specificity for Rac1 and Cdc42 
(Gadea & Blangy, 2014; Kiyokawa et al., 1998; Kukimoto-Niino et al., 2019; Miyamoto et al., 2007; 
Namekata et al., 2004; Vives et al., 2011; Xiao et al., 2013). Multiple subunits of each of these DOCK 
families are present at high levels in the GDP-locked Rac1 samples, namely DOCK1, 3, 4, 5, 6, and 7 (Fig. 
3.10D). The presence of DOCK-C subunits in both Cdc42 and Rac1 GDP-locked samples, corroborates the 
suggestion that DOCK-C has dual specificity for both small GTPases. In addition, PDLIM7/Enigma, a 
member of the PDZ-LIM family, is specifically enriched in GDP-locked Rac1 samples (Fig. 3.10D). Even 
though there are as yet no reports showing that PDLIM7 can function as a GEF, another member of the 
PDZ-LIM family has been shown to regulate Cdc42 activation, suggesting that PDLIM7 could share this 
function (Z. Liu et al., 2014; Velthuis & Bagowski, 2007). 
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Figure 3.10. Analysis of GDP-locked GTPases illuminates novel putative regulators. (A) Bubble plot aligned for the second replicates 
of GDP-locked N-Ras. Shown here are all three biological replicates of BirA* (BirA-HA-MAO control) and both chimeras of N-Ras, 
though GDP-locked Rab2A was compared against all other GTPases in the full data list to generate this plot. Circle area corresponds to 
WD-score. The top 35 hits are shown. Yellow column indicates alignment. (B) as (A) but showing Cdc42 chimeras and aligned for the 
second replicate of GDP-locked Cdc42. (C) as (A) but showing RhoA chimeras and aligned for the first replicate of GDP-locked RhoA. 
(D) as (A) but showing Rac1ΔC chimeras and aligned for the third replicate of GDP-locked Rac1ΔC. 
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Taken together, these results show that MitoID can effectively detect exchange factors of some small 
GTPases of the Rab, Ras and Rho families. One possible reason why this is not as effective for all small 
GTPases tested could be the dominant negative mutations that were used. Several of the mutations used 
have been well established and used in numerous laboratories, however, certain dominant negative 
mutations we have developed ourselves, based on the sequence of the protein and the location of its residues 
in the P-loop. The mass spectrometry data shows a clear difference between the constitutively active and 
dominant negative mutations, though it is possible that the conformational change of the protein is not 
identical to what the GEFs of certain GTPases require for binding. Taking this into consideration, further 
research needs to be done to identify exchange factors of the other G-proteins, by testing multiple mutations 
and performing MitoID experiments on these chimeras.  
 
 
3.3 Discussion 
 
By applying the MitoID approach to a subset of 25 small GTPases from the Rab, Rho, and Ras families, 
we were able to identify numerous previously known and potentially novel interactors. An in-depth 
examination of Rab2A, Rab9A and Rab11 has led to the validation of several novel effectors, namely 
ARFGEF3/BIG3 and STAMBPL1 for Rab2A, NDE1 and HPS3 for Rab9A and ALS2/Alsin for Rab11A. 
 
Interestingly, certain small GTPases appear to have a more expansive set of known and/or potential 
interactors than others. A multitude of factors could have contributed to this discrepancy. A biological 
explanation would be that small GTPases with fewer identified interactors, just naturally have fewer 
interactors; while certain small GTPases – such as Rab2A and Rab5A – are known to be essential key 
regulators with an extensive network of interactors, other GTPases play a less extensive role in the cell, and 
are thus bound to have fewer binding partners. In addition, the functionality of GTP- and GDP-locked 
mutations could also have contributed in the discrepancy between the different G proteins. The possibility 
of using different mutations was examined in the discussion of the previous chapter, and could potentially 
increase the efficiency and validity of the MitoID approach on these GTPases. 
 
Throughout this study, I have chosen to transiently express the mitochondrially-localised GTPase chimeras. 
As is evident from the data presented above, transiently expressing the chimeras is sufficient to identify 
both known and novel interactors. Furthermore, overexpressing the chimeras does not appear to disrupt the 
mitochondria to the extent of inducing stress, nor does it seem to disrupt any essential cellular processes or 
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cause cell death. That being said, stably expressing the chimeras could potentially enhance the MitoID 
approach further – creating stable cell lines using the CRISPR-Cas9 technique would mean that expression 
efficiency would be ubiquitous and the expression levels would be more similar to the endogenous GTPases 
present in the genome (Doudna & Charpentier, 2014). With the continued increase of the ease and efficiency 
of stable genome editing methods such as the FLP recombinase or the PiggyBac transposase systems, using 
stable expression could be an excellent option for future studies (Ivics, 2016; Shah et al., 2015).  
 
As mentioned above, the localisation patterns of small GTPases are not necessarily as distinct as 
traditionally thought. Collectively, we continuously gain more information on the function, interaction 
partners, and localisation of small GTPases, which leads us to continuously adjust our knowledge base. A 
relatively recent example of this is Rab2A; traditionally known as a Rab GTPase involved in ER-to-Golgi 
trafficking, until studies reported a role of Rab2A in endosomal-lysosomal fusion and dense-core vesicle 
maturation (Ailion et al., 2014; Lőrincz et al., 2017; Lund et al., 2018; Sandoval & Simmen, 2012; 
Sumakovic et al., 2009). Our study has highlighted two novel Rab2A effectors, one of which 
(ARFGEF3/BIG3) is found to be localised to lysosomes in neurons and thus aligns with the known 
localisation of Rab2 (Tao Liu et al., 2016). However, STAMBPL1, another novel Rab2A effector, is known 
to localise to early endosomes, which potentially places Rab2A at this previously unreported location (M. 
Nakamura et al., 2006). This shows that gaining more knowledge on the interaction partners of small 
GTPases can potentially increase our knowledge on their localisation patterns, placing the proteins at 
previously unreported intracellular membrane compartments.  
 
Arf GTPases were excluded from this study due to inherent differences between them and other families of 
small GTPases, as explained in the discussion of Chapter 2. However, besides Arf GTPases, the other tested 
families of small GTPases do not appear to show family-specific differences in efficiency. While several 
hits do recur in multiple members of the same family, the ability of the MitoID approach to identify 
interactors seems to be protein-dependent, not family-dependent. The family of Rab GTPases highlight this 
distinction clearly; belonging to the same family of GTPases, there is a clear disparity between the datasets 
produced by for instance Rab2A or Rab5A (many known and novel hits) versus for instance Rab33B or 
Rab19B (very few known and novel hits) (data not displayed, raw data in Table 2-4). 
 
One of the key aspects of performing a screen is an effective method of validation. In this study, we have 
identified numerous potential GTPase interactors, of which several were validated by biochemistry or 
immunofluorescence experiments. However, several tested putative interactors could not be validated 
through these methods. While it is possible that this means that they are in fact not true interactors, failure 
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to validate binding through affinity chromatography could also be due to one of the intrinsic draw backs of 
this latter method. When using affinity chromatography with bacterially expressed and purified proteins, 
incorrect folding could occur which interrupts the effector binding site or certain essential post-translational 
modifications (PTMs) could be missing due to bacterial expression. Another factor is the stability of the 
interaction; if the interaction is transient or weak, the protein can be washed off the Rab-coated beads more 
easily which results in it not being detected in the resulting sample. While using microscopy techniques to 
examine protein interactions is a possibility in theory, applying this to our small GTPase chimeras has 
proven to be challenging. Immunofluorescence antibody probing for possible interactors has not resulted 
in any visible relocation to the mitochondrially-localised GTPases, even for well-established interactions 
such as GTP-locked Rab2A and GMAP-210 (data not shown) (Sinka et al., 2008). In the cases where 
confocal microscopy was successful in validating interactions, we had overexpressed tagged versions of 
both bait and prey. While confocal microscopy, even with overexpression of the proteins involved, is a 
satisfactory way of validating interactions, weaker or transient interactions are unlikely to be detected. 
Perhaps redirecting the baits to a more densely localised organelle could aid in this, or implementing split-
GFP to stabilise the interaction once it occurs (Cabantous et al., 2013).  
While, in this study, the MitoID protein samples were resolved by Western blot solely to verify the accuracy 
of the mass spectrometry output, this method can also be used as a validation method in and of itself. Even 
though validating the presence of proteins in the tested MitoID samples will not definitively show whether 
the interactions are physical or whether the proteins are simply proximal, the context can indicate the 
likelihood of this being an interaction of interest – if a bait and a prey are consistently observed, and 
validated, to be proximal (~10 nm distance) solely when the bait is in its active state, this finding would be 
considered highly interesting regardless of whether these proteins physically interact.  
 
Interestingly, we have occasionally come across discrepancies between the mass spectrometry output and 
the biochemical analysis of the same samples. For example, in Figure 3.4A we have shown that the mass 
spectrometry output indicates that OSBPL9 is almost exclusively present in Rab11A samples while BIG2 
is solely present in Rab11B samples. However, Figure 3.4B shows that resolving these same samples by 
SDS-Page and Western blotting shows a very different interaction pattern; both OSBPL9 and BIG2 appear 
to be present approximately equally in both Rab11 paralogues. It is likely that this discrepancy reflects a 
shortcoming of the semi-quantitative mass spectrometry approach, underscoring the necessity of validating 
the found interactions through other methods. If more quantitative methods are needed, the MitoID 
approach could be combined with stable isotope labelling techniques such as SILAC (stable isotope 
labelling by amino acids in cell culture) or TMT (tandem mass tags) (Chahrour et al., 2015). 
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Taken together, we believe that the MitoID approach is highly valuable. It allows for efficient detection of 
weaker and transient interactions, which conventional methods such as affinity chromatography and yeast 
two-hybrid could miss. With the unique benefits of proximity labelling combined with internal larger-scale 
comparisons, we believe MitoID should be added to the general repertoire of widely used protein-protein 
interaction examination methods. 
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Chapter 4: Investigating adaptations of the MitoID 
method 
 
4.1 Introduction 
 
After performing a MitoID screen on a wide range of small GTPases, we aimed to test several ways to alter, 
adapt, or even improve this method. Adaptations that were tested include the ability of MitoID to examine 
differences in interactomes due to post-translational modifications (PTMs) of the bait protein, testing new 
possible nucleotide-locked mutations, and comparing the use of different generations of the biotin ligase 
BirA. 
 
 
4.2 Results 
 
4.2.1 MitoID analysis allows detection of differences in the interactome based on phospho-mutations 
As previous chapters have shown, MitoID has proven to be a very effective method for identifying protein 
interactors. We set out to test whether this approach also allows for the rapid testing of sequence variants, 
such as mutations other than the nucleotide-locked forms examined above. One prime example of point-
mutations leading to functional adaptations are phosphomimetics – point-mutations that mimic either the 
phosphorylated or unphosphorylated state of a certain protein residue. 
 
Rab GTPases can be phosphorylated by kinases such as the leucine-rich repeat kinase LRRK2, which has 
recently gained a lot of attention due its role in pathological aspects of Parkinson’s disease (Seol et al., 
2019). Recently, a study found that, in addition to the well-known LRRK2 substrates Rab8A and Rab10, 
12 other Rab GTPases are regulated by LRRK2, including Rab5A upon overexpression (Steger et al., 2017). 
In order to test whether the MitoID approach is effective in identifying differences in Rab GTPase 
interactions due to modifications such as phosphorylation, we used phosphomimetics to create mutants of 
Rab5A, Rab8A, and Rab10, and examined their interactomes. 
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We substituted the Serine/S or Threonine/T on the identified phosphorylation site for non-phosphorylated 
amino acids that are negatively charged (Glutamate/E) or unable to be phosphorylated (Alanine/A), which 
mimics phosphorylation or non-phosphorylation, respectively (Dissmeyer & Schnittger, 2011; Eidenmüller 
et al., 2000). These sites are S84 for Rab5A, T72 For Rab8A, and T73 for Rab10 (Lis et al., 2018).  
 
After performing triplicate MitoID experiments with these phospho-mutant Rab chimeras, the samples were 
examined by tandem mass spectrometry and spectral count data was gathered, in an identical manner as the 
MitoID experiments explained in chapters 2 and 3. Importantly, for these experiments the wildtype, S/TàA 
and S/TàE versions of the GTP-locked mutants were tested, in order to more efficiently identify specific 
interactors. 
 
 
Figure 4.1. MitoID can detect differences in interactomes after phosphomimetic point mutations on Rab8A. (A-C) Bubble plots 
showing MitoID results of BirA* control (BirA*-HA-MAO) and GTP-locked Rab5A, Rab8A, and Rab10, as indicated. Point mutations 
were made on S84 (Rab5A), T72 (Rab8A), and T73 (Rab10), substituting them for either Glutamate/E or Alanine/A to mimic 
phosphorylation or non-phosphorylation, respectively. Bubble plots are aligned for GTP-locked Rab8 (A), Rab8 T72A (B), and Rab8 T72E 
(C). Circle area corresponds to WD-score. Yellow columns indicate alignment. 
 
 
Rab8A functions in the formation of actin-containing structures such as lamellipodia, filopodia, and primary 
cilia, and is known to play a role in membrane recycling (Peränen, 2011). It is therefore unsurprising that 
several Rab8A top hits include proteins involved in actin regulation, endosomal trafficking, and cytoskeletal 
adaptors. A number of proteins stand out for interacting solely with the non-mutated protein and not with 
either phospho-mutant, such as the known Rab8A interactors SYTL4, Rab11FIP2, and VANGL1/2 (Fig. 
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4.1A) (Hampson et al., 2013; Hatakeyama et al., 2014; Machesky, 2019). Interestingly, Rab3A is also found 
to specifically bind to wildtype GTP-locked Rab8A, which could be explained by both Rab8A and Rab3A 
being known to interact with SYTL4 (Fukuda, 2003). There are also a number of cytoskeletal/trafficking 
proteins enriched for the phospho-mutants, such as MON2, DCTN1/Dynactin subunit 1, and the WASH 
complex subunit WASHC2A for the non-phosphorylated (T72A) mutant (Fig. 4.1B) and MIS18A, 
TBC1D25/OATL1, and ARFGEF3/BIG3 for the phospho-mimicking mutant (T72E) (Fig. 4.1C) (Carter et 
al., 2016; Tao Liu et al., 2016; Mahajan et al., 2019; Panarella et al., 2016; Spiller et al., 2017; Jing Wang 
et al., 2018). In addition, the golgin GCC1/GCC88 appears to bind to the wildtype and the phospho-
mimicked mutant, but not to the non-phosphorylated mutant, suggesting that GCC88 requires 
phosphorylation (or the possibility of phosphorylation) to bind. 
 
Since Rab8 and Rab10 stem from a gene duplication and have related functions, it is not surprising that 
Rab10 is also found to interact with many cytoskeletal and membrane trafficking-related proteins (Peränen, 
2011). Proteins that solely bind to non-mutated GTP-locked Rab10 but not the phospho-mutants of GTP-
locked Rab10 include CLASP1 and exocyst subunits EXOC5, 6, and 7, which are both involved in the 
regulation of endomembrane organisation and trafficking (Fig. 4.2A) (Boal & Stephens, 2010; Bouchet et 
al., 2016; Hong et al., 2018; Wu & Guo, 2015). Conversely, not many proteins stand out for solely binding 
to the phospho-mutants of GTP-locked Rab10 except for the Rab GDP dissociation inhibitor GDI2 and the 
actin bundler PLS1 for T73A and COPB2 and MAP4K2 for T73E (H.-C. Chuang et al., 2015; Shisheva et 
al., 1999; L. Wang et al., 2020; Y. Wang et al., 2017; T. Zhang et al., 2020) (Fig. 4.2B,C). The Arf GEF 
ARFGEF2/BIG2 is detected in both the non-mutated Rab10 and the non-phosphorylated mutant (T73A), 
which suggests that BIG2 strongly favours binding when Rab10 is unphosphorylated (Fig. 4.2A,B). This 
distinction detected by mass spectrometry was confirmed by Western blotting of the samples (Fig. 4.2D). 
The known Rab10 interactors KIF13A/B are also detected in GTP-locked Rab10 samples (Etoh & Fukuda, 
2019) (Fig. 4.2A). Interestingly, although both KIF13 isoforms have been reported to interact with Rab10, 
they show different binding patterns when phospho-mutations are introduced; while KIF13A is strongly 
enriched in non-mutated GTP-locked Rab10 compared to the two phospho-mutants, KIF13B appears to 
interact with all three GTP-locked Rab10 samples indeterminately. Further research is necessary to 
determine whether this discrepancy indicates slightly separate functions for both isoforms. 
 
Finally, we tested the two phospho-mutants for Rab5A, since it is perhaps the best characterised Rab 
GTPase with many known effectors, which allows for more in depth examination of the differential 
interactomes. Several known effectors show equal affinity to all three tested Rab5A forms, showing that 
substitution of that residue does not affect binding of those effectors. These proteins include VPS8, EEA1,  
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Figure 4.2. MitoID can detect differences in interactomes after phosphomimetic point mutations on and Rab10. (A-C) Bubble plots 
showing MitoID results of BirA* control (BirA*-HA-MAO) and GTP-locked Rab5A, Rab8A, and Rab10, as indicated. Point mutations 
were made on S84 (Rab5A), T72 (Rab8A), and T73 (Rab10), substituting them for either Glutamate/E or Alanine/A to mimic 
phosphorylation or non-phosphorylation, respectively. Bubble plots are aligned for GTP-locked Rab10 (A), Rab10 T73A (B), and Rab10 
T73E (C). Circle area corresponds to WD-score. Yellow columns indicate alignment. (D). Western blot of MitoID samples of GTP-locked 
Rab10 with and without phospho-mutations, as indicated. GTP-locked Rab5A was used as a negative control. Input: wildtype HEK293T 
lysate. Blot was probed with BIG3 antibodies. 
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TSC1/2 and two of the core components of the class III PI3-kinase complex; PIK3R4/VPS15 and 
PIK3C3/VPS34 (Fig. 4.3A-C) (Huang & Manning, 2008; Markgraf et al., 2009; Ohashi et al., 2018; 
Simonsen et al., 1998). Interestingly, the two class III PI3K complex II-specific subunits (UVRAG and 
Rubicon) are strongly enriched in wildtype GTP-locked Rab5A samples compared to the two phospho-
mutants (Fig. 4.3A) (Itakura et al., 2008; Matsunaga et al., 2009). Notably, no complex I-specific subunits 
are detected in any of the Rab5A samples, even though Rab5A is known to interact with both complexes 
(to be discussed in detail in Chapter 6). Other proteins that are preferentially present in non-mutated GTP-
locked Rab5 samples include OSBPL9, KIAA1468/RELCH and the CORVET/HOPS subunits (and 
recently also identified as E3 ubiquitin ligases) VPS11 and VPS18 (Fig. 4.3A) (Xinwei Liu & Ridgway, 
2014; Segala et al., 2019; Sobajima et al., 2018). Intriguingly, Rab11A is also present in this list, which can 
perhaps be explained by OSBPL9 and RELCH also being strong Rab11A interactors (Fig. 3.4C). 
The strongest interactor with the non-phosphorylated mutant (S84A) is the centrosomal protein CEP192, a 
regulator of the microtubule organising centre (MTOC), which is not detected in the other two Rab5 
samples (Fig. 4.3B) (Gomez-Ferreria & Sharp, 2008; O’Rourke et al., 2014). Contrarily, the phospho-
mimicking Rab5 mutant (S84E) appears to interact specifically with proteins including the centrosomal 
protein CEP290, and the cytoskeletal regulators FLNC/filamin-C and BCAS3 (Fig. 4.3C) (Jain et al., 2012; 
Ambuj Kumar et al., 2013; Mao & Nakamura, 2020). Interestingly, APPL1/2 and WDR7 are strongly 
enriched in non-mutated and S84A samples, but not in S84E, implying that these proteins interact with 
GTP-locked Rab5A when it is not phosphorylated (Fig. 4.3A-C) (Kawabe et al., 2003; Miaczynska et al., 
2004).  
The selective interactor response of phospho-mutated GTP-locked Rab5A was further examined by probing 
Western blots of the MitoID samples against EEA1, PIK3R4, OSBPL9, and HA (internal chimera epitope 
tag). We were able to confirm that whilst introducing phospho-mutants into Rab5A does not affect its 
binding to EEA1 and PIK3R4, it does indeed affect its binding to OSBPL9 (Fig. 4.3D). OSBPL9 shows a 
significantly decreased binding pattern when Rab5A is mutated to mimic either a non-phosphorylated or 
constitutively phosphorylated state. 
 
Together, this data shows that MitoID is able to detect differential changes in effector binding due to point 
mutations and residue modifications. Comparing multiple mutations with the wildtype protein allows for 
closer examination of the effect of the mutants and the nature of the interactions. These results are promising 
and suggest that MitoID can be effective when testing the effect that point mutations have on the protein’s 
interactome. 
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Figure 4.3. MitoID can detect differences in interactomes after phosphomimetic point mutations on Rab5A. (A-C) Bubble plots 
showing MitoID results of BirA* control (BirA*-HA-MAO) and GTP-locked Rab5A, Rab8A, and Rab10, as indicated. Point mutations 
were made on S84 (Rab5A), T72 (Rab8A), and T73 (Rab10), substituting them for either Glutamate/E or Alanine/A to mimic 
phosphorylation or non-phosphorylation, respectively. Bubble plots are aligned for GTP-locked Rab5A (A), Rab5 S84A (B), Rab8 S84E 
(C). Circle area corresponds to WD-score. Yellow columns indicate alignment. (D). Western blots of MitoID samples from indicated 
mutants of GTP-locked Rab5. Blots were probed against PIK3R4, EEA1, OSBPL9, and the epitope tag present in the chimera (HA) as an 
expression level control. Input: wildtype HEK293T lysate. GTP-locked Rab8 sample was used as a negative control.  
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4.2.2 Investigating the validity of a novel GTP-locked Rab29 mutant 
As previously mentioned, the leucine-rich repeat kinase LRRK2 is strongly involved in the occurrence of 
Parkinson’s disease (Kluss et al., 2019). Above, several Rab GTPases that are known substrates for LRRK2 
were further investigated by generating phospho-mutants and examining their interactomes by comparative 
MitoID. In addition to Rab5A, Rab8A and Rab10, eleven other Rab GTPases are known to be regulated by 
LRRK2, including Rab29 (also known as Rab7L1) (Seol et al., 2019; Steger et al., 2017). Furthermore, 
Rab29 was found to be one of the 5 genes located on the PARK16 locus, which is also linked to Parkinson’s 
disease and is found mutated in patients (Purlyte et al., 2017). With the aim of gaining more knowledge on 
the function and interactors of Rab29, the Rab GTPase was included in our list of tested GTPases for the 
MitoID screen. However, an issue arose when creating a GTP-locked mutant for Rab29/Rab7L1. 
Throughout our study, the GTP- and GDP-locked mutations we have used for Rab GTPases were QàL 
(GTP-locked) and S/TàN (GDP-locked). However, a study has shown that while Rab29 T21N is indeed 
deficient in GTP binding (and thus an excellent GDP-locked mutant), Rab29 Q67L has a 10-fold increased 
nucleotide dissociation rate (Beilina et al., 2014). Due to this inability to retain GTP, Beilina and colleagues 
concluded that both Rab29 mutants function as loss-of-function mutants. In this study, we aimed to create 
a bona fide GTP-locked mutant to compare against the GDP-locked T21N. The GTPases RalB and Cdc42 
are mutated on a different residue to create their GTP-locked forms, namely RalB G23V and Cdc42 G12V. 
These known mutations were utilised to generate Rab29 A16V, a corresponding mutation which we hoped 
would lock Rab29 in a GTP-bound conformational state.  
 
After performing MitoID experiments on all three discussed Rab29 mutants and analysing the generated 
datasets, we found that the main Rab29 interactors are not present (Fig. 4.4A,B). Missing from the GTP-
locked samples are for instance the Parkinson’s disease associated LRRK2 kinase, the transport protein 
IFT20, the SNARE BET1L/GS15 and the golgin TGN46/TGOLN2 (Onnis et al., 2015; Purlyte et al., 2017; 
S. Wang et al., 2014). However, Rab11 is known to interact with Rab29, which is reflected in our results 
by Rab11B interacting specifically with A16V and to a lesser extend with Q67L, while not being present 
in the GDP-locked form (Fig. 4.4A) (Onnis et al., 2015). Similarly, C9orf72 is a known Rab29 effector 
that, even though it is present in both A16V and Q67L, is only detected in very low amounts (Sup. Tables 
2 and 3) (Aoki et al., 2017). We are able to detect a number of previously unreported potential Rab29 
interactors in the A16V form, including the non-centrosomal microtubule binder CAMSAP3, the V-snare 
VTIB, and CEP44, a centrosomal protein known to be involved in centriole to centrosome conversion and 
centrosome cohesion (Fig. 4.4A) (Atorino et al., 2020; Hossain et al., 2020; Nozawa et al., 2016; Jing Wang 
et al., 2017).  
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Figure 4.4. MitoID can be used to investigate novel nucleotide-locked mutations of GTPases (A,B) Bubble plots showing MitoID 
results of BirA* control (BirA*-HA-MAO) and all tested GTP- and GDP-locked GTPases, as indicated. Plots aligned for Rab29 A16V 
(A) and Rab29 Q67L (B). Circle area corresponds to average WD-score from three biological replicates. Yellow columns indicate 
alignment. T: GTP-locked form, D: GDP-locked form. 
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Moreover, several identified hits have specific neuronal functions, such as the scaffolding protein 
GPHN/Gephyrin in both A16V and Q67L mutants, and Neurobeachin/NBEA and ZNF106 (Fig. 4.4A,B) 
(Celona et al., 2017; Farzana et al., 2015; Groeneweg et al., 2018). Finally, Arf3 is found to interact with 
all three forms of Rab29, which could be due to both proteins being active at the trans-Golgi (Manolea et 
al., 2010; S. Wang et al., 2014) (Fig. 4.4A,B). 
 
Taken together, while several potential Rab29 interactors are identified, most known Rab29 interactors are 
not identified in the MitoID samples of either of the ‘GTP-locked’ forms, which is reason for concern 
regarding these specific samples. Further research is necessary to examine the accuracy and validity of the 
Rab29 mutations. However, these results do show the potential of assessing the validity of other potential 
nucleotide-locked mutations by comparing interactomes against a wide range of similar baits.  
 
4.2.3 Various biotin ligase generations function slightly differently 
Since the original publication describing the use of a mutated, promiscuous biotin ligase to create the BioID 
approach, numerous studies have reported adaptations of this approach. One common adjustment to BioID 
is the substitution of the original promiscuous biotin ligase (R118G, resulting in biotin ligase called BirA*) 
to other, possibly more efficient, promiscuous mutations. The two most commonly used BioID adaptations 
are called BioID2 and TurboID, both generated to result in more efficient labelling, better localisation, and 
a decreased need for exogenous biotin (Branon et al., 2018; D. I. Kim et al., 2016). BioID2 makes use of a 
biotin ligase humanised from A. aeolicus, which is substantially smaller than its counterpart from E. coli. 
The mutation R40G within the biotin catalytic domain results in a promiscuity similar to BirA* (D. I. Kim 
et al., 2016). TurboID, on the other hand, was generated by using directed evolution on the E. coli biotin 
ligase with the promiscuous mutation R118S (Branon et al., 2018). To compare the efficiency of these three 
BioID generations, we have performed MitoID experiments on three different Rab GTPases (Rab1A, 
Rab6A and Rab11A) with each of the biotin ligase enzymes, following our original MitoID protocol and 
chimera lay-out (Rab-BirA-HA-MAO) and using the same biotinylation duration throughout. Results for 
the Rab1A MitoIDs will be discussed extensively in Chapter 5. 
 
Rab6A plays a role in both trans-Golgi regulation and vesicular cytoskeletal transport, and it is thus 
unsurprising that many top hits for Rab6A include either endosomal or cytoskeletal proteins (Fridmann-
Sirkis et al., 2004; Grigoriev et al., 2007; P. L. Lee et al., 2015; Miserey-Lenkei et al., 2017; Short et al., 
2002). A few well-characterised Rab6A interactors are present in all three biotin ligase samples, namely 
the previously identified effectors ERC1/ELKS, bicaudal-D1/BICD1, and GCC2/GCC185, as well as the 
putative novel interactor MB21D2/C3orf59 (Fig. 4.5A-C) (Fernandes et al., 2009; Grigoriev et al., 2007; 
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Matanis et al., 2002, 2002). The presence of MB21D2 in all three GTP-locked Rab6A experiments 
underscores the likely validity of this protein as a Rab6A interactor. Unfortunately, we were unable to 
validate this interaction by affinity chromatography, possibly due to one of multiple possible explanations 
given in the discussion of Chapter 3 (data not shown). Further investigations are necessary to assess whether 
MB21D2 is indeed a true novel Rab6A interactor. 
 
Numerous previously identified Rab6A interactors are observed in the original BioID and BioID2 samples, 
but not in TurboID samples. These include the dynactin subunit p150-glued (DCNT1), the Rab GEFs 
DENND5A/B, and myotubularin related protein 1 (MTMR1) which has been highlighted as a potential 
interactor in comparisons against the full set of tested GTPases (Fig. 4.5A-B, Sup. Fig. 3.1A) (Fukuda et 
al., 2011; Short et al., 2002). There is no significant overlap found between samples of the original BioID 
and TurboID, as well as between BioID2 and TurboID, indicating that TurboID appears to biotinylate a 
different set of interactors. 
 
In order to gain more insight of the efficiency and quality of the three GTP-locked Rab6A samples, the 
samples were examined separately. Proteins solely identified in the original BioID sample include several 
cytoskeletal proteins such as kinesin light chain KLC1 and the cytoskeletal regulator RUFY2 (Fig. 4.5A) 
(DeBoer et al., 2008; Kitagishi & Matsuda, 2013). Specific GTP-locked Rab6A BioID2 hits include 
centrosomal proteins (CEP290, CEP135, and CEP250), cytoskeletal regulators (ERC2, CLASP2, and 
MICALL1), and motor proteins (the kinesin KIF15 and the myosin MYO18A) (Fig. 4.5B) (Arancibia et 
al., 2019; Buschman & Field, 2017; Frémont et al., 2017; Ko et al., 2006; Lawrence et al., 2018; McHugh 
et al., 2018). Conversely, proteins solely identified in the TurboID sample include proteins involved in 
DNA repair (BLM, ERCC6), the Rab6-interacting golgin GORAB, and the E3 ubiquitin-protein ligase 
HERC1 (Fig. 4.5C) (J.-W. Liu et al., 2013; Patel et al., 2017; Schneider et al., 2018; Witkos et al., 2019). 
Importantly, when aligning the bubble plot for GTP-locked Rab6 with TurboID, it immediately becomes 
apparent that the top hits include fewer Rab6-specific interactors and more background proteins (Fig. 4.5C).  
 
When assessing GDP-locked Rab6A samples, we find that the only previously reported Rab6A GEF – 
RAP1GDS1/smgGDS – is identified in the original BioID and BioID2 samples, but not in TurboID (Fig. 
4.5D) (Hamel et al., 2011; Shimizu et al., 2017). No other potential GEFs are identified with TurboID 
samples (Sup. Tables 2 and 3). 
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Figure 4.5. Several generations of BioID produce a different sets of potential interactors for Rab6A. (A-D) Bubble plots showing 
MitoID results of GTP- and GDP-locked Rab1A, Rab6A and Rab11A. Different BirA* generations were cloned into Rab-BirA*-HA-
MAO constructs, using ID1 (original BioID), ID2 (BioID2) and IDT (TurboID). Circle area corresponds to WD-score, calculated by 
comparing single replicates of the baits shown. BirA* is a control showing mitochondrial background levels (BirA*-HA-MAO) and 
contains the original BioID biotin ligase. Plots are aligned for GTP-locked Rab6A chimeras containing original BioID (A), BioID2 (B), 
and TurboID (C), and the original GDP-locked Rab6A (D) (yellow columns). Top 35 hits are shown. 
 
 
Similarly to Rab6A, MitoID experiments were performed on Rab11A using the three aforementioned biotin 
ligase enzymes. When examining the results, we only detected one previously known Rab11A effector in 
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all three samples; KIAA1468/RELCH (Sobajima et al., 2018) (Fig. 4.6A-C). The Rab6A GAP 
RABGAP1/GAPCenA and the Rab5A effector RABEP1/Rabaptin5 are also detected in all three GTP-
locked Rab11A samples, indicating they could have a second function as a Rab11A GAP or effector (Cuif 
et al., 1999; Stenmark et al., 1995). As previously mentioned, the Rab11A hit UHRF1BP1L is also found 
to interact with other GTP-locked GTPases such as Rab1B, Rab5A, Rab6A, Rab10, and Rab11B (Fig. 
3.3A). However, throughout our study the highest WD-scores for UHRF1BP1L arise for Rab11A, and we 
are able to detect the protein in all three MitoID experiments with different biotin ligases, suggesting it to 
be a true Rab11A interactor (Fig. 4.6A-C).  
 
The Rab5A effector OSBPL9 is detected in GTP-locked Rab11A samples when using original BioID and 
BioID2, but not when using TurboID (Fig. 4.6A,B). Similarly to what we observed for Rab6A, there is no 
overlap found between Rab11 samples when using TurboID compared to the other two biotin ligases. 
Proteins that are solely detected in TurboID include the senescence regulators UBN1 and UBN2, and 
several proteins involved in trafficking (GOLPH3L and SYTL4) (Hampson et al., 2013; Ng et al., 2013; 
Ricketts et al., 2019; Xiong et al., 2018; Y.-L. Zhao et al., 2019). However, the vast majority of proteins 
identified with Rab11A-TurboID appear to be background proteins, as becomes apparent when examining 
the full list (Fig. 4.6C).  
 
When comparing the GTP-locked Rab11A interactomes identified through the original BioID and BioID2, 
we detect numerous proteins that are only present in either one of the samples. Proteins that are solely 
present in the original BioID sample include the known Rab11 effectors RAB3IP/Rabin8 and 
Rab3IL1/GRAB, as well as potential Rab11 interactors ALS2, ARFGEF1/BIG1, VPS8, and C9orf72, 
which are all known to be involved with endo-lysosomal trafficking, as previously discussed in paragraph 
3.2.3 (Fig. 4.6A) (Boal & Stephens, 2010; Horgan et al., 2013; Kunita et al., 2007; Markgraf et al., 2009; 
Topp et al., 2004; Vetter et al., 2015; Webster et al., 2018). Proteins solely present in the BioID2 sample 
also include numerous possible Rab11 interactors which act on the endosomal pathway, such as LYST, 
DENND5A/B and Ccd42BPA (Fig. 4.6B) (Sepulveda et al., 2015; Yoshimura et al., 2010; Z. Zhao & 
Manser, 2015). 
 
Together, this suggests that, in this set-up, BioID and BioID2 are more effective than TurboID in detecting 
Rab6A- and Rab11A-specific interactors. The output of BioID and BioID2 seem mostly consistent with 
each other, detecting proteins that largely align with the literature, whereas using TurboID appears to create 
more background than the other biotin ligases. The use of different generations of biotin ligases for different 
types of experiments will be examined in the discussion of this chapter.   
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Figure 4.6. Several generations of BioID produce a different sets of potential interactors for Rab11A. (A-D) Bubble plots showing 
MitoID results of GTP- and GDP-locked Rab1A, Rab6A and Rab11A. Different BirA* generations were cloned into Rab-BirA*-HA-
MAO constructs, using ID1 (original BioID), ID2 (BioID2) and IDT (TurboID). Circle area corresponds to WD-score, calculated by 
comparing single replicates of the baits shown. BirA* is a control showing mitochondrial background levels (BirA*-HA-MAO) and 
contains the original BioID biotin ligase. Plots are aligned for GTP-locked Rab11A chimeras containing original BioID (A), BioID2 (B), 
and TurboID (C), and the original GDP-locked Rab11A (D) (yellow columns). Top 35 hits are shown. 
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4.3 Discussion 
 
Small changes to canonical sequences can have large effects on the functionality of the protein in question. 
Point-mutations can increase or disrupt binding to interaction partners, cause misfolding, or alter the 
intracellular localisation of the protein (Krauss et al., 2009; Adesh Kumar & Biswas, 2019; Shanthirabalan 
et al., 2018). In this study, we have generated specific point-mutants that mimic phosphorylation of certain 
residues in order to examine whether the MitoID approach can assess differential changes to interactions. 
Indeed, numerous changes in binding patterns are observed, several of which are confirmed by Western 
blotting of the samples. Although further research is necessary to validate these differential changes, these 
results are promising and suggest that MitoID can be effective when testing the effect that point mutations 
have on a protein’s interactome. 
 
A major aspect of this MitoID study is the use of nucleotide-locked mutations to internally compare active 
and inactive GTPases to search for effectors and regulators. One of the baits we intended on studying, 
Rab29/Rab7L1, has not been reported with a true GTP-locked mutation – the traditionally used QàL 
mutation has been shown to function as a loss-of-function mutation rather being constitutively active 
(Beilina et al., 2014). After generating a different possible GTP-locked mutation of Rab29, A16V, we 
examined using the MitoID approach to test the functionality of mutations such as these. Performing 
biological triplicates of Rab29 chimeras in the three different mutations (T21N, Q67L, and A16V) and 
compare these against the full data set of small GTPases, we were able to assess the functionality of the 
A16V mutation as a true GTP-locked mutation. Unfortunately, in this case, most known Rab29 interactors 
are not identified in the MitoID samples of the A16V mutation. The results of Rab29 A16V resemble those 
of Rab29 Q67L, which does not appear to function as a true constitutively active Rab29. While this is a 
reason for concern regarding these specific samples, these results do show the potential of assessing the 
validity of other potential nucleotide-locked mutations by comparing interactomes against a wide range of 
similar baits.  
 
Finally, we performed MitoID experiments using three different generations of BirA biotin ligases with the 
aim of comparing their functionality and efficiency. With BioID, BioID2 and TurboID being the most used 
biotin ligases at the time of our study, we compared these three ligases on Rab1A, Rab6A and Rab11A 
(with Rab1A being discussed in Chapter 5). We have been able to show that, while able to detect certain 
known effectors, the use of TurboID in our MitoID experiments decreased the number of putative effectors 
identified and drastically increased background levels. On the other hand, using the original BioID and 
BioID2 led to similar datasets which contain numerous known effectors and several putative novel 
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interactors. Interestingly though, both biotin ligases appear to biotinylate several proteins that the other does 
not, suggesting that one biotin ligase is not superior over the other, but rather that they might be suitable 
for different types of experiments. Interestingly, several proteins are found to bind to multiple Rab GTPases 
only when using the same biotin ligase; for instance, DENND4A, VPS13C and Cdc42BPA are found in 
almost all BioID2 samples, highlighting how different biotin ligases function slightly differently (Fig. 
4.6B). The steep decrease in interactors identified by TurboID compared to BioID and BioID2 could 
theoretically be due to a number of reasons; a. the proteins do not interact when TurboID is fused, b. the 
proteins did not get biotinylated, or c. the proteins interacted and got biotinylated, but were not identified 
by mass spectrometry. Since the amount of non-specific background proteins drastically increased in 
TurboID samples, I believe it most likely that the proteins were properly biotinylated but got missed by the 
mass spectrometry analysis because of the vast amount of background proteins overflowing the machine. 
Perhaps dialling down the speed of the mass spectrometric flow could allow for more careful analysis of 
all proteins in the sample.  
 
Since TurboID and BioID2 were generated to be more time efficient and require less biotin addition, those 
ligases could be used for shorter duration experiments or whenever adding exogenous biotin is challenging. 
Troubleshooting the specific requirements of these methods will most definitely lead to better results than 
those presented here, since these experiments were performed with a protocol optimised for the original 
BioID biotin ligase. Furthermore, it should be noted that the BirA* control in this experiment was 
performed using the original BioID, not the other two generations of the biotin ligase. Even though 
distinguishing the background proteins is done mainly based on the comparison with other samples and 
mutations, adding in an empty mitochondrial control specific for that biotin ligase could aid in this process.  
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Chapter 5: Maximising the set of known Rab1 effectors 
 
5.1 Introduction 
 
The MitoID study described in the previous chapters has identified many novel putative GTPase interactors, 
showing that MitoID is an effective tool for examining protein interactomes. In this chapter, we set out to 
use the MitoID approach to maximise the set of known Rab1 effectors and study this GTPase in more depth. 
 
Rab1 is an essential and highly conserved Rab GTPase, with orthologues present in most eukaryotes, 
ranging from protozoa to plants and humans (Klöpper et al., 2012). In mammals, Rab1 exists as two 
paralogues – Rab1A and Rab1B – which are predominantly found at the ER and Golgi membranes (X.-Z. 
Yang et al., 2016). While Rab1 is mainly known for being a key regulator of ER-to-Golgi membrane 
trafficking by tethering COPII-coated vesicles to the cis-Golgi, it is also reported to be one of the main 
targets of a Legionella pneumophila infection, an mTORC1 activator, and an oncogene (Hardiman & Roy, 
2014; Moyer et al., 2001; J. D. Thomas et al., 2014). Furthermore, mammalian Rab1 is found to localise to 
autophagosomes, specialised vesicles containing cellular contents to be degraded by autophagy (Zoppino 
et al., 2010).  
 
Even though many studies have investigated the role of the yeast orthologue of Rab1, Ypt1, in autophagy, 
a thorough understanding of the role of mammalian Rab1 in the initiation and regulation of autophagy is 
lacking. Relatively recent reports show contradicting results regarding the general effect Rab1A and Rab1B 
have on autophagy. One study reports that not only do GTP-locked and wildtype Rab1B co-localise with 
LC3, their expression levels affect the amount of autophagosomes in the cell; overexpression of GTP-
locked or wildtype Rab1B leads to an increase in autophagosomes and LC3-II levels, whereas depleting 
Rab1B with RNAi leads to a decrease in autophagosomes and LC3-II levels (Zoppino et al., 2010). 
However, Winslow and colleagues found the opposite to be true, observing an increase of LC3-II after 
Rab1B depletion (Winslow et al., 2010). Furthermore, yet another study reports Rab1A and Rab1B to co-
localise to ATG9-positive vesicles, and Rab1B to co-localise with LC3B and p62, another autophagosome 
marker (Kakuta et al., 2017). Of note, the lack of evidence of Rab1A co-localising with LC3B and other 
autophagy markers is due to a lack of a good Rab1A-specific antibody, not because of negative results. 
Interestingly, this study also reports that depletion of Rab1B increases the number and intensity of LC3B 
and p62 vesicles, which contradicts Zoppino and colleagues, while they also report that depleting Rab1A 
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not only decreases LC3B levels but also inhibits the recruitment of ATG9 to autophagosomes, contradicting 
Winslow and colleagues (Kakuta et al., 2017; Winslow et al., 2010; Zoppino et al., 2010). Comparing these 
results, it becomes apparent that research into the roles of Rab1A and Rab1B has led to discrepancies and 
contradictions within the field.  
 
Several other studies show links of mammalian Rab1 to autophagy that have remained undisputed. For 
instance, Webster and colleagues observed that GTP-bound Rab1A interacts with C9orf72, which functions 
as a link between Rab1A and the ULK1 complex and aids in the recruitment of the ULK1 complex to the 
phagophore (Webster et al., 2016, 2018). Furthermore, Mochizuki and colleagues have reported that Rab1B 
interacts with and regulates the localisation of MTMR6, a myotubularin-related protein known to play a 
role in autophagy (Mochizuki et al., 2013).  
 
Taken together with the yeast studies showing a link between Ypt1 and autophagy, these reports indicate 
that Rab1 has an additional, non-secretory function in the pathway leading to autophagy. Even though large 
gaps in knowledge remain regarding the function of Rab1 in autophagy, identifying novel Rab1 effectors 
and thus maximising the set of known effectors identified by the MitoID approach, could greatly aid in 
increasing our understanding of autophagy regulation. This is crucial because mis-regulation of autophagy 
can result in a range of human pathological conditions (Levine & Kroemer, 2008, 2019). Furthermore, it is 
not clear how Rab1 is able to distinctively regulate both autophagy and vesicle trafficking; whether this is 
regulated by specific and defined sets of Rab1 interactors or if certain interactors adjust their functions 
according to the stress state of the cell. In this study, we aim to find clarity in this intriguing phenomenon. 
 
Unfortunately, investigating Rab1 can be challenging due to the difficulty of performing certain traditional 
experimental methods such as depletion experiments and generating Rab1 knock-outs. Since Rab1 is 
essential, knocking out or severely depleting both paralogues would lead to significant cell death. However, 
Rab1A and Rab1B have 92% sequence similarity and they are partially redundant, which means that the 
effect of depleting only one of the two paralogues could be masked by the function of the other (Homma et 
al., 2019; Touchot et al., 1989).  
 
Furthermore, performing in vitro affinity chromatography experiments with Rab1 GTPases has proven to 
be challenging. Difficulties applying in vitro methods to Rab1 possibly arise because of the lack of 
necessary post-translational modifications (PTMs) when expressing Rab1 GTPases in bacteria (personal 
communication, Munro group). Moreover, certain proteins might not fold correctly when expressed in 
bacteria, since bacteria do not express the proteins which usually aid in this folding. One example of these 
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proteins is Mss4, a mammalian protein which has been reported to interact with several Rab GTPases 
including Rab1A and Rab1B and potentially function as a chaperone (Wixler et al., 2011). Challenges 
regarding commonly used experimental methods probably account for a number of contradicting results, 
as previously highlighted, and a relatively low number of published reports for a master regulator of two 
vital cellular processes. 
 
I aimed to shed light on the roles of Rab1A and Rab1B on autophagy, and investigate how these Rab 
GTPases are able to distinctively regulate vesicle trafficking and autophagy. In this study, I used the 
previously mentioned MitoID screen to identify and validate novel Rab1A and Rab1B interactors, hereby 
maximising the set of known Rab1 effectors and allowing for a thorough investigation into Rab1 function. 
Using in vivo methods such as MitoID, I hope to overcome previous issues regarding protein folding and 
missing PTMs. 
 
 
5.2 Results 
 
5.2.1 MitoID analysis identifies known and potential novel Rab1A effectors 
Utilising the MitoID screen, we were able to identify approximately 800 and 1200 proteins potentially 
interacting with Rab1A and Rab1B, respectively. Broadly examining the full list of Rab1A interactions, we 
observe a clear overlap between the Rab1A and Rab1B interactomes, suggesting a degree of redundancy 
(Fig. 5.1A). Moreover, the pattern of interactions with Rab1A shows some similarities to those of Rab5A, 
Rab8A, and Rab10, indicating that the Rab GTPases may function in the same or overlapping processes. 
Interestingly, aligning the full list for Rab1B reveals a much lesser degree of overlap with Rab5A, Rab8A, 
Rab10, and most interestingly Rab1A (Fig. 5.1B). This could either point to Rab1B having additional, 
isoform-specific functions, or to the Rab1B chimera picking up on a distinct set of background proteins, a 
difference that we will examine later in this section. 
 
5.2.1.1 Rab1A 
Looking closer at the triplicate runs of the Rab1A and Rab1B samples, several high-scoring proteins were 
identified which are known to interact with Rab1 (Fig. 5.2). For GTP-locked Rab1A, this includes the 
vesicle tether giantin (GOLGB1), the COG-complex component COG4, the inositol phosphatase OCRL, 
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Figure 5.1. Overview of putative interactomes and binding patterns of Rab1A and Rab1B. (A,B) Bubble plots showing MitoID results 
of BirA* control (BirA*-HA-MAO) and all tested GTP- and GDP-locked GTPases, as indicated. Plots aligned for Rab1A Q70L (A) and 
Rab1B Q67L (B) (yellow columns). Circle area corresponds to average WD-score from three biological replicates. T: GTP-locked form, 
D: GDP-locked form. Top 35 hits are shown. 
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and the Arp2/3 activator WHAMM (Fig. 5.2A) (Guo & Linstedt, 2013; Hayes et al., 2009; Hyvola et al., 
2006; Rosing et al., 2007; Russo et al., 2016; Saraste, 2016). 
 
Whereas the Arf GEF GBF1 has previously been reported to be a Rab1B interactor, no such binding 
experiments were done for Rab1A (Dumaresq-Doiron et al., 2010; Monetta et al., 2007). Akam and 
colleagues do show that Rab1A plays a role in GBF1 recruitment to the Golgi, hence it is perhaps 
unsurprising that we have found GBF1 to be enriched in GTP-locked samples of both Rab1A and Rab1B, 
compared to their inactive forms (Fig. 5.2A,B). 
 
While the presence of these previously known interactors indicates that the method is effective at 
identifying Rab1A interactors, our primary interest lays in the identification of putative novel interactors. 
One of the proteins enriched in GTP-locked Rab1A and Rab1B samples is GCC1/GCC88, a golgin known 
to play a role in retrograde trafficking from endosomes to the Golgi (Fig. 5.2A,B, Fig. 5.3) (Wong et al., 
2017). GCC88 has also recently been shown to regulate Golgi ribbon structure, through which it affects 
mTOR signalling and autophagosome formation, indicating a link to both vesicle trafficking and autophagy 
(Gosavi et al., 2018). While an interaction between GCC88 and Rab1 has at the time of writing not been 
previously reported, our data suggests that GCC88 is a novel effector for both Rab1A and Rab1B. 
 
GRIPAP1, also known as GRASP-1, was also found to interact with GTP-locked Rab1A and Rab1B but 
not with the GDP-locked Rab1 paralogues (Fig. 5.2A,B, Fig. 5.3). GRIP (glutamate receptor interacting 
protein 1) associated protein is known to function as a neuronal scaffolding protein and RasGEF (Ye et al., 
2000, 2007). In neurons, GRIPAP1 has been shown to promote endosome maturation by facilitating the 
transition between Rab4- and Rab11-positive recycling endosomes (Chiu et al., 2017). To date, an 
interaction between Rab1 and GRIPAP1 has not yet been reported, though our data suggests GRIPAP1 to 
be a putative effector for Rab1A and Rab1B – possibly playing a role in endosomes or in autophagosome 
interaction with the endocytic pathway (Fig. 5.2A,B, Fig. 5.3).  
 
AKAP10 (A-kinase anchoring protein 2/D-AKAP2) is a member of a family of scaffold proteins known as 
A-kinase anchoring proteins. AKAP10 binds the regulatory subunit of cAMP-dependent protein kinase A 
(PKA) and targets the kinase to various intracellular locations (A. S. Edwards & Scott, 2000). AKAP10 has 
previously been shown to have a nucleotide-dependent localisation to Rab4- and Rab11-positive 
endosomes, in addition to playing a role in the regulation of Rab4- and Rab11-positive recycling endosome 
morphology and Rab11 vesicle exocytosis (Sorvina et al., 2016). Our data suggests a previously unreported 
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interaction between AKAP10 and the GTP-locked mutants of Rab1A and Rab1B, suggesting that AKAP10 
is a novel Rab1 effector functioning in endosomal trafficking (Fig. 5.2A,B, Fig. 5.3). 
Interestingly, both GRIPAP1 and AKAP10 have been linked to the Rab4- and Rab11-positive endosomes, 
suggesting a link of this endosome subset with the Rab1 paralogues. Indeed, Rab1 has previously been 
recorded to function in the same cellular process with Rab4 and Rab11 – Rab1 has been shown to regulate 
transferrin recycling, which involves Rab4- and Rab11-positive endosomes (Mukhopadhyay et al., 2014). 
Further research is necessary to assess whether GRIPAP1 and AKAP10 are involved in these processes or 
whether they have additional functions as Rab1 effectors. 
 
Another protein that we have identified with the GTP-locked Rab1 isoforms but not to their GDP-locked 
states, is TBC1D23 (Fig. 5.2A,B, Fig. 5.3). While TBC1D23 is a member of the TBC (Tre-2/Bub2/Cdc16) 
family of Rab GAPs, it appears to lack GAP activity when tested on a broad panel of Rab GTPases (Marin-
Valencia et al., 2017). Even though it is still possible that the Rab GAP domain of TBC1D23 interacts with 
Rab GTPases in a non-regulatory capacity, a recent study by Shin and colleagues identified TBC1D23 as a 
bridging factor between golgins and endocytic vesicles, where the N-terminal Rab GAP domain of 
TBC1D23 interacts with golgins at the trans-Golgi, while the C-terminal domain interacts with the WASH 
complex on the surface of endosomes (J. J. H. Shin et al., 2017). Thus, while interactions between Rab 
GTPases and TBC1D23 have not yet been reported, it is not surprising that we have identified several 
possible interactions – TBC1D23 is enriched in GTP-locked Rab1A, Rab1B, and Rab8A samples, and to a 
much lesser extent in GTP-locked Rab10 and both GTP- and GDP-locked and Rab39 samples (Fig. 
5.1A,B). The strongest enrichment of TBC1D23 is identified in GTP-locked Rab1B samples, where it is 
found consistently in all three triplicates, while the potential interactor is found in two out of three triplicates 
for active Rab1A. (Fig. 5.2B). 
 
Rabaptin5 (RABEP1) is a well-characterised Rab5 effector, mostly known for its role in the regulation of 
early endosome trafficking ((Kälin et al., 2015, 2016)). We have found Rabaptin5 to be enriched 
specifically in GTP-locked Rab1A and Rab1B (Fig. 5.2A, Fig. 5.3), suggesting it to be a novel putative 
Rab1 effector. 
 
The protein phosphatase inhibitor PPP1R37, also called leucine-rich repeat-containing protein 68 
(LRRC68), is also found to be enriched in GTP-locked Rab1A and Rab1B samples, suggesting it plays a 
role as a Rab1 effector (Fig. 5.2A,B, Fig. 5.3). Besides the presence of five central leucine-rich repeats and 
a proline-rich stretch near the C-terminus, the protein remains largely uncharacterised and its function 
unclear, making it an intriguing potential Rab1 interactor to further investigate.  
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Figure 5.2. Identifying novel Rab1 effectors through MitoID. (A-D) Bubble plots showing MitoID results of GTP- and GDP-locked 
Rab1A and Rab1B and the BirA* control (BirA*-HA-MAO). Circle area corresponds to WD-score, calculated by comparing triplicates of 
all previously tested small GTPases. Plots are aligned for one of the triplicates using baits Rab1A Q70L (A),  Rab1B Q67L (B), Rab1A 
S25N (C), and Rab1B S22N (D), as indicated by yellow columns. Top 35 hits are shown. 
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Figure 5.3. Comparing the interactomes of GTP-locked Rab1A and Rab1B. (A) Plot of WD-scores of potential interactors of GTP-
locked Rab1A and Rab1B. The WD-scores shown represent means of triplicate biological repeats. Several potential or known interactors 
are highlighted in orange and labelled, whereas Rab1A/B themselves are labelled in dark brown. The y-axis (GTP-locked Rab1B) shifts in 
increments after the break, as annotated.  
 
 
The myotubularin PI3-phosphatase MTMR6 has been found to interact with the GTP-locked mutants of 
both Rab1A and Rab1B (Fig. 5.2A,B, Fig. 5.3). Previously, MTMR6 has been shown to be regulated by 
Rab1B in both secretory and autophagic pathways, however, our data suggests that MTMR6 associates 
with both Rab1A and Rab1B to possibly regulate both vesicle trafficking and autophagy (Mochizuki et al., 
2013). 
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Another novel putative Rab1A and Rab1B effector is CALCOCO1 (calcium-binding and coiled-coil 
domain-containing protein 1), a protein of unknown function (Fig. 5.2A,B, Fig. 5.3). CALCOCO1 contains 
3 relatively large coiled-coil domains and an N-terminal SKICH domain. BLAST alignments show that this 
domain scheme is also present in the autophagy receptors NDP52 (CALCOCO2) and TAX1BP1 
(CALCOCO3), suggesting that CALCOCO1 plays a role in the regulation of autophagy (Y. Yang et al., 
2015). Interestingly, TAX1BP1 is specifically enriched in GTP-locked Rab1B samples, suggesting it to be 
a Rab1B specific effector (Fig. 5.2B, Fig. 5.3). 
 
Interestingly, we also identified multiple subunits of a class III phosphatidylinositol 3-kinase (PI3K) 
complex that bind to active Rab1A and Rab1B. The PI3K complexes contains 7 subunits, which are able 
to form two related complexes, both of which share a core of PIK3C3 (VPS34), PIK3R4 (VPS15) and 
BECN1 (Beclin-1)  (Ohashi et al., 2018). ATG14L and NRBF2 form an autophagy-specific complex 
(complex I) on phagophore membranes along with the core three subunits, whereas the complex existing 
of the core, UVRAG, and RUBCN, is present on endosomal membranes (complex II) (Ma et al., 2017; 
Ohashi et al., 2016). We identified the two core subunits PIK3C3 and PIK3R4 and the complex I-specific 
subunit NRBF2 to be enriched in GTP-locked Rab1A and Rab1B samples compared to their GDP-locked 
forms (Fig. 5.2A,B, Fig. 5.3). Notably, the three mentioned PI3K subunits have also been consistently 
identified in GTP-locked Rab5A samples, which is unsurprising since Rab5 is known to be involved in 
PI3K activity (Fig. 5.1A,B) (H.-W. Shin et al., 2005). 
 
Finally, examining GDP-locked Rab1A, we find the TRAPPIII component TRAPPC8 to be enriched in 
both GDP-locked Rab1A and Rab1B (Fig. 5.2C,D). TRAPPIII is a known GEF for the yeast homologue of 
Rab1 (Ypt1) and Drosophila melanogaster Rab1, and while this interaction has not yet been reported for 
mammalian Rab1, it is likely to be a conserved function (Riedel et al., 2017; L. L. Thomas et al., 2018).  
 
Another protein that is enriched in GDP-locked Rab1A, is the exocyst component EXOC7 (Fig. 5.2C). The 
exocyst is a multi-subunit protein complex that mediates tethering of secretory vesicles to the plasma 
membrane (Mei & Guo, 2018). A recent study has shown that Rab1 activation is necessary for the 
recruitment of the exocyst complex to Legionella-containing vacuoles (LCVs), in mammalian cells with a 
Legionella pneumophila infection (Arasaki et al., 2018). While the role of Rab1 on LCVs is studied 
extensively, and it is known that the Legionella protein DrrA functions as a Rab1 GEF, the link between 
GDP-locked Rab1A and the exocyst has not yet been reported. Interestingly, the original study showing the 
functionality as DrrA as a Rab1 GEF uses both Rab1A and Rab1B tools for different experiments, which 
suggests that DrrA functions as a GEF for both Rab1 paralogues and thus also that both Rab1 paralogues 
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are involved with LCVs (Murata et al., 2006). However, our data indicate that only GDP-locked Rab1A 
interacts with the exocyst, of which the only reported link to date is the LCVs. Since only one component 
of the exocyst complex is identified, further research is necessary to study whether the Rab1A-exocyst 
interaction is true, and whether this interaction has a function outside of a Legionella-infection background. 
 
5.2.1.2 Rab1B 
Although a lot of overlap is found between the interaction partners of GTP-locked Rab1A and Rab1B, there 
are also stark differences. At first glance, the amount of non-specific background appears to be strongly 
reduced in the Rab1B samples when compared to Rab1A (Fig. 5.1, Fig. 5.2). Upon closer examination, 
however, we find that a several of the ‘specific’ Rab1B hits appear to be DNA/RNA-binding proteins (such 
as PUM1, CUX1, and BRD4) and proteins thought to be linked to voltage-dependent membrane channels 
(such as GPR89A, CACHD1, and CLCN7), indicating non-specific background (Fig. 5.2B). These (likely) 
background proteins possibly appear to be top hits because they are not found in other baits in the MitoID 
screen, the cause of this discrepancy is unclear – it is unlikely that the Rab1B chimeras are less stable than 
Rab1A, since many Rab1 interactors bind more strongly to Rab1B than to Rab1A.  
 
Numerous proteins stand out for being possible Rab1B-specific effectors. Interestingly, the MitoID method 
has picked up many more potential Rab1B-specific effectors than for Rab1A (Fig. 5.2A,B, Fig. 5.3). This 
could be explained by Rab1B being approximately four times more abundant than Rab1A in cultured 
HEK293T cells; since endogenous Rab1B is more abundant than endogenous Rab1A, it is likely that its 
effectors are also more abundant, which increases the likelihood of identifying them (Georg Borner, 
personal communication). The discrepancies and similarities between the Rab1A and Rab1B interactomes 
identified through MitoID are visualised in Figure 5.3 (note the different increments in the axes). 
 
While the C-type lectin family 16 member A (CLEC16A) is also present in one of the GTP-locked Rab1A 
triplicates, it is consistently enriched in GTP-locked Rab1B samples (Fig. 5.2A,B, Fig. 5.3). CLEC16A is 
a membrane-associated endo-lysosomal protein which regulates mitophagy (Soleimanpour et al., 2014). 
Previously, CLEC16A has been shown to down-regulate starvation induced autophagy by stimulating 
mTOR activity (Tam et al., 2017). Interestingly, Tam and colleagues also found CLEC16A to relocate to 
the Golgi upon starvation. Although the Drosophila melanogaster ortholog of CLEC16A has been found 
to interact with D. melanogaster Rab39, a close relative of human Rab2, no interaction with Rab1 has been 
reported. Our data suggests CLEC16A to be a putative novel Rab1A and Rab1B effector, possibly 
functioning in autophagy initiation or regulation. 
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Interestingly, several proteins involved in cytoskeletal regulation are specifically and consistently enriched 
in GTP-locked Rab1B samples. For example, CARMIL1 (LRRC16A) is known to bind barbed end actin 
capping proteins, is involved in Rac1 activation, and is necessary for cell migration (M. Edwards et al., 
2013; Liang et al., 2009). Moreover, the actin nucleation promoting factor WHAMM (WASP homologue 
associated protein with actin, membranes and microtubules) is known to bind to (and be regulated by) Rab1 
(Russo et al., 2016). In addition, WHAMM is also known to bind to microtubules and intracellular 
membranes and has recently been shown to function on autophagosomes; initiating autophagosome 
tubulation by promoting actin polymerisation (Dai et al., 2019; Tianyang Liu et al., 2017). Finally, one of 
the top hits for Rab1B is the motor protein KIF18A which has recently gained notoriety as a negative 
outcome marker for several types of cancer (Alfarsi et al., 2019; F.-T. Chen & Zhong, 2019; Luo et al., 
2018). In healthy cells, KIF18A is mostly reported to be involved with mitotic spindle assembly (Janssen 
et al., 2018; F. Yang et al., 2015) (Fig. 5.2B, Fig. 5.3). 
 
Furthermore, the potential Rab1B-specific effectors neogenin (NEO1) and FAM160B1 both show links to 
neuronal differentiation or pathologies (Fig. 5.2B). While the function of FAM160B1 remains elusive, a 
cellular deficit of this protein is associated with neurological pathologies such as microcephaly and severe 
intellectual disability (Mavioğlu et al., 2019). Neogenin, on the other hand, is known to be a transmembrane 
receptor expressed by differentiating neurons in the central nervous system, and has been shown to bind to 
the axon guiding molecule RGM (repulsive guidance molecule) (Wilson & Key, 2007). It remains unknown 
why several potential Rab1B interactors act on neuronal cells and processes, further research is necessary 
to elucidate whether they are true effectors and what function they fulfil. 
 
Interestingly, we also identify several components of multi-subunit protein complexes involved in 
endosomal trafficking to be potential Rab1B effectors. Vps50/Syndetin is a component of the EARP 
(endosome-associated recycling protein) complex, which was found to be specifically enriched in GTP-
locked Rab1B samples (Fig. 5.2B). Vps50 is known to localise to Rab4-positive recycling endosomes, 
promoting the recycling of internalised transferrin receptor (Schindler et al., 2015; Spang, 2016). The 
CHEVI (class C homologues in endosome-vesicle interaction) complex component VPS33B is also 
enriched in GTP-locked Rab1B samples (Fig. 5.2B, Fig. 5.3). While the exact function and composition of 
CHEVI remain elusive, the tethering complex is thought to be involved in recycling and the biogenesis of 
certain lysosome related organelles (Beek et al., 2019; Rogerson & Gissen, 2016). 
Similarly to Rab1A, inactive Rab1B also interacts with components of the TRAPPIII complex – both 
TRAPPC8 and TRAPPC9 are enriched in GDP-locked Rab1B samples (Fig. 5.2D). While TRAPPIII is a 
known Rab1 GEF, several novel proteins stand out for being enriched specifically in GDP-locked Rab1B 
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samples (L. L. Thomas et al., 2018). Several top hits appear to be DNA/RNA-binding proteins (HNRNPH1 
and SF3A1) and are thus unlikely to be true GEFs (Fig. 5.2D) (Y. Li et al., 2018; Martelly et al., 2019). 
The same is true for the E3-ubiquitin ligase TRIP12, which is known to function in DNA damage response 
and thus unlikely to function as a Rab GEF (Fig. 5.2D) (Xiaoliang Liu et al., 2016).The most likely of these 
being a true Rab1 GEF, is the known Rab35 GEF DENND1A (Langemeyer et al., 2014) (Fig. 5.2D). Rab35 
shows high sequence overlap with Rab1A and Rab1B, especially in the N-terminal and mid domains, and 
is therefore also called Rab1C (Klinkert & Echard, 2016). Although no interaction has been reported 
between Rab1A/Rab1B and DENND1A, the high degree of similarity with Rab35 makes it possible that 
they share certain interactors or regulators, and it is thus conceivable that DENND1A could function as a 
Rab1 effector or GEF. Interestingly, a study examining DENN domain exchange factors reported no 
detectable GEF activity of DENND1A on Rab1A or Ra1B (Yoshimura et al., 2010). However, it should be 
noted that the Rab GTPases used in this study were purified from bacteria, which could cause Rab1 to not 
be capable of being activated in their assay.  
 
Taken together, we were able to identify several known Rab1 effectors, validating the effectiveness of the 
method, and identify numerous putative novel Rab1A and Rab1B interactors. Many potential interactors 
appear to bind to both Rab1A and Rab1B, though a subset of the hits seem to be paralogue-specific. Next, 
we aim to increase the set of known Rab1 effectors by performing validation experiments on the 
aforementioned hits. 
 
5.2.1.3 Comparing identified interactomes with different biotin ligase generations 
As previously discussed for Rab6A and Rab11A in paragraph 4.2.3, we tested different generations of the 
BirA* biotin ligase with the aim of identifying different interactors. In order to pursue this, we used the 
same chimera lay-out and simply exchanged the biotin ligase for that of a different generation, meaning 
that all these tested chimeras are redirected to the mitochondria and should have similar expression levels. 
Even though we expect the comparison between the biotin ligases to be similar for Rab1A as we found for 
Rab6A and Rab11A, it is valuable to investigate this since novel effectors could possibly be identified. 
Previously, we have found that BioID and BioID2 are more effective than TurboID in detected Rab6A- and 
Rab11A-specific interactors; the hits detected through BioID and BioID2 show overlap with each other and 
align with literature, whereas TurboID appears to create more background. 
We find that the proteins that are specific for the original BioID and GTP-locked Rab1A include several 
proteins that are involved with microtubule/cilia; even though the seemingly specific occurrence of 
TUBA1C/tubulin alpha is most likely an anomaly, the axonemal proteins DNAAF5/dynein assembly factor 
5 and DNAH5/dynein heavy chain 5 are potential true interactors (Fig. 5.4A). Moreover, several BioID-
 98 
specific hits are known to play in role in vesicle trafficking, including the GTPase-activating protein 
CHN2/ARHGAP3, OPTN/optineurin, and SNX4, all of which are potential true effectors. Finally, multiple 
proteins that are enriched only in the original BioID samples are likely background proteins, such as the 
ER mannosidase MAN1B1, the zinc transporter SLC30A1, and RNA/DNA binding proteins MCM7 and 
EIF4A2. Interestingly, none of these proteins are picked up by the empty mitochondrial BirA* control, 
which is probably due to the fact that hits that appear in fewer columns get a higher WD-score and will thus 
appear higher in the list.  
 
Examining proteins that are enriched only in the BioID2 sample with GTP-locked Rab1A, we identified 
multiple potential novel Rab1A interactors. These include several proteins related to vesicle sorting and 
tethering (UHRF1BP1, VPS13B, VPS33B, VPS54, GGA2, and FCHSD2) and potential Rab GAPs 
TBC1D5 and TBC1D13 (Fig. 5.4B). Furthermore, the previously mentioned CALCOCO1-related 
TAX1BP1, the scaffolding protein AKAP9, and the F-actin uncapping protein CARMIL1/LRRC16A are 
also potential Rab1 effector candidates. As expected, several proteins that are specifically enriched in the 
BioID2 sample are likely non-specific background proteins, such as the mitochondrial proteins ATAD3B 
and ALDH1L2, the oxidative damage regulator OXR1, and the oxidoreductase DHRS7B. 
 
However, the GTP-locked Rab1A TurboID samples include many more proteins that are likely to be non-
specific background, such as the DNA-binding proteins DNASE2B, ZNF512B, and LRRFIP1, nuclear 
import factor KPNA3, mitochondrial import factor TIMM44, and NADPH reductase CBR1 (Fig. 5.4C). 
Potential true Rab1 effectors that are enriched solely in the TurboID samples are PAK2, an effector of 
Cdc42 and Rac1, and AP3B1, a subunit of the AP3 complex which is involved in vesicle cargo sorting. 
 
Numerous proteins are enriched in multiple GTP-locked Rab1A samples. The three main hits that are 
identified with all three biotin ligase generations are the PI3K component PIK3R4, the myotubularin related 
protein MTMR6, and the vesicle bridging factor TBC1D23, all of which have been discussed above (Fig. 
5.4A-C). Furthermore, the known Rab1A GEF subunit TRAPPC8 is found in all three GDP-locked Rab1A 
samples, further confirming its validity (Fig. 5.4D). 
 
Although there is hardly any overlap between the interactomes identified by TurboID and the other biotin 
ligases, there is significant overlap between the original BioID and BioID2. Numerous proteins that are 
enriched in both GTP-locked Rab1A samples are either previously known Rab1A effectors or are proteins 
that we have previously discussed in detail. These proteins include COG4, CALCOCO1, INPP5B, NRBF2, 
PIK3C3, RABEP1, USO1/p115, and GRIPAP1 (Fig. 5.4A,B). 
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Figure 5.4. Several generations of BioID produce a different sets of potential interactors for Rab1A. (A-D) Bubble plots showing 
MitoID results of GTP- and GDP-locked Rab1A, Rab6A and Rab11A. Different BirA* generations were cloned into Rab-BirA*-HA-
MAO constructs, to give ID1 (BioID), ID2 (BioID2) and IDT (TurboID). Circle area corresponds to S-score, calculated by comparing 
single replicates of the baits shown. BirA* is a control showing mitochondrial background levels (BirA*-HA-MAO) and contains the 
original BioID biotin ligase. Plots are aligned for GTP-locked Rab1A chimeras containing BioID (A), BioID2 (B), and TurboID (C), and 
the BioID-GDP-locked Rab1A (D) (yellow columns). Top 35 hits are shown. 
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It should be noted that several possible Rab1 effectors that were picked up by BioID2 or TurboID but not 
the original BioID, were in fact picked up in one or more of the triplicate runs in the MitoID screen using 
the original BioID. For instance, TAX1BP1 is strongly enriched in all three GTP-locked Rab1B samples 
and in one of the GTP-locked Rab1A samples, while in our biotin ligase comparison experiment it was only 
identified when BioID2 was used (Fig. 5.2B, Fig. 5.4B). This discrepancy is likely due to this experiment 
only consisting of a single run per biotin ligase, which will be less likely to pick up less abundant interactors 
than duplicate or triplicate runs are. While this would indicate that our biotin ligase comparison experiment 
is not as conclusive, it does give us a rough idea of the efficiency and specificity of the biotin ligases. 
Interestingly, other similar proteins were originally identified as possible Rab1B – but not Rab1A – binders, 
including UHRF1BP1, VPS33B, and CARMIL1, whereas they are enriched in GTP-locked Rab1A samples 
when BioID2 was used (Fig. 5.2B, Fig. 5.4B). The validity of the identified interactors can be tested by, for 
instance, Western blotting, to determine whether the proteins are present in GTP-locked Rab1A samples. 
 
Together, these results lead to similar conclusions as previously drawn in paragraph 4.2.3 – using the 
original BioID and BioID2 lead to a large degree of overlap in the interactors they identify, whereas the use 
of TurboID causes more suspected background proteins to be enriched. However, as mentioned in the 
discussion of Chapter 4, the use of BioID2 and TurboID have not been optimised to the same degree as the 
original BioID in this set-up. Furthermore, it is likely that the different generations of BirA biotin ligases 
are useful in different types of experiments, as also discussed in Chapter 4. Taken together, the proteins 
that most intrigued us as potential Rab1A and/or Rab1B interactors are GCC88, CALCOCO1, Rabaptin5, 
AKAP10, GRIPAP1, PPP1R37, and the VPS34/VPS15/BECN/ATG14L/NRBF2 PI3K-complex. 
 
5.2.2 Maximising the set of validated Rab1 effectors 
The main aim of our study is to gain more understanding of the functioning of the Rab1 paralogues and 
their effectors. In order to study this, it is essential to maximise the set of true, known Rab1 effectors. As 
discussed in the previous paragraph, the MitoID approach has highlighted numerous potential novel Rab1A 
and Rab1B effectors. In order to validate these potential interactors we applied both biochemical and 
immunofluorescence-based techniques to several of the hits. 
First, to confirm the presence of the hits in the MitoID samples and thus validate the identification by mass 
spectrometry, we performed Western blots of the samples and probed with antibodies to the interactors. We 
were able to identify the interactions of the putative effectors GCC88, CALCOCO1, Rabaptin5, AKAP10, 
GRIPAP1 and PPP1R37 in GTP-locked Rab1A and Rab1B samples (Fig. 5.5A). Interestingly, GCC88, 
Rabaptin5, AKAP10, and GRIPAP1 appear to be strongly enriched in Rab1B samples compared to Rab1A, 
though this is not reflected in the mass spectrometry data (Fig. 5.2A).  
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Figure 5.5. Validation of mass spectrometry identification of potential Rab1 interactors. (A) Western blot of MitoID samples of GTP- 
and GDP-locked Rab1A and Rab1B, probed with antibodies against GCC88, CALCOCO1, Rabaptin5, AKAP10, GRIPAP1, PPP1R37 
and HA (loading control), as indicated. Input: wildtype HEK293T lysate. (B) Immunofluorescence micrographs of HeLa cells expressing 
the GTP-locked Rab1A chimera and stained for HA (internal chimera tag), CALCOCO1, and TGN46 (trans-Golgi marker). (C) 
Immunofluorescence micrographs of HeLa cells expressing GTP-locked Rab2A chimera and stained for HA (internal chimera tag), 
MTCO2 (mitochondrial marker), and GCC185 (Golgi marker and known Rab2A effector) (of note; this GCC185 antibody shows 
significant nuclear staining).  
 
 
We then aimed to validate the potential new Rab1 interactors by visualising whether the hits are effectively 
recruited to the chimera at the mitochondria. When expressing Rab1A chimeras in HeLa cells and probing 
against the potential effector CALCOCO1, we found the effector to remain localised at the Golgi (Fig. 
5.5B). After testing several potential Rab1 effectors and in all cases observing that the proteins remained at 
their endogenous location, we decided to test whether a well-established Rab-effector couple could be 
validated through this method. Interestingly, overexpression of the GTP-locked Rab2A chimera did not 
result in relocation of its established effector GCC185, which suggests that visualising recruitment might 
not be an efficient method of validation of interactions with Rabs (Fig. 5.5C) (Hayes et al., 2009). 
A possible reason for this is that the interactions between the GTPases and their effectors tend to be transient 
and don't allow for stable mitochondrial recruitment. In order to try to overcome this, we exogenously over-
expressed the potential effectors alongside the Rab chimeras. As shown in Figure 5.6, Rabaptin5-FLAG 
was recruited by mitochondrially localised GTP-locked Rab1A. Occasionally, partial re-localisation was 
observed, where Rabaptin5 was found both at the Golgi apparatus and on the mitochondria (Fig. 5.6, middle 
panel). When co-expressed with GDP-locked Rab1A, Rabaptin5 showed no recruitment to mitochondria, 
even in highly expressing cells (Fig. 5.6, lower panel). 
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Figure 5.6. Recruitment of Rabaptin5 by mitochondrially localised Rab1A. Confocal micrographs of HeLa cells expressing Rabaptin5-
FLAG and Rab1A chimeras, as indicated. Cells are probed against HA (internal chimera tag), FLAG, and the Golgi marker giantin. T: 
GTP-locked, D: GDP-locked. Scalebars: 10 μm. 
 
 
 
CALCOCO1-FLAG, on the other hand, remained dispersed/peri-nuclear when co-expressed with GTP-
locked Rab1A but was recruited to the mitochondria by GTP-locked Rab1B. No recruitment was observed 
by either GDP-locked Rab1 chimeras (Fig. 5.7).  
 
Next, PPP1R37 was N-terminally tagged with the Myc epitope and co-expressed with mitochondrially 
localised Rab1 chimeras. Clear recruitment is observed for both GTP-locked Rab1 paralogues, whereas 
GDP-locked Rab1 does not show any mitochondrial recruitment (Fig. 5.8). In cells not expressing GTP-
locked Rab1, Myc-PPP1R37 appeared largely dispersed and occasionally punctate. The nature of these 
puncta will be further examined in Chapter 6.  
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Figure 5.7. Recruitment of CALCOCO1 by mitochondrially localised Rab1. Confocal micrographs of HeLa cells expressing 
CALCOCO1-FLAG and Rab1 chimeras, as indicated. Cells are probed against HA (internal chimera tag), FLAG, and the Golgi marker 
giantin. T: GTP-locked, D: GDP-locked. Scalebars: 10 μm. 
 
 
Another way to validate the interactions is by in vitro affinity chromatography experiments. Since Rab1 
has proven to be challenging to work with in several in vitro experiments, namely when bacterially 
expressed Rab1 is used, I decided to use a more native expression system. Using Sf9 insect cells and a 
baculoviral expression system, the GST-fused Rab1 forms were expressed in a background that likely 
allows for native protein folding and any post-translational modifications. Both N- and C-terminally GST-
tagged Rab1 were tested, to maximise the chance of identifying binding interactors. Mixing HEK293T 
lysate with beads coated in GST-fused Rab1 and then eluting binding proteins off the beads with SDS-
based lysis buffer, Rab1-interacting proteins were isolated. Western blots of these samples indicate that 
CALCOCO1 and CLEC16A specifically interact with GTP-locked Rab1A and Rab1B (Fig. 5.9A). 
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Interestingly, CALCOCO1 shows additional bands which are smaller than expected, here occurring in 
GDP-locked GST-Rab1 samples, though these are most likely degradation bands. AKAP10 also shows a 
clear band for GTP-locked Rab1A-GST at a lower size, and thus more research is needed to test whether 
this is a true interactor and where this discrepancy arises from.  
 
 
 
Figure 5.8. Recruitment of PPP1R37 by mitochondrially localised Rab1. Confocal micrographs of HeLa cells expressing Myc-
PPP1R37 and Rab1 chimeras, as indicated. Cells are probed against HA (internal chimera tag), Myc, and the mitochondrial marker COXIV. 
T: GTP-locked, D: GDP-locked. Scalebars: 10 μm. 
 
 
Although PPP1R37 appears to be a very specific and strong hit for GTP-locked Rab1A and Rab1B, this 
interaction could not be identified through affinity chromatography with wildtype HEK293T lysate and 
Sf9-expressed Rab1 (Fig. 5.9A). With the aim to overcome this, affinity chromatography experiments were 
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performed using Sf9-expressed Rab1 chimeras, now applying lysate from HEK293T cells overexpressing 
FLAG-PPP1R37. Probing the resulting Western blot with anti-FLAG shows a clear interaction between 
FLAG-PPP1R37 and GTP-locked Rab1A and Rab1B, tagged with GST on either terminus (Fig. 5.9B). 
 
 
Figure 5.9. In vitro affinity chromatography experiments validate several novel Rab1 effectors. (A) Affinity chromatography of GST-
Rab1 and Rab1-GST with wildtype HEK293T lysate. GST-fused Rab1 variants were expressed in Sf9 with the aid of the baculoviral 
system. Western blots were probed against several antibodies, as indicated. Input: wildtype HEK293T lysate, T: GTP-locked, D: GDP-
locked. (B) Affinity chromatography of GST-Rab1 and Rab1-GST with lysate of HEK293T cells overexpressing FLAG-PPP1R37, probed 
against FLAG. GST-fused Rab1 expressed in Sf9 cells, as in (A). Input: lysate of HEK293T cells expressing FLAG-PPP1R37, T: GTP-
locked, D: GDP-locked. (C) Mass spectrometry results of the GST-based affinity chromatography samples used in (A). Several proteins 
of interest are shown for GTP- (T) and GDP-locked (D) Rab1A and Rab1B. Circle area corresponds to spectral counts.  
 
 
Examining the samples obtained by affinity chromatography with HEK293T lysate and Rab1-GST by mass 
spectrometry, validated effectors such as CALCOCO1 and CLEC16A were confirmed (Fig. 5.9C). 
Furthermore, several previously known Rab1 interactors such as Giantin, MTMR6, OCRL1, and Golgin-
84, were also identified. Together, this suggests that the purified Rab1-GST is functional and effective for 
affinity chromatography experiments.  
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Further studying the proteins detected by mass spectrometry, several additional interesting hits were 
identified (Fig. 5.9C). Firstly, the affinity chromatography data suggests that the previously mentioned 
autophagy receptor TAX1BP1 (also known as CALCOCO2) is a possible effector for both Rab1A and 
Rab1B, while the MitoID data showed enrichment solely in GTP-locked Rab1B samples (Fig 5.2B, Fig. 
5.8C). Moreover, the myotubularin related protein MTMR9 is strongly enriched in GTP-locked Rab1A and 
Rab1B samples, suggesting an interaction with both Rab1 paralogues. Even though MTMR9 is known to 
interact with MTMR6, a known Rab1B effector, the interaction between MTMR9 and Rab1A has only very 
recently been reported (Doubravská et al., 2019; Zou et al., 2009). 
 
With regards to potential new effectors, the three ubiquitin-like proteins Atg5, Atg12, and Atg16L1 were 
found to be enriched in GTP-locked Rab1A and Rab1B samples (Fig. 5.9C). Interestingly, Atg5, Atg12, 
and Atg16 are known to form a complex that regulates autophagosome formation by tethering proteins such 
as Atg8 and Atg3 to the membrane, though any interaction with Rab1 has so far remained unreported 
(Walczak & Martens, 2013). Furthermore, although the ATPase transport subunits ATP1A1 and ATP2A2 
were found to interact specifically with GDP-locked Rab1A and Rab1B, they are unlikely to be true Rab1 
regulators. COPA, a subunit of the coatomer complex, is a more likely candidate for truly interacting with 
inactive Rab1 (Fig. 5.9C). The coatomer is a cytosolic complex that associates with vesicles with the aid of 
Arf1 and hereby forms the COPI coat (Arakel & Schwappach, 2018). Although an interaction between 
Rab1 and the coatomer remains unreported, the TRAPPII complex has been reported to interact with both 
GDP-locked Rab1 and the COPI coat, making this a potential link between the two proteins (Yamasaki et 
al., 2009). It should be noted, however, that the GST-based affinity chromatography method was unable to 
identify any TRAPP complex subunits, underscoring the potentiality of a direct link between the coatomer 
and inactive Rab1 (Fig. 5.9C). 
 
Interestingly, there are some minor inconsistencies when using the different validation methods – some 
proteins will appear to bind through immunofluorescence but not through affinity chromatography, or the 
other way around. Most notably, Rabaptin-5 does not appear to show any binding to active Rab1 through 
affinity chromatography, but shows clear recruitment to active mitochondrial Rab1 when using 
immunofluorescence (Fig. 5.8, Fig. 5.9A). Conversely, mitochondrial re-localisation experiments suggest 
that CALCOCO1 is only recruited by mitochondrial active Rab1B and not Rab1A, while the affinity 
chromatography data shows that CALCOCO1 binds to both GTP-locked paralogues, albeit stronger to 
Rab1B (Fig. 5.8, Fig. 5.9A).  
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5.3 Discussion 
 
Using the MitoID approach set out in Chapters 2, and 3, Rab1A and Rab1B were examined – two Rab1 
paralogues known to function in ER-to-Golgi and endosomal trafficking, as well as playing an as of yet 
unknown role in autophagy. By performing triplicate MitoID experiments of GTP- and GDP-locked Rab1A 
and Rab1B, and comparing them against the full set of tested small GTPases, several previously known 
Rab1 interactors, as well as numerous potential novel Rab1 effectors, were identified.  
As previously discussed, studying Rab1 in vitro has been challenging in the past, likely due to a combination 
of factors including incorrect folding and lack of necessary PTMs of the bacterially expressed protein. It 
remains unclear which modifications would influence which interactions, although Rab1 has previously 
been shown to be phosphorylated and can be phosphocholinated or AMPylated during to pathogen invasion 
(Mukherjee et. al, 2012; Levin et. al, 2016; Du et. al, 2021). Furthermore, the presence or absence of PTMs 
can greatly affect their ability to bind interaction partners such as GDIs, GEFs, GAPs, or other effectors 
(Shinde & Maddika, 2018),. 
 
Even though our MitoID set up does not study the true endogenous situation, it allows us to study Rab1 in 
vivo and therefore could highlight novel Rab1 interactors. Moreover, MitoID is a much more sensitive 
detection method than traditional affinity chromatography – while the background is inherently higher, the 
in vivo proximity labelling approach over a relatively large period of time (48 hours transfection, 18 hours 
exogenous biotin addition) also inherently allows for the detection of weaker and more transient 
interactions. It is therefore unsurprising that a relatively large amount of potential new interactors for 
Rab1A and Rab1B were identified, most notably Rabaptin5, CALCOCO1, GRIPAP1, AKAP10, 
CLEC16A, PPP1R37, GCC88, and several components of the autophagy-specific PI3-kinase complex 
(NRBF2, VPS34, and VPS15). 
 
As previously done for Rab6A and Rab11A, the Rab1A interactors identified by the BirA* used in the 
original BioID method, were compared to those identified with other generations of biotin ligases (BioID2, 
TurboID). Similar to Rab6A and Rab11A, the Rab1A BioID and BioID2 datasets share a relatively large 
amount overlap, whereas the TurboID experiment seems to result in more non-specific background. 
Studying the resulting datasets, I was most interested in proteins that are either present in both BioID and 
BioID2 or in all three tested biotin ligases. As largely expected, comparing the interactomes did not 
highlight any additional potential effectors, but rather underscored the proteins I wished to study further, 
such as CALCOCO1, Rabaptin5, GRIPAP1, and the PI3K complex. 
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As a first step of validating the potential interactors, the MitoID samples were resolved by Western blot 
and probed against potential interactors. This confirmed the enrichment of  GCC88, CALCOCO1, 
Rabaptin5, AKAP10, GRIPAP1, and PPP1R37 in GTP-locked Rab1B, while only CALCOCO1, 
Rabaptin5, and PPP1R37 appeared enriched in GTP-locked Rab1A samples.  
 
Interestingly, the PPP1R37 antibody highlights two bands, one band at approximately 85 kDa and one at 
approximately 120 kDa. The lower band most likely contains the wildtype, unmodified protein, running 
slightly higher than the expected molecular weight of 75 kDa. The higher band could represent protein that 
has been post-translationally modified, and the pattern of binding suggests that Rab1 would preferentially 
interact with PPP1R37 containing PTMs. It remains unclear which PTM(s) could result in a 35kDa shift in 
weight, although the considerable size of the shift indicates that numerous modifications occur on the same 
protein. The platforms iPTMnet proposes 12 phosphorylation sites which are largely located in the C-
terminal region of the protein. Although these phosphorylation sites together do not fully add up to the 
observed shift in weight, considerable protein phosphorylation is known to cause proteins to run slower on 
SDS-PAGE and thus appear to be (much) bigger than they truly are. 
Further research needs to be done to elucidate which modifications PPP1R37 receives, and how these 
modifications influence its interaction with Rab1. 
 
Next, the interactions between Rab1 and the proteins listed above were validated. For CALCOCO1, 
Rabaptin5, and PPP1R37, the interactions were validated by ectopically localising active Rab1 to the 
mitochondria and observe whether the potential interactors are recruited there. However, upon 
overexpression of AKAP10, GRIPAP1, and CLEC16A, the potential interactors remained dispersed 
throughout the cell and were not observed to co-localise with any of the Rab1 chimeras (CLEC16A shown 
in Fig. 6.8A, others not shown). Several immunofluorescence experiments were performed using Rab1A 
and Rab1B solely tagged with an HA epitope, with the aim of keeping the endogenous localisation of the 
Rab1 paralogues – perhaps certain potential interactors require their endogenous environment and lipid 
composition to interact with Rab1. However, no co-localisation was observed of the HA-Rab1 paralogues 
with the potential interactors, suggesting that the inability to observe the interaction by mitochondrial 
recruitment is not due its ectopic location (data not shown). 
 
Through affinity chromatography, the interactions between Rab1 and GCC88, CALCOCO1, AKAP10, 
PPP1R37, and CLEC16A, were confirmed. Although the interaction of Rab1 with GRIPAP1 remained 
unvalidated, this does not mean that it is not a true interactor. When using affinity chromatography or 
visualising the recruitment of interactors, only the sufficiently strong and stable interactions will be 
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detected. The ability to detect weaker and more transient interactions is one of the main advantages of the 
MitoID technique, however, confirming these types of interactions is a challenge. With the aim of finding 
a novel method of interaction validation, I attempted to combine the recruitment visualisation with the split-
GFP method; fusing the Rab and the potential interactor to GFP fragments, so that when they interact they 
not only form a functional GFP, but they also remain bound together, solving the problem of visualising 
transient interactions. As yet, this method needs further improvement and optimisation, hence a 
combination of affinity chromatography and the visualisation of recruitment was used in this study. 
Unfortunately, until validation methods are developed that allow for the detection of weaker and transient 
interactions, it is inevitable that certain interactors might be disregarded. Further research and method 
development is necessary to overcome this challenge. 
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Chapter 6: Examining the roles of novel Rab1 effectors on 
vesicle trafficking and autophagy 
 
6.1 Introduction 
 
In the previous chapter, numerous possible Rab1A and Rab1B binding partners were identified using the 
MitoID approach, of which several were validated, including CALCOCO1, PPP1R37, and CLEC16A. 
Since Rab1 is known to play a role in both vesicle trafficking and autophagy, the roles of these effectors on 
these two distinct processes are further investigated.  
 
The study towards understanding (and manipulating) autophagy is a topic of great interest, particularly 
since the process of autophagy is involved in metabolic adaptation and can potentially be used as an anti-
cancer approach (Kim & Lee, 2014; Kimmelman & White, 2017; Onorati et al., 2008). In order to study 
the molecular and cellular aspects of autophagy, several different approaches were developed to induce and 
monitor autophagy in cultured cells.  
 
6.1.1 Inducing autophagy 
The most widely used method to induce autophagy in mammalian cultured cells is through starvation. The 
nutrient-sensing kinase mTOR (mechanistic target of rapamycin) forms a complex called MTORC1 which 
inhibits autophagy induction in nutrient-rich conditions. Upon glucose starvation, its kinase activity is 
inhibited which initiates the formation of the phagophore, as schematically shown in Figures 1.3 and 1.4. 
In mammalian cultured cells, cells are starved by thoroughly removing their growth medium and replacing 
this with starvation medium (without growth serum) for a few hours (Velazquez & Jackson, 2018). 
 
Other approaches used to induce autophagy also center around the inhibition of mTOR, such as the well-
known compound rapamycin. With the kinase named ‘mechanistic target of rapamycin’, it is no surprise 
that the small compound specifically targets and inhibits the kinase mTOR (Benjamin et al., 2011). 
Rapamycin has several useful analogues called Rapalogs, which are also commonly used to induce 
autophagy (Schreiber et al., 2019).  
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Another group of small compounds which specifically inhibit mTOR are called Torins. While Torin-1 
inhibits both mTOR complexes (MTORC1 and MTORC2), Torin-2 specifically inhibits MTORC1 (Wang 
et al., 2015). 
 
Finally, the disaccharide Trehalose can be used to induce autophagy in an mTOR-independent manner 
(Sarkar et al., 2007). While the precise mechanism surrounding Trehalose-induced autophagy remains 
elusive, a recent study has shown that Trehalose rapidly damages and permeabilizes lysosomes which could 
induce autophagy in an attempt to address lysosomal damage (Rusmini et al., 2019). 
 
6.1.2 Monitoring autophagy 
The most widely used method to monitor autophagy in mammalian cultured cells, is through the detection 
of LC3B-II. LC3B (microtubule-associated protein light chain 3B, a homologue of ATG8) exists as a 
cytosolic form (LC3B-I) and a lipidated form (LC3B-II), the latter of which is incorporated into the 
autophagosomal membrane.  
Most commonly, LC3B-II levels are measured through Western blot analysis of lysed cells. Since LC3B-
II is a key component of the autophagosomal membrane, the intracellular amount of LC3B-II increases as 
autophagy is induced (Baeken et al., 2020). On the other hand, intra-autophagosomal LC3B-II is degraded 
by proteases during the fusion of autophagosomes with lysosomes (Mizushima & Yoshimori, 2007). This 
means that LC3B-II levels are linked to the autophagic flux, and can be hard to interpret. The same issue 
arises when studying LC3B-II via imaging techniques; the relatively quick turnover can make it hard to 
properly visualise autophagosomes.  
With the aim to halt the autophagic flux and appropriately monitor the induction and effects of autophagy, 
LC3B-II (and many other autophagic markers) are often studied in the presence of lysosomal inhibitors. 
Lysosomal inhibitors can either inhibit lysosomal proteases or block autophagosome-lysosome fusion 
(Mizushima & Yoshimori, 2007). Bafilomycin-A1, the most commonly used lysosomal inhibitor and the 
one used in this thesis, belongs to the latter category. Other commonly used autophagic markers include 
p62/SQTM1 and members of the autophagy-related (ATG) protein family. 
 
Besides measuring the accumulation of autophagosomes, as described above, the autophagic flux can be 
measured to monitor the turnover rate of autophagosome formation and degradation. While this can be 
accomplished by comparing the amount of lipidated LC3B (or other ATG8-related proteins) with and 
without lysosomal inhibitors, a perhaps more sophisticated and versatile approach is by using tandem 
fluorescent tags, as will be further discussed in Chapter 7 (Mizushima & Murphy, 2020). Finally, the 
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exploration of distinct steps in autophagosomal maturation can be explored by monitoring specific markers 
such as proteins involved in autophagic induction or lysosomal fusion. 
 
In this thesis, starvation and Trehalose addition are the main approaches used to induce autophagy, and 
their use will be clearly indicated throughout this chapter. Here, autophagy is almost exclusively monitored 
after Bafilomycin-A1 addition. The most commonly used autophagy markers used are LC3B-II or p62, and 
other markers used are clearly indicated where appropriate. All autophagic induction and measuring 
methods are disclosed in the figure legends. 
 
 
6.2 Results 
 
6.2.1 Inducing autophagy in cultured mammalian cells 
In order to examine the role that Rab1 and its effectors have on the initiation and maturation of autophagy,  
an efficient and robust protocol is needed to induce autophagy in mammalian cultured cells. The most 
widely used approach for inducing autophagy is cell starvation. In mammalian cell culture, this involves 
replacing the incubation medium with media which does not contain any nutrients for several hours (for 
instance Earle’s Balanced Salt Solution, EBSS). 
 
In order to measure a change in autophagic induction and/or flux, the formation and maturation of 
autophagosomes are studied. As previously mentioned, autophagosomes fuse with lysosomes as they 
mature, which leads to degradation by the lysosome’s acidic components. Thus, as autophagy progresses, 
the steady state of certain autophagic markers are decreased due to degradation. On the other hand, other 
commonly used markers such as LC3B-II are upregulated when autophagy is induced (Ravanan et al., 
2017). This causes the expression levels of these proteins to be influenced both by the upregulation of 
expression levels and increased degradation, which complicates the measuring of the autophagic flux rates. 
To overcome these challenges, the cells can be treated with the lysosomal inhibitor Bafilomycin-A1, which 
blocks the acidification of the lysosomes and thus inhibits degradation after fusing with autophagosomes 
(Ravanan et al., 2017). This means that autophagic cells treated with Bafilomycin-A1 should show an 
increase of the number of autophagosomes, and hereby an increase of LC3B-II levels. The top panel of 
Figure 6.1A confirms this; showing that HEK293T cells that are starved for 2 or 4 hours show an increase 
of LC3B-II levels only when Bafilomycin-A1 is added. 
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Figure 6.1.  Starvation and Trehalose addition both induce autophagy in HEK293T cells. (A) Western blots of lysed HEK293T cells, 
treated with or without 100 nM Bafilomycin-A1 and grown in either DMEM (fed) or EBSS (starvation medium) for either 2 or 4 hours, 
all as indicated. Blots were probed for autophagosomal markers LC3A/B (with LC3A/B I being the soluble form, and LC3A/B II being 
the lipidated, autophagosomal form) and p62. Asterisk indicates non-specific background band (loading control). (B) Western blots of 
lysed HEK293T and HeLa cells, treated either with or without 100 mM Trehalose and with or without 100 nM Bafilomycin-A1, as 
indicated. Blots were probed for the autophagosomal marker LC3A/B and α-tubulin (loading control). 
 
 
Contrarily to LC3B-II, the expression levels of the autophagosome marker p62/SQSTM1 are not solely 
regulated by the autophagic flux. While certain reports suggest that the expression levels of p62 are strictly 
regulated by basal autophagic degradation, other reports state that p62 is involved in numerous activities 
which could affect its expression levels independently of autophagy (Sahani et al., 2014; K. C. Yang et al., 
2018). Examining the expression levels of p62 after 2 or 4 hours of starvation, showed that this autophagic 
marker gives a less straightforward output than LC3B, showing only minor fluctuations in expression levels 
upon autophagic induction (Figure 6.1A, bottom panel). Taken together, these results underscore the 
necessity of using multiple assays and approaches to measure autophagic flux. In this study, LC3B-II will 
be used as the main marker for autophagic induction. 
 
Although starvation is a relatively quick and easy method to induce autophagy, it does not lend itself well 
to live imaging; in order to adequately starve the cells, all growth medium should be removed and the cells 
thoroughly washed with EDTA or PBS before the starvation medium is added. Thoroughly washing the 
cells on a mounted sample is challenging, particularly when aiming to preserve the current location on the 
slide. Furthermore, this process could be damaging to the microscope if any medium was spilled. While 
starvation medium could be added before placing the slide under the microscope, this would result in less 
imaging time of the cells in their fed (i.e. control) state. Therefore, an additional method of autophagic 
induction was tested; cells were treated with Trehalose, a disaccharide that has been shown to induce 
autophagy in an mTOR-independent manner (Sarkar et al., 2007). Interestingly, 24 hours of Trehalose 
induction indeed increased the levels of LC3B-II in HEK293T cells, but not in HeLa cells (Figure 6.1B). 
Even though the levels of α-tubulin (the loading control) are decreased in HeLa cell samples compared to 
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those from HEK293T cells, this does not explain the discrepancy of LC3B-II levels between the two cell 
types. 
 
 
6.2.2 GTP-locked Rab1 associates with LC3B-positive autophagosomes   
Another approach of investigating autophagy induction and maturation, is observing autophagosomes with 
confocal microscopy. While HEK293T cells are valuable for biochemistry-based approaches requiring 
large volume of cells, they are not the most useful for microscopy-based techniques since they are quite 
small and cell structures tend to be more difficult to distinguish. Many mammalian cultured cells have high 
basal autophagy levels, and several trial experiments with HeLa, CHO and MEFS cells have confirmed 
this, making them particularly challenging to work with (data not shown). In our hands, visualising 
autophagosomal structures was the most successful in U2OS cells and hence these were consequently used 
throughout the study. Vesicular structures labelled by LC3B indicate autophagosomes, as confirmed by the 
co-labelling of p62 (Fig. 6.2).  
 
Figure 6.2 also shows that GTP-locked HA-tagged Rab1A and Rab1B had considerable overlap with 
autophagosomes, whereas their GDP-locked counterparts did not. While wildtype and GTP-locked Rab1B 
have been reported to localise to autophagosomes, the localisation of GDP-locked Rab1B in autophagic 
cells has remained unreported (Zoppino et al., 2010). However, since GDP-locked Rab1A and Rab1B do 
not interact with any of the potential autophagy receptors studied in Figures 5.5 and 5.9, it was unsurprising 
that GDP-locked Rab1 forms are not recruited to autophagosomes (Fig. 6.2).  
 
I next compared autophagosome characteristics and Rab1 localisation in U2OS cells when autophagy was 
induced with the two distinct approaches mentioned previously. Both Trehalose treatment and cell 
starvation caused an increase of both size and number of autophagosomes in cells overexpressing GTP- 
locked Rab1A (Fig. 6.3, left panel). These changes were not observed in cells overexpressing GDP-locked 
Rab1A (Fig. 6.3, right panel). This is in line with previous reports on the effect of Rab1 overexpression on 
autophagosomes – overexpression of GTP-locked Rab1 paralogues was shown to result in an increase of 
size and number of autophagosomes, while overexpression of GDP-locked Rab1 paralogues decreased the 
autophagosomes in cells (Song et al., 2018; Zoppino et al., 2010).  
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Figure 6.2. Autophagosomes co-localise with GTP-locked Rab1A and Rab1B, but not with their GDP-locked forms. Confocal 
micrographs of U2OS cells transiently expressing HA-tagged GTP- and GDP-locked Rab1A and Rab1B (as indicated). Cells were treated 
with 100 mM Trehalose for 24 hours prior to fixing and stained for HA and the autophagosomal markers LC3B and p62. Arrows indicate 
several puncta of co-localisation with all three antibodies. Scalebars: 10 μm. 
 
 
With the aim of gaining more understanding of the localisation of Rab1 on autophagosomes, cells were 
imaged live, expressing fluorescently tagged LC3B and GTP-locked Rab1A. After inducing autophagy by 
Trehalose treatment for 18 hours, cells expressing eGFP-LC3B and mCherry-Rab1A(QL) were studied on 
a spinning disc confocal microscope. Figure 6.4 displays a number of time points, showing that LC3B and 
Rab1A positive puncta are present, that they are mobile, and they occur separately as well as in close 
proximity of each other and occasionally overlapping (Fig. 6.4). 
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Figure 6.3. Starvation and Trehalose addition both increase size and number of autophagosomes, which co-localise with GTP-
locked Rab1A. Confocal micrographs of U2OS cells transiently expressing either GTP- or GDP-locked HA-Rab1A, probed against HA 
and the autophagosomal marker LC3B. DMEM: untreated cells, EBSS: cells incubating in EBSS for 4 hours, EBSS+BAF: cells incubating 
in EBSS and treated with 100 nM Bafilomycin-A1 for 4 hours, +T: cells treated with 100 mM Trehalose for 24 hours. All times indicate 
treatment time before fixation. Scalebars: 10 μm. 
 
 
The inserts shown in Figure 6.4 highlight four puncta; two Rab1A-positive puncta and two LC3B-positive 
puncta. The stills indicate that while the four puncta appear to merge into one, the puncta are swiftly 
transported onwards and actually remain as separate entities, suggesting that the merging is an imaging 
artifact caused by their increasingly close proximity (Fig. 6.4, inserts). Moreover, closely examining the 
stills and the time-lapse from which they were taken, it becomes apparent that the Rab1A-positive puncta 
move in unison with their accompanying LC3B-positive puncta. Whether the Rab1A- and LC3B-positive 
puncta both coat the same autophagosome, or whether they are simply neighbouring puncta, remains to be 
clarified. Further research including super-resolution microscopy could gain more insight into this 
phenomenon, although the observation that they are transported together indicates they might be linked. 
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Figure 6.4. Neighbouring GTP-locked Rab1A and LC3B puncta are transported in unison. U2OS cells transiently expressing LC3B 
and mCherry-Rab1A (QL) were imaged for 30 seconds on a spinning disc confocal microscope.  
 
 
 
6.2.3  GTP-Rab1A regulates autophagy by activating PI3-kinase complex I 
 
6.2.3.1 GTP-locked Rab1A recruits and specifically activates PI3K complex I 
Having confirmed that active Rab1 associates with autophagosomes, I set out to further investigate what 
role Rab1 plays in autophagosome formation and/or regulation. Since the functions of small GTPases are 
performed through their effectors and regulators, studying Rab1 interactors is key in shedding light its 
function.  
 
Utilising the MitoID approach, numerous potential novel interactors for Rab1 were identified, including 
multiple subunits of the class III phosphatidylinositol-3-kinase (PI3K) complex (Fig. 5.1, Fig. 5.2A,B). The 
PI3K complexes phosphorylate phosphatidylinositol (PI) to form phosphatidylinositol-3-phosphate (PI3P) 
and exist as two related complexes, both of which share a core of PIK3C3 (Vps34), PIK3R4 (Vps15) and 
BECN1 (Beclin-1), and additionally contain either ATG14L and NRBF2 (complex I) or UVRAG and 
RUBCN (complex II) (Ohashi et al., 2016, 2018). While complex I is known to be involved in the regulation 
of autophagy, complex II is found mostly on endosomal membranes and is involved in vesicle trafficking 
(Ohashi et al., 2018). Recently, a study identified a positive feedback loop where the presence of PI3P aids 
in the recruitment of Rab5 to endosomal membranes, suggesting that Rab5 itself modifies the local lipid 
environment to stabilise itself in the membrane (Cezanne et al., 2020). 
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Two of the core components, PIK3C3 and PIK3R4, as well as the complex I specific protein NRBF2, was 
found to be present in GTP-locked Rab1A and Rab1B (Fig. 5.1, Fig. 5.2A,B). These components were also 
identified in GTP-locked Rab5A samples, which is known to be involved in PI3K activity and is thought 
to mainly interact with complex II (Ohashi et al., 2020; H.-W. Shin et al., 2005) (Fig. 5.1).  
 
Aiming to validate the mass spectrometry data shown in Figure 5.1, and examine if Rab1 binds to one or 
both subcomplexes, Western blots were performed on the Rab1A and Rab5A MitoID samples. PIK3C3, 
PIK3R4, BECN1, ATG14L and NRBF2 were identified by Western blot, but not RUBCN or UVRAG, 
indicating that Rab1 binds specifically to the autophagy-specific PI3K complex (Fig. 6.5A). Moreover, all 
seven PI3K subunits were found in GTP-locked Rab5A samples, suggesting that active Rab5A interacts 
with both PI3K complexes (Fig. 6.5A). The GST-based affinity chromatography experiments discussed 
above further validate the interactions between the Rab1 paralogues and the PI3K complex; mass 
spectrometry analysis shows the presence of PIK3R4 and PIK3C3 in GTP-locked Rab1A and Rab1B 
samples (Fig. 5.9C).  
 
While it is suggested that Rab5 aids the recruitment and activation of complex II, its exact mechanism 
remains unclear (Christoforidis et al., 1999; Murray et al., 2002). The recruitment and activation of complex 
I, on the other hand, is unknown. Since our data suggest that Rab1 is an interactor of complex I, we aimed 
to examine the possibility of Rab1 playing a role in PI3K membrane recruitment and activation. 
 
For this study, I collaborated with the group of Roger Williams (MRC LMB, UK), in particular Shirley 
Tremel and Yohei Ohashi. Tremel, Ohashi, and colleagues have previously designed an assay to study the 
activation of PI3K on liposomes; PI3K complexes I or II were incubated with giant unilamellar vesicles 
(GUVs) containing PI and an AlexaFluor647-labelled PX domain which binds specifically to PI3P (Ohashi 
et al., 2020). By studying the rate of recruitment of the fluorescently labelled PX domain to the GUVs, the 
generation of PI3P – and thereby the activity of PI3K – can be extrapolated (Fig. 6.5B).  
 
In this study, Rab GTPases were coupled to the GUVs by a covalent bond between the GTPase’s C-terminal 
cysteine and maleimide-fused lipids in the GUV, mimicking the C-terminal geranylgeranylation which 
anchors the GTPases to membranes in vivo. In order to assure correct lipid anchoring solely at the C-
terminal cysteine, the remaining cysteines in Rab1A and Rab5A were mutated to serines. The functionality 
of the mutated Rab GTPases was tested by performing MitoID experiments and studying their interactomes. 
The identified interactions with GTP- and GDP-locked Rab1A (C26S, C126S) showed identical patterns 
as compared to their non-mutated forms, which suggests very similar functionality (data not shown). 
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Figure 6.5. Active Rab1A binds and activates PI3K complex I. (A) Western blots of MitoID samples of Wildtype (WT), GTP- (QL) 
and GDP-locked (SN) Rab1A and Rab5A. Blots were probed with PIK3C3, PIK3R4, BECN1, ATG14L, NRBF2, RUBCN, UVRAG, and 
HA antibodies, as indicated. (B) Schematic representation of the GUV assay as shown in (Ohashi et al., 2020). Fluorescence from 
Lissamine-Rhodamine (Liss-Rhod) delineates the GUV membrane, while the AF647-PX channel indicates PI3K activity on the membrane. 
Scalebar: 5 μm. (C,D) GUV-based activity with membrane-tethered Rab1A with complex I (C) and complex II (D). The reaction progress 
curves, initial rates, and micrographs showing AF647-PX signals at the end of the reactions are shown. Scalebars: 5 μm. Data obtained by 
Shirley Tremel, figures as shown in (Tremel et al., 2021). 
 
 
First examining Rab5A, we found that the presence of the GTP-loaded GTPase was found to increase 
complex I activity 3-fold, while increasing complex II activity an astonishing 40-fold (data not shown, 
(Tremel et al., 2021). Contrarily, the presence of GTP-loaded Rab1A was shown to increase complex I 
activity 11-fold, while not affecting complex II activity (Fig. 6.5C,D, data obtained by Shirley Tremel). 
GDP-loaded Rab1A showed little activation of PI3K, and neither did soluble Rab1A (Fig 6.5C, data 
obtained by Shirley Tremel). Together, this shows that membrane-bound Rab5A activates its previously 
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known effector, PI3K complex II. Interestingly, GTP-bound Rab5A was shown to specifically activate the 
endosomal complex II but not the autophagy-related complex I. Complex I, on the other hand, was activated 
specifically by GTP-bound Rab1A. 
 
6.2.3.2 The C2 helical hairpin insertion (C2HH) domain on VPS34 is key for Rab1A binding 
Next, we set out to map the Rab1 and Rab5 interaction sites on complex I and II, respectively. Using a 
combination of unnatural amino acid (UAA) mediated crosslinking and hydrogen/deuterium exchange 
mass spectrometry (HDX-MS), Tremel, Ohashi, and colleagues were able to identify several binding 
interfaces – the C2 helical hairpin insertion (C2HH) on VPS34, and the SGD and WD40 domains on VPS15 
(Tremel et al., 2021). While the UAA crosslinking method identified C2HH as the sole interaction site, it 
should be noted that crosslinking occurred much more efficiently to the full complexes (complex I with 
Rab1 and complex II with Rab5) compared to VPS34 alone. This indicates that other proteins within the 
PI3K complexes could influence the interaction, potentially the SGD and WD40 domains on VPS15. 
 
Since the VPS34 C2HH domain appears to have the most extensive interface with the Rab5A switch 
regions, which undergo nucleotide-specific conformational changes, we tested the importance of this 
domain for binding Rab1A and Rab5A by mutating the 199-REIE-202 residues to alanine (REIE>AAAA). 
In order to examine the interaction between PI3K and the Rab GTPases, we co-expressed all subunits of 
complex I or II with GTP-locked Rab1A or Rab5A, respectively. VPS34 was C-terminally tagged with 
eGFP to allow visualisation of the complexes, and was tested in either its wildtype (WT) or mutated 
(REIE>AAAA) form. Complex I containing wildtype VPS34-eGFP strongly co-localised with GTP-locked 
Rab1A, but this was lost completely with VPS34-eGFP (REIE>AAAA) (Fig. 6.6A,B, data obtained by 
Yohei Ohashi). Surprisingly, Rab5A showed a strongly contrasting pattern of localisation – while wildtype 
complex II was found to co-localise with GTP-locked Rab5A on enlarged endosomes, using VPS34-eGFP 
(REIE>AAAA) strongly increased their co-localisation (Fig. 6.6C,D, data obtained by Yohei Ohashi). 
 
To confirm these observations, we performed MitoID proximity labelling experiments, co-expressing 
mitochondrially localised GTP- and GDP-locked Rab1A and Rab5A chimeras together with all subunits of 
either complex I or complex II, respectively. VPS34-eGFP, in either its wildtype (WT) or mutated 
(REIE>AAAA) form, was included to observe the presence of PI3K and the influence of the mutation on 
the interaction between the Rab GTPases and the PI3K complexes. Performing a Western blot on the 
MitoID samples and probing with antibodies against GFP and HA, we were able to confirm the 
immunofluorescence results – mutating 109-REIE-202 to alanines on VPS34 decreases its ability to interact  
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Figure legend on next page. 
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Figure 6.6. The interaction between Rab1A/Rab5A and VPS34 is regulated through the C2 helical hairpin insertion (C2HH) 
domain, and is key in activation of the PI3K complex. (A,B) Confocal micrograph images of HEK293T cells co-expressing GTP-locked 
mCherry-Rab1A and all four components of complex I with wildtype (A) or REIE>AAAA (B) eGFP-VPS34. To the right of each panel, 
a line plot showing the fluorescence traces is shown. Scalebars: 10 μm. Data obtained by Yohei Ohashi. (C,D) Confocal micrographs of 
HEK293T cells co-expressing GTP-locked mCherry-Rab5A and all four components of complex II with wildtype (C) or REIE>AAAA 
(D) eGFP-VPS34. To the right of each panel, a line plot showing the fluorescence traces is shown. Scalebars: 10 μm. Data obtained by 
Yohei Ohashi. (E) Western blots of MitoID samples of GTP- and GDP-locked Rab1A and Rab5A, as indicated, co-expressed with all four 
components of either complex I or complex II, respectively. EGFP-VPS34 was used to track PI3K, and was co-transfected in either its 
wildtype (WT) or REIE>AAAA form. Input: HEK293T lysate expressing GTP-locked Rab1A and WT complex I. Blots were probed with 
either anti-GFP (eGFP-VPS34) or HA (bait loading control). (F,G) GUV-based activity with membrane-tethered Rab5A with complex II 
(F) and Rab1A with complex I (G). The reaction progress curves and micrographs showing AF647-PX signals at the end of the reactions 
are shown. Scalebars: 5 μm. Data obtained by Shirley Tremel. Figures (A,B,C,D,F,G) as shown in (Tremel et al., 2021).  
 
 
 
with Rab1A and increases the interaction with Rab5A (Fig. 6.6E). Moreover, Rab5A was shown to more 
potently activate complex II containing VPS34 (REIE>AAAA) compared to WT, whereas Rab1A showed 
a strong decrease in activation of VPS34 (REIE>AAAA) compared to WT (Fig. 6.6F,G). 
 
Taken together, these data indicate that the class III phosphatidylinositol-3-kinase complexes I and II are 
activated by GTP-Rab1A and GTP-Rab5A, respectively. Interestingly, the Rab GTPases bind to the same 
interface on VPS34 –  the C2 helical hairpin – but appear to regulate PI3K activity distinctly. While 
mutating the C2 helical hairpin in complex I decreases the ability to bind and be activated by Rab1A, the 
same mutation in complex II strongly increases activation by Rab5A. Identifying Rab1A as an activator of 
PI3K complex I gives us insight into the mechanisms by which Rab1A might regulate autophagy. 
 
 
6.2.4 CALCOCO1 partially localises on autophagosomes and binds directly to Rab1 
One of the proteins highlighted from our Rab1 MitoID data is CALCOCO1 (Fig. 5.1). The calcium-binding 
and coiled-coil domain-containing protein was found to co-localise with GTP-locked Rab1B, but not 
Rab1A, while a GST-based affinity chromatography binding assay showed that CALCOCO1 interacts with 
both paralogues (Fig. 5.5, Fig. 5.9). 
 
Performing GST-based affinity chromatography, CALCOCO1 was found to bind directly to GTP-locked 
Rab1A and Rab1B (Fig. 6.7A). To test direct binding, purified FLAG-CALCOCO1 was incubated with 
beads coated in GTP- or GDP-locked Rab1A or Rab1B. Rab1 was expressed in Sf9 cells using the 
baculoviral expression system to allow for post-translational modifications, if necessary, and to aid protein 
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folding by chaperones. The data indicates that CALCOCO1 only binds to N-terminally tagged Rab1B and 
C-terminally tagged Rab1A, suggesting that CALCOCO1 would bind Rab1B at its C-terminus and Rab1A 
at its N-terminus (Fig. 6.7A). However, this discrepancy is very unlikely – the high sequence similarity 
between Rab1A and Rab1B (92%) strongly suggests that any interactors would bind on the same interface. 
Although further research can shed light on this, I believe that the absence of an interaction with 
CALCOCO1 with GST-Rab1A and Rab1B-GST is an experimental artefact. Regardless, this data shows 
that CALCOCO1 binds to GTP-locked Rab1A and Rab1B without any need for intermediate or adaptor 
proteins. 
 
Until recently, the role of CALCOCO1 was mostly unknown. Indications of CALCOCO1 being involved 
in autophagy came solely from sequence similarities with the autophagy receptors NDP52 (CALCOCO2) 
and TAX1BP1 (CALCOCO3) (Y. Yang et al., 2015). Recently, however, a study by Stefely and colleagues 
found CALCOCO1 to interact with LC3C, and identified CALCOCO1 as a selective autophagy receptor 
which is regulated by mTOR inhibition (Stefely et al., 2020). Confirming the findings by Stefely and 
colleagues, CALCOCO1 was found to be partially localised on autophagosomes (Fig. 6.7B).  
 
 
Figure 6.7. CALCOCO1 is a direct Rab1 binder and partially localises on autophagosomes. (A) Western blot of GST-based affinity 
chromatography samples in which FLAG-CALCOCO1 was washed over beads covered in GST-tagged Rab1 variants expressed in Sf9 
cells with the baculoviral expression system. The blot was stained with an antibody against the FLAG epitope tag. Input: purified FLAG-
CALCOCO1. (B) Confocal micrographs of U2OS cells treated with 100 mM Trehalose for 24 hours before fixation and staining with 
antibodies against the autophagosomal marker p62, CALCOCO1, and the trans-Golgi network marker TGN46. Scalebar: 20 μm. 
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As schematically represented in Figure 1.3, mTORC1 and PI3K function in the same pathway of autophagic 
induction. Interestingly, while we have shown Rab1 to activate PI3K, Stefely and colleagues found that 
mTOR inhibition causes autophagic CALCOCO1 degradation. More specifically, they found that loss of 
CALCOCO1 decreases the specific autophagy of the ER (reticulophagy) but increases macro-autophagy 
(Stefely et al., 2020). While this suggests another route through which Rab1 might affect autophagy in the 
mTORC1/PI3K pathway, the effect of mTORC1 inhibition degradation on Rab1 and CALCOCO1 appears 
contradictory – upon mTORC1 inhibition, autophagy is induced, CALCOCO1 is degraded, and Rab1A 
further activates PI3K to aid in the generation of autophagosomes.  
 
Furthermore, it was shown that CALCOCO1 binds to LC3-family members, particularly LC3C, and is 
important for lipidation of LC3C (Stefely et al., 2020). How the interaction between CALCOCO1 and Rab1 
influences autophagy, and potentially also ER-to-Golgi trafficking, remains to be elucidated. Further 
research including mapping and mutating the CALCOCO1-Rab1 binding sites would shed light on the role 
this interaction plays on vesicle trafficking and autophagy. 
 
 
6.2.5 CLEC16A plays a role in Golgi morphology and binds directly to Rab1 
Another protein that was highlighted as a Rab1 effector through our MitoID proximity labelling assays is 
CLEC16A (Fig. 5.1, Fig. 5.2A,B). CLEC16A is a membrane-associated endo-lysosomal protein which 
regulates mitophagy (Soleimanpour et al., 2014). Previously, CLEC16A has been shown to down-regulate 
starvation induced autophagy by stimulating mTOR activity (Tam et al., 2017). Interestingly, Tam and 
colleagues also found CLEC16A to partially relocate to the Golgi apparatus upon starvation, while Kim 
and colleagues find the opposite to be true; the Drosophila melanogaster orthologue of CLEC16A, Ema, 
was found to relocate from the Golgi to the autophagosomes upon starvation (S. Kim et al., 2012). Potential 
explanations for this discrepancy could be that the CLEC16A orthologues play slightly different roles in 
different organisms, and the different markers used to visualise autophagosomes (LC3B vs Atg8), although 
both explanations appear unlikely. 
 
Regardless of the exact localisation pattern of CLEC16A, it has become apparent that CLEC16A is found 
partly on the Golgi and partly on autophagosomes. With the aim of confirming the localisation of CLEC16A 
under starved and fed conditions, Myc-CLEC16A was expressed in U2OS cells. Unfortunately, whether 
expressing Myc-CLEC16A alone (data not shown), or co-expressing the Rab1 MitoID chimeras with the 
aim of observing mitochondrial recruitment, CLEC16A remained fully cytoplasmic and dispersed 
throughout the cell (Fig. 6.8A). Interestingly, though, overexpression of CLEC16A was found to cause the  
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Figure 6.8. CLEC16A plays a role in Golgi morphology and binds directly to Rab1A and Rab1B. (A) Confocal micrographs of U2OS 
cells overexpressing Myc-CLEC16A and Rab1 MitoID chimeras (Rab1-BirA*-HA-MAO). Cells were probed with antibodies against the 
HA epitope (Rab1 chimeras), the Myc epitope (Myc-CLEC16A) and the Golgi marker ZFPL1. Scalebars: 10 μm. (B) Confocal micrographs 
of U2OS cells overexpressing Myc-CLEC16A and probed with antibodies against the Myc epitope and the Golgi marker Giantin. 
Scalebars: 10 μm. (C) Western blot of GST-based affinity chromatography samples in which FLAG-CLEC16A was washed over beads 
covered in GST-tagged Rab1 variants expressed in Sf9 cells with the baculoviral expression system. The blot was stained with an antibody 
against the FLAG epitope tag. Input: purified FLAG-CLEC16A. 
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Golgi to fragment (Fig. 6.8A,B). Although exceptions remain, Figure 6.8B clearly shows that cells 
overexpressing CLEC16A have a much more dispersed and fragmented Golgi apparatus compared to 
surrounding cells not expressing Myc-CLEC16A. While this does not shed light on the question whether 
CLEC16A is redirected to or from the Golgi upon starvation, it does suggest that CLEC16A might have a 
role in either establishing or maintaining Golgi morphology. 
 
Finally, in order to study the interaction between Rab1 and CLEC16A further, I set out to examine whether 
the interaction requires any adaptor proteins or whether they bind directly and unaided. To test this, purified 
FLAG-CLEC16A was incubated with beads coated in GTP- and GDP-locked Rab1A and Rab1B. Western 
blots of the resulting samples show us that CLEC16A is able to directly bind GTP-locked Rab1A and 
Rab1B, but appears to only do so when the Rab1 proteins are C-terminally tagged (Fig. 6.8C). Binding 
assays of Rab1A, Rab1B, and CLEC16A fragments could elucidate the exact binding site and allow for 
directed mutagenesis, hereby studying the effect the interaction has on processes such as Golgi morphology, 
vesicle trafficking, and autophagy. 
 
 
6.2.6 PPP1R37 binds to Rab1A and Rab1B with its leucine rich repeats  
The protein phosphatase inhibitor PPP1R37, also known as leucine-rich repeat-containing protein 68 
(LRRC68), was also identified as a novel Rab1 effector through MitoID proximity labelling assays (Fig. 
5.1, Fig. 5.2A,B). Besides the presence of five central leucine-rich repeats and a proline-rich stretch near 
the C-terminus, the protein remains largely uncharacterised and its function unclear, making it an intriguing 
Rab1 interactor to further investigate.  
 
GST-based affinity chromatography binding assays have confirmed the interaction between Rab1A/Rab1B 
and PPP1R37 (Fig. 5.9B). To test whether the proteins bind directly or with the aid of an adaptor protein, 
purified FLAG-PPP1R37 was incubated with beads coated in GTP- and GDP-locked Rab1A and Rab1B. 
Western blots of these samples show that PPP1R37 indeed binds directly and unaided to GTP-locked 
Rab1A and Rab1B (Fig. 6.9A, upper panel). Further examining this interaction, the interaction interface 
was narrowed down by cleaving PPP1R37 and performing binding assays. The platform InterPro predicts 
PPP1R37 to have two disordered regions flanking a leucine-rich repeat (LRR) domain containing 5 
predicted LRR (Fig. 6.9B). Since leucine-rich repeats are well-characterised as frameworks for protein-
protein interactions, Rab1 was expected to bind in this domain (Kobe & Kajava, 2001).  
 127 
 
Figure  6.9. PPP1R37 plays a role in Golgi morphology and binds directly to Rab1A and Rab1B with its leucine rich repeats. (A) 
Western blot of GST-based affinity chromatography samples in which variants of FLAG-PPP1R37 (Full length protein, residues 1-448, 
and residues 449-691) ware washed over beads covered in GST-tagged Rab1 variants expressed in Sf9 cells with the baculoviral expression 
system. The blot was stained with an antibody against the FLAG epitope tag. Input: purified FLAG-PPP1R37. (B) Confocal micrographs 
of U2OS cells transiently expressing mCherry-PPP1R37 and probed with anti-TGN46. Scalebars: 10 μm. 
 
 
 
GST-based binding assays were performed on PPP1R37 residues 1-448 and residues 449-691. Since direct 
binding between PPP1R37 and Rab1A/Rab1B was already established, full HEK293T lysate expressing 
the PPP1R37 fragments was washed over Rab1-coated beads. Western blots on these samples clearly show 
that Rab1A and Rab1B bind to the PPP1R37 fragment containing residues 1-448, but not to residues 449-
691, suggesting that the binding interface lies at one of the leucine rich repeats (Fig. 6.9A, middle and lower 
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panels). Further binding essays exploring which of the leucine rich repeats is responsible for Rab1A and 
Rab1B binding could unfortunately not be completed due to time restraints. 
 
 
6.2.7 PPP1R37 plays a role in Golgi morphology and partially localises to autophagosomes and the TGN 
After validating the interaction between PPP1R37 and Rab1A/Rab1B, I set out to further examine the 
function of PPP1R37 in cells. While overexpressing mCherry-PPP1R37 in U2OS cells did not appear to 
disrupt autophagosomal or endosomal expression or localisation (data not shown), the trans-Golgi network 
(TGN) was extremely affected (Fig. 6.9C). The overexpression of PPP1R37 caused extreme Golgi 
fragmentation, with in some cases causing such severe disruption that the TGN was barely visible anymore 
(6.9C). Interestingly, the cells remained viable and appeared relatively healthy despite the severe Golgi 
disruption. This leads us to question whether the entire TGN and/or the entire Golgi apparatus is indeed 
fragmented, or whether it solely affects the marker chosen here, TGN46. Further research could elucidate 
this, for instance by co-staining multiple Golgi markers ranging from cis- to trans- and including several 
TGN markers. 
 
In general, overexpression of mCherry-PPP1R37 resulted in a diffused, cytoplasmic localisation of 
PPP1R37. Interestingly, however, a large proportion of cells showed PPP1R37-positive puncta, appearing 
to be vesicles (Fig. 6.9C). These puncta were visible with or without co-expression of GTP-locked 
mitochondrial Rab1, where PPP1R37 is recruited to mitochondria (Fig. 5.8, Fig. 6.9C).  PPP1R37 puncta 
appear to partially co-localise to LC3B-positive puncta (Fig. 6.10A). While large subsets of PPP1R37- and 
LC3B-puncta appear clearly distinct from each other, numerous overlapping or partially overlapping puncta 
are found. In most cases, the overlap observed between LC3 and PPP1R37 is partial; the two proteins appear 
to reside on the same vesicle but potentially covering different domains (Fig. 6.10A, inserts). While 
PPP1R37 and p62 are occasionally observed to be partially overlapping, the pattern is much less clear than 
for LC3B and PPP1R37 and p62 are mostly found to belong to different vesicle subsets (Fig. 6.10B). 
 
No clear overlap was observed between PPP1R37-positive puncta and EEA1 or CD63 (Fig. 6.10C,D). 
While Sec16A, indicating ER exit sites, did not show direct overlap with PPP1R37, an intriguing pattern 
was observed where Sec16A puncta appeared to directly neighbour patches of PPP1R37 (Fig. 6.10E).  
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Figure 6.10.  PPP1R37 puncta partially co-localise with LC3B and fragmented TGN. (A-F) Confocal micrographs of U2OS cells 
transiently expressing mCherry-PPP1R37, fixed, and probed with antibodies against LC3B (A), p62 (B), EEA1 (C), TGN46 (D), CD63 
(E), and Sec16A (F). Autophagy was induced in (A,B) by 24 hours 100 mM Trehalose incubation. Scalebars: 10 μm. 
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Finally, I aimed to observe co-localisation of PPP1R37 with the Golgi apparatus, since several images 
appeared to show a perinuclear, Golgi-esque staining pattern (Fig, 6.10C). As previously mentioned, over-
expression of mCherry-PPP1R37 was found to fragment the TGN (Fig. 6.9C). Examining whether the 
PP1R37 puncta co-localise to fragmented TGN puncta, I indeed found a proportion of the puncta to overlap 
(Fig. 6.10F). While distinct PPP1R37 and TGN46 puncta remain, as with PPP1R37 and LC3B, a subset of 
vesicles shows overlap with both, suggesting that PPP1R37 resides both on the Golgi and the 
autophagosomes.  
 
Taken together, I was able to show several routes through which Rab1A and Rab1B affect autophagy. 
Firstly, the localisation of active Rab1A and Rab1B to autophagosomes was confirmed, finding a degree of 
association of Rab1 and LC3B on neighbouring puncta by observing their transport through live imaging. 
Secondly, in collaboration with the Roger Williams group, Rab1 was shown to recruit and activate the class 
III PI3K complex I, which plays a key role in initiating autophagosome formation. The binding site between 
Rab1A and PI3K complex I was identified on the PI3K component VPS34, and, although identical to the 
Rab5A binding site to PI3K complex II, was found to function in different ways. Furthermore, Rab1A and 
Rab1B were found to bind the novel interactors CALCOCO1, CLEC16A, and PPP1R37 in a direct, unaided 
manner. CALCOCO1 and PPP1R37 were shown to partially co-localise to autophagosomes, while 
CLEC16A and PPP1R37 appear to play a role in Golgi morphology. 
 
6.3 Discussion 
 
Using the MitoID proximity labelling assay, numerous novel potential Rab1A and Rab1B interactors were 
identified in Chapter 5. Several of these interactors were validated, including CALCOCO1, CLEC16A, 
PPP1R37, Rabaptin5, GCC88, and AKAP10. Here, I set out to further investigate a number of these 
interactions, notably CALCOCO1, CLEC16A, and PPP1R37. All three proteins were confirmed to be true 
direct binders to Rab1A and Rab1B, binding as isolated proteins from mammalian cultured cells to beads 
covered in Rab1 expressed in insect cells. 
 
CALCOCO1 was found to partially co-localise with autophagosomes, as was PPP1R37. Furthermore, 
overexpression of either CLEC16A or PPP1R37 lead to fragmentation the Golgi, with at least PPP1R37 
partially localising to the resulting puncta. Interestingly, both CLEC16A and CALCOCO1 have been 
independently shown to negatively influence autophagy by stimulating mTOR activity (Stefely et al., 2020; 
Tam et al., 2017). What role PPP1R37 might have on the regulation of autophagy remains unknown, but it 
is likely involved in autophagic regulation since it is partially localised on autophagosomes. 
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Whether CALCOCO1, CLEC16A, and PPP1R37 share an association with each other, besides all being 
Rab1 effectors, remains to be examined. While all three proteins could bind Rab1A/B and affect the same 
processes in manners distinct from each other, it is definitely possible that they might be involved in the 
same pathway. Examining what effect depletion of one of these proteins has on the other two could shed 
light on this, as could performing binding assays to see if the effectors might interact with each other 
independently of Rab1A/B. 
 
Since CALCOCO1 and PPP1R37 were both found to partially co-localise with autophagosomes, the link 
between these proteins and autophagy is easily drawn. However, after observing the interaction between 
CALCOCO1 and LC3C, Stefely and colleagues propose an interesting question; since LC3-family 
members were found to be located to ER exit sites (ERES) where they are involved in the generation of 
COPII-coated vesicles, could CALCOCO1 play a role in ER-to-Golgi trafficking (Stadel et al., 2015; 
Stefely et al., 2020)? Having newly identified CALCOCO1 as a Rab1 effector, which is known to be a key 
player in ER-to-Golgi trafficking, might shed more light on this question. Although, interestingly, while 
LC3-family members are found to play a role in the formation of COPII-coated vesicles at the ER, Rab1 
are only known to aid in the tethering and fusion of COPII vesicles at the ERGIC and the Golgi apparatus. 
Whether the interaction between Rab1 and CALCOCO1 might facilitate the transfer of recently budded 
vesicles to p115 remains to be examined.  
Moreover, after identifying PPP1R37 as a novel Rab1 interactor and observing it to be partially localised 
on fragmented Golgi puncta, LC3B-positive puncta, and neighbouring to ERES, the suggestion that could 
PPP1R37 be involved in COPII vesicle trafficking is not far-fetched. Further research, including mapping 
and mutating the CALCOCO1-Rab1 and PPP1R37-Rab1 binding sites, would shed light on the role this 
interaction plays on vesicle trafficking and autophagy. 
 
A widely used method of studying the role of proteins in certain processes is protein depletion by RNAi. 
Unfortunately, preliminary knockdown experiments were unsuccessful – after testing several methods of 
siRNA transfection in U2OS cells, including Fugene6 (Promega), FugeneHD (Promega), Lipofectamine 
RNAiMAX (Thermo Fisher), polyethyleneimine (PEI) (MRC LMB Media Kitchen), and GenMute 
(SignaGen), only GenMute allowed for enough cell viability to perform further experiments. Due to time 
constraints, I was unable to optimise this further, and adequate depletion levels were only achieved for 
siRNAs against Rab1A. 
Successful RNAi depletion of CALCOCO1, CLEC16A, PPP1R37, and Rab1B, would be a very useful tool 
to study the role that these proteins play in vesicle trafficking, Golgi morphology, autophagosome formation 
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and maturation, and the (co-)localisation of the other proteins including Rab1A/B. Troubleshooting the 
siRNA transfections in U2OS cells was necessary, since autophagic induction and examination was most 
effective in these cultured cells. Future investigations could include other cell lines used to study autophagy, 
such as MEFS or CHO cells, with the aim of increasing the efficiency of RNAi depletion. Ultimately, 
creating knock-outs using the CRISPR-Cas9 technique will be the most successful way to deplete protein 
levels. Inducible knock-outs might be most useful to carefully study the exact functions of these proteins, 
since permanent knock-outs might not be viable. 
 
Aside from the Rab1 effectors discussed above, the class III PI3K complex was also identified as a novel 
Rab1 effector. In collaboration with the Roger Williams group, Rab1A was found to recruit and activate 
the autophagy-specific PI3K complex I. Whereas Rab5A was a known PI3K binder, and was shown here 
to preferentially activate complex II, the identification of Rab1A as a specific activator of complex I is 
novel and potentially ground-breaking. Opening up new avenues of research, not only to further understand 
how PI3K complexes I and II are differentially regulated, but also gaining more understanding of the role 
of Rab1 in the regulation of autophagy. 
 
While Rab1A and Rab1B were primarily known as master regulators of ER-to-Golgi trafficking, in this 
chapter, several links were shown through which Rab1 might influence the regulation of autophagy, as 
previously discussed. Investigating Rab1 broadly, I was able to confirm that GTP-locked Rab1A and Rab1B 
are partially localised on autophagosomes. The localisation of GDP-locked Rab1 on autophagosomes was 
severely decreased compared to GTP-locked, although studying this was challenging. As previously found 
by Zoppino and colleagues, overexpressing GTP-locked Rab1B appears to increase the amount of 
autophagosomes, while GDP-locked Rab1B decreases it (Zoppino et al., 2010). I was able to confirm these 
findings and extend this further to Rab1A, finding that autophagosomes often appeared bigger and more 
plentiful when GTP-locked Rab1A/B was expressed, and smaller and fewer when GDP-locked Rab1A/B 
was expressed. Studying the movement of puncta of GTP-locked Rab1A and LC3B, seemingly 
neighbouring vesicles were found to move in unison, further confirming their association.  
 
Taken together, our data shows several routes through which Rab1A and Rab1B could be involved in the 
regulation of autophagy and vesicle trafficking. The identification of GTP-bound Rab1 as a specific 
activator of the autophagy-specific PI3K complex I, together with the identification and validation of three 
novel Rab1 effectors that directly bind active Rab1 and show involvement in both autophagy and vesicle 
trafficking, paves the way for further research which could shed light on one of the great questions in cell 
biology – how are vesicular processes regulated, and where lies the overlap and distinction.  
 133 
Chapter 7: Discussion 
Membrane trafficking is a highly specialised and tightly regulated process, and it is widely accepted that 
peripheral membrane proteins and small GTPases of the Arf and Rab families are its key regulators. With 
Rab GTPases being the largest family of small GTPases in mammals, elucidating their localisation patterns 
and interaction partners is key to gaining more understanding of how Rab GTPases contribute to membrane 
trafficking specificity and regulation. In this thesis, a highly effective adaptation to an in vivo proximity 
labelling approach was introduced, resulting in the identification of numerous novel Rab GTPase effectors 
and regulators. Here, I will discuss the main findings of this thesis and evaluate their broader impact on the 
field of membrane trafficking, as well as explore future experimental procedures to bring this research 
further. 
 
7.1 Large-scale MitoID experiments and comparative analyses are able to identify novel interactors 
Aiming to increase the array of known Rab GTPase effectors and regulators, the proximity labelling 
approach BioID, using the promiscuous biotin ligase mutant BirA*, was adapted (Roux et al., 2012; Shin 
et al., 2017). The novel technique, called MitoID, redirects BirA*-fusion proteins to the unrelated, ectopic 
location of the outer mitochondrial membrane, where they are stably incorporated (Gillingham et al., 2019). 
Comparing a large range of small GTPases in their GTP- and GDP-locked states at the same location, 
followed by a computational scoring analysis, allowed for a relatively clear distinction between potential 
interactors and background proteins. Using this MitoID screen, several potential novel effectors were 
identified for many of the tested GTPases. Moreover, several of these proteins were validated to be true 
interactors, mainly ARFGEF3 and STAMBPL1 for Rab2A, OSBPL9 and TBCK for Rab5A, NDE1 and 
HPS3 for Rab9A, and Alsin for Rab11A and Rab11B, further highlighting the efficacy of the MitoID 
approach. Most effective appeared to be the study for novel Rab1A and Rab1B effectors – by performing 
mitochondrial recruitment assays and GST-based affinity chromatography I was able to validate GCC88, 
CALCOCO1, Rabaptin5, CLEC16A, PPP1R37, and AKAP10 as Rab1 interactors.  
 
To assess the efficiency of MitoID compared to traditionally used methods, the MitoID-identified 
interactors of two well-characterised Rabs were compared to those identified through an affinity 
chromatography screen previously performed in the Munro group (Gillingham et al., 2014). The 
comparative study found that for both Rab2A and Rab5A, the MitoID approach not only identified more of 
the previously known effectors compared to the affinity chromatography screen, but was also able to 
identify several effectors which were not previously reported and were later confirmed to be real interactors 
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(Gillingham et al., 2019). This analysis indicates that the MitoID approach can be just as, if not more, 
effective than traditional affinity chromatography methods in identifying Rab GTPase interactors. It should, 
however, be noted that MitoID, just as any experimental method, comes with its own set of inherent 
limitations. While we were able to address several BioID-related drawbacks by stably localising BirA*-
fusion proteins to the mitochondria, and equalising the backgrounds in comparable samples, the ectopic 
localisation could also diminish the interactions of certain effectors. For instance, if the association of an 
effector relies on the composition of the lipid environment, then removing the Rab GTPase from its 
endogenous membrane compartment could disrupt binding. However, since we were able to identify 
numerous binding partners for GTPases from several different locations and with different endogenous 
lipid compositions, it is unlikely to be a common problem.  
 
Furthermore, validating interactions identified through MitoID can be challenging. One of the main 
advantages of proximity labelling is the ability to detect weaker and transient interactions, which can be 
notoriously tricky to detect by conventional biochemistry and microscopy techniques. In this thesis, I used 
a combination of mitochondrial recruitment and affinity chromatography, overexpressing both the GTPase 
and the potential effector in one system in an attempt to increase detection opportunities. However, the 
interactions of several MitoID-identified interactors remained unvalidated, which could indicate either that 
the interaction is false or that the interaction is true but simply not strong or stable enough to be detected 
through conventional methods. In an attempt to overcome this hurdle, I set out to combine split-GFP with 
the GTPase:effector pair – coupling GFP fragment to the GTPase, and the other GFP fragment to the 
potential effector. The idea being that, when effector and GTPase come in close contact, no matter how 
briefly, the two GFP fragments form a fully functioning GFP molecule and remain bound and fluorescing. 
Unfortunately, preliminary experiments were unsuccessful and this approach could not be optimised due to 
time constraints. Until a more sensitive and appropriate validation method will be developed, false 
negatives are unfortunately inevitable.  
 
Despite these inherent drawbacks, this thesis has shown that the MitoID approach is highly effective for 
identifying GTPase effectors. The technique has great potential to uncover novel GTPase interactors and 
hereby potentially gain more understanding in the roles of many less well characterised members of the Ras 
superfamily. I anticipate that the MitoID approach, as well as the specific interactions identified in this 
thesis, will aid many labs in working towards their goal of further elucidating the roles of small GTPases 
and potentially other families of proteins. 
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7.2 The dual roles of Rab1 in vesicle trafficking and autophagy 
Rab1A and Rab1B are key regulators of ER-to-Golgi trafficking, and have increasingly been suggested to 
play a role in autophagy. With the aim of further uncovering the seemingly dual roles of Rab1A and Rab1B, 
the MitoID screen was utilised to maximise the set of known Rab1 effectors.  
 
7.2.1 CALCOCO1, CLEC16A, and PPP1R37 
As previously described, numerous novel effectors were identified, of which several are known to play a 
role in vesicle trafficking (Rabaptin5, GCC88, and AKAP10), known or speculated to be involved with 
autophagy (GCC88, CLEC16A, and CALCOCO1) or remain uncharacterised to date (PPP1R37). Further 
binding assays found that CALCOCO1, CLEC16A, and PPP1R37 bind Rab1A and Rab1B in a direct and 
unaided manner. Preliminary data suggests that overexpression of CLEC16A and PPP1R37 causes Golgi 
fragmentation, suggesting that both proteins are involved in the maintenance of Golgi morphology. 
Furthermore, CALCOCO1 and PPP1R37 are found to co-localise with autophagosomes, indicating that 
they may play a role in autophagy.  
 
In the aim to further uncover the exact roles that CALCOCO1, CLEC16A, and PPP1R37 play in vesicle 
trafficking and autophagy, I set out to deplete protein levels through RNAi. Unfortunately, depletion of 
these proteins in U2OS cells turned out to be extremely challenging. Due to time constraints, I could not 
continue working on optimising the protocols. For future research, I suggest using a more stable but 
inducible system, such as the genome editing techniques CRISPR-Cas9 or Flp-In T-Rex. Other suitable 
approaches include Trim-Away, auxin-induced degron (AID), and Protacs, which all rapidly degrade 
proteins, or knocksideways, which swiftly relocalises the protein hereby causing a localised depletion (Clift 
et al., 2017; Nishimura et al., 2009; Lambrus et al., 2018; Sakamoto et al., 2001; Robinson & Hirst, 2013). 
The versatility of rapid degradation methods is particularly valuable when combined with time-limited 
techniques such as the induction of autophagy. 
A more sophisticated approach would be to investigate the role that the interaction between Rab1 and the 
effector plays on membrane trafficking and autophagy. Instead of simply depleting the entire protein from 
the cell, the binding site could be determined and disrupted through directed mutagenesis. A start was made 
by examining the binding regions of Rab1 with PPP1R37, although interesting next steps would be to 
narrow down the binding interface to a particular leucine rich repeat on PPP1R37, and potentially even 
single residues. Interesting domains on CALCOCO1 to examine would be the N-terminal SKICH domain, 
the central coiled-coil domains, or the C-terminal C2H2 Zn-finger domain (Ensembl). While coiled-coil 
domains are common interfaces for Rab GTPase binding, the SKICH domain was shown to bind NAP1, an 
adaptor protein vital for autophagy regulation, in both of the other CALCOCO family members NDP52 
 136 
and TAX1BP1, and the Zn-finger is thought to play a role in ubiquitin binding in NDP52 (Fu et al., 2018; 
Xie et al., 2015). Since CALCOCO1 shares these key domains with its fellow CALCOCO family members, 
it would be intriguing to study the importance of these domains further, and potentially narrow down the 
binding site with Rab1A and Rab1B. As discussed for PPP1R37, pinpointing the binding site with Rab1 
would allow directed mutagenesis and the precise investigation of the effect of this interaction on autophagy 
and membrane trafficking. The same is true for CLEC16A; the protein contains an N-terminal domain of 
highly conserved FPL motifs, which would be interesting to examine further since its function remains 
unknown to date (UniProt, Pfam).  
 
Further investigation of the roles of CLEC16A, CALCOCO1, and PPP1R37 in vesicle trafficking could be 
done by observing the endosomes, the Golgi apparatus, and COPI-, COPII- and clathrin-coated vesicles. 
Visualising these structures and examining their morphology, abundance, and localisation patterns after 
depleting the Rab1 effectors, or disrupting the specific interaction between Rab1 and its effectors, could 
give insight into the role that these proteins have in membrane trafficking. Another method to examine the 
role of proteins in vesicle trafficking would be through the RUSH system (Boncompain et al., 2012). This 
system is based upon the reversible interaction between a reporter protein and a hook protein, which is 
stably expressed in a donor membrane compartment. In the assay, the hook protein is fused to streptavidin, 
while the reporter protein is fused to streptavidin-binding protein (SBP). Addition of biotin will outcompete 
the binding of streptavidin and allow for the synchronous release of the reporter. Finally, in order to examine 
the timing of Rab1 effector association, the compound Brefeldin-A could be used. Brefeldin-A functions 
by inhibiting a subset of Arf1 GEFs, hereby disrupting COPI function. Since COPII function is unaffected, 
using Brefeldin-A in combination with effector depletion or interaction disruption through mutagenesis 
could aid in studying the timing or sequence of effector function in depth.  
 
Similarly to vesicle trafficking, studying the role that the identified interactors might have on autophagy 
can largely be examined by immunofluorescence and live imaging microscopy. While performing co-
staining upon effector over-expression has shed some light on the protein’s function, studying the 
morphology and abundance of autophagosomes upon protein depletion or interaction disruption through 
mutagenesis could give great insight into their roles in the regulation of autophagy. In addition, live imaging 
would be a great asset in studying dynamics of effector association/disassociation with autophagosomes. 
Studying co-localisation of the effectors with autophagosomal markers of different stages (phagophore, 
early autophagosome, mature autophagosome) could aid in studying the timing of effector function or 
association. Another useful is tandem fluorescence-tagged LC3 or acridine orange, techniques which utilise 
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changes of the fluorophores in acidic environments, allowing for close examination of the maturation of 
autophagosomes as they fuse with lysosomes (Kimura et al., 2007; Thomé et al., 2016). 
 
Another route to investigate the functions of CALCOCO1, CLEC16A, and PPP1R37, is by examining 
whether they have any other interaction partners besides Rab1A and Rab1B. I set out to perform MitoID 
assays on the three effectors, however, the C-terminally tagged CALCOCO1 chimera did not express well 
in mammalian cultured cells. An N-terminally fused CALCOCO1 MitoID plasmid would be an alternative, 
using Tom70-HA-BirA*-bait as previously used for Arf1 and Arl1 by the Munro group, but time constraints 
did not allow me to perform this. Ideally, the effector MitoID assays would be performed in two situations; 
one set of assays in healthy, fed cultured cells, and one set of assays in starved or Trehalose induced cultured 
cells. Comparing the interactomes of the Rab1 effectors in endogenous and autophagic conditions could 
highlight interaction patterns and give further insights into their roles. However, another difficulty I 
encountered when trialling the effector MitoID assays, was that autophagic induction for 4-24 hours did 
not allow for clear comparative output. Because the MitoID assays take approximately 72 hours, the 
differences in interactomes due to autophagic induction would be minimal and hard to detect. Attempting 
to shorten the duration of biotinylation, MitoID assays were performed with and without exogenous biotin 
pulse, as well as using media and FCS depleted in biotin. However, even though the amount of biotinylation 
was indeed overall decreased, there was still a significant amount of biotinylation occurring in both the bait 
and several tested effectors (data not shown). Unfortunately, while TurboID is used for shorter biotinylation 
pulses than the original BioID and BioID2, it showed the same sensitivity issues; the bait and several tested 
preys were biotinylated even without addition of exogenous biotin (data not shown).  
 
With the aim of making the MitoID approach more useful for short time courses, I set out to adapt MitoID 
into an inducible system. Combining split-BioID with inducible heterodimerisation system iDimerize, one 
of the split-BioID fragments to each of the iDimerize domains with the aim to generate a fully functioning 
BioID only upon addition of the dimerising compound (Schopp et al., 2017). While preliminary results 
indicate that further optimisation is necessary, I strongly believe that developing this system, or a similar 
inducible approach, will be extremely useful and beneficial for studying interactomes in time-sensitive 
systems. 
 
7.2.2 The class III PI3K complex I 
The unexpected hits of the Rab1 MitoID assays included components of the class III PI3K complex I. In 
collaboration with Shirley Tremel and Yohei Ohashi from the Williams group (MRC LMB), we were able 
to show that Rab1A specifically activates the autophagy-related PI3K complex I. Interestingly, Rab1A and 
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Rab5A were found to utilise a similar site on VPS34 to interact with complex I and complex II, respectively. 
Unexpectedly, disruption of the binding interface lead to drastically opposing results – mutating the VPS34 
199-REIE-202 residues to alanine (REIE>AAAA) diminished the interaction between complex I and 
Rab1A, but strengthened the interaction between complex II and Rab5A. Furthermore, we found the WD40 
domain in VPS15 to be greatly shifted in complex I compared to complex II, causing the VPS34 C2HH 
domain to tilt (Tremel et al., 2021). It is possible that the shift of the WD40 domain is due to the binding of 
ATG14L or UVRAG in complex I or II, respectively, since the binding interface of these proteins lies 
against WD40. This could partly account for the selectivity of complex I with Rab1 and complex II with 
Rab5, although the possibility that direct interactions of ATG14L/UVRAG with the Rab GTPases could 
play a role in selectivity should not be discarded. While direct interactions of this kind were not observed 
in our study, they would be hard to pick up on if they are transient in nature. Although HDX-MS analyses 
were performed in our study, it is possible that interactions occurred one of the unobserved regions. Further 
examinations using HDX-MS and cross-linking, as well as increasing the resolution of the cryo-EM 
structure, could aid in identifying potential transient interactors. Regardless, the identification of Rab1A as 
a specific PI3K complex I activator provides great insight into how Rab1 affects autophagy, opening up the 
fields of study towards PI3-kinases, Rab GTPases, and the intersection of vesicle trafficking and autophagy. 
 
7.3 Concluding remarks 
In this thesis, I have shown that the MitoID approach is a very efficient and effective method to identify 
interactors of small GTPases. Adding to the array of available techniques, MitoID is certainly a valuable 
tool to study protein-protein interactions, and has the potential to greatly aid many fields of research. 
Identifying and validating six previously unreported Rab1A and Rab1B effectors greatly increases the set 
of known Rab1 effectors, which aids us in our journey to closely dissect the seemingly dual roles of Rab1; 
a master regulator of vesicle trafficking and autophagy.  
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Materials and Methods 
 
I. Materials 
I.I Plasmids 
 
Unique 
code  
Coding region of interest Description Vector (Source) 
JB74 Rab1AWT-BirA*-HA-MAO 
 
Wildtype (WT) or GTP-locked (QL), or 
GDP-locked (SN/TN) protein fused at 
the C-terminus to a GAGAGA linker, 
the biotin ligase BirA* (BioID), an HA 
epitope tag, and the transmembrane 
domain of monoamine oxidase as a 
mitochondrial targeting sequence.  
pcDNA3.1+ 
JB49 Rab1AQ70L-BirA*-HA-MAO 
 
JB50 Rab1AS25N-BirA*-HA-MAO 
 
JB75 Rab1BWT-BirA*-HA-MAO 
 
JB76 Rab1BQ67L-BirA*-HA-MAO 
 
JB77 Rab1BS22N-BirA*-HA-MAO 
 
pH38 Rab2AWT-BirA*-HA-MAO 
  
pcDNA3.1+ 
(Alison 
Gillingham) pN40 Rab2AQ65L-BirA*-HA-MAO  
JB2 Rab2AS20N-BirA*-HA-MAO 
 
pcDNA3.1+ 
JB39 Rab5AWT-BirA*-HA-MAO 
 
JB28 Rab5AQ79L-BirA*-HA-MAO 
 
JB40 Rab5AS34N-BirA*-HA-MAO 
 
pG38 Rab6AWT-BirA*-HA-MAO 
 pcDNA3.1+ (Alison 
Gillingham) pO40 Rab6AQ72L-BirA*-HA-MAO  
JB4 Rab6AT27N-BirA*-HA-MAO 
 
pcDNA3.1+ JB93 Rab7AQ67L-BirA*-HA-MAO  
JB94 Rab7AT22N-BirA*-HA-MAO 
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JB12 Rab8AWT-BirA*-HA-MAO 
 
Wildtype (WT), GTP-locked (QL), or 
GDP-locked (SN/TN) protein fused at 
the C-terminus to a GAGAGA linker, 
the biotin ligase BirA* (BioID), an HA 
epitope tag, and the transmembrane 
domain of monoamine oxidase as a 
mitochondrial targeting sequence. 
pcDNA3.1+ 
JB24 Rab8AQ67L-BirA*-HA-MAO 
 
JB23 Rab8AT22N-BirA*-HA-MAO 
 
JB83 Rab9AWT-BirA*-HA-MAO 
 
JB84 Rab9AQ66L-BirA*-HA-MAO 
 
JB85 Rab9AS21N-BirA*-HA-MAO 
 
JB80 Rab10WT-BirA*-HA-MAO 
 
JB81 Rab10Q68L-BirA*-HA-MAO 
 
JB82 Rab10T23N-BirA*-HA-MAO 
 
JB16 Rab11AWT-BirA*-HA-MAO 
 
JB20 Rab11AQ69L-BirA*-HA-MAO 
 
JB19 Rab11AS25N-BirA*-HA-MAO 
 
pX49 Rab11BQ70L-BirA*-HA-MAO 
 pcDNA3.1+ (Alison 
Gillingham) pY49 Rab11BS25N-BirA*-HA-MAO  
JB5 Rab18WT-BirA*-HA-MAO 
 
pcDNA3.1+ 
JB11 Rab18Q67L-BirA*-HA-MAO 
 
JB10 Rab18S22N-BirA*-HA-MAO 
 
JB7 rab19BWT-BirA*-HA-MAO 
 
JB18 Rab19BQ76L-BirA*-HA-MAO 
 
JB17 Rab19BT31N-BirA*-HA-MAO 
 
 
pG48 Rab21WT-BirA*-HA-MAO 
 
pcDNA3.1+ (Alison 
Gillingham) 
pH48 Rab21Q78L-BirA*-HA-MAO 
 
pI48 Rab21T33N-BirA*-HA-MAO 
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JB89 Rab29WT-BirA*-HA-MAO 
 
Wildtype (WT), GTP-locked (QL), or 
GDP-locked (SN/TN) protein fused at 
the C-terminus to a GAGAGA linker, 
the biotin ligase BirA* (BioID), an HA 
epitope tag, and the transmembrane 
domain of monoamine oxidase as a 
mitochondrial targeting sequence. 
pcDNA3.1+ 
JB90 Rab29T21N-BirA*-HA-MAO 
 
JB91 Rab29Q67L-BirA*-HA-MAO 
 
JB92 Rab29A16V-BirA*-HA-MAO 
 
pI38 Rab30BWT-BirA*-HA-MAO 
 
 
 
pcDNA3.1+ (Alison 
Gillingham) 
 
 
JB15 Rab30BQ68L-BirA*-HA-MAO 
 
pcDNA3.1+ 
JB3 Rab30BT23N-BirA*-HA-MAO 
 
JB13 Rab33BWT-BirA*-HA-MAO 
 
JB26 Rab33BQ92L-BirA*-HA-MAO 
 
JB25 Rab33BT47N-BirA*-HA-MAO 
 
JB6 Rab39BWT-BirA*-HA-MAO 
  
JB8 Rab39BQ68L-BirA*-HA-MAO 
  
JB9 Rab39BS22N-BirA*-HA-MAO 
  
JB14 Rab43WT-BirA*-HA-MAO 
  
JB21 Rab43Q77L-BirA*-HA-MAO 
  
JB22 Rab43T32N-BirA*-HA-MAO 
  
JB41 Rac1WT-BirA*-HA-MAO 
 
JB42 Rac1Q60L-BirA*-HA-MAO 
 
JB54 Rac1T17N-BirA*-HA-MAO 
 
JB47 Cdc42WT-BirA*-HA-MAO 
 
JB48 Cdc42G12V-BirA*-HA-MAO 
 
JB57 Cdc42T17N-BirA*-HA-MAO 
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JB46 RhoAWT-BirA*-HA-MAO 
 
Wildtype (WT), GTP-locked 
(QL/GV/GD), or GDP-locked 
(SN/TN/SA) protein fused at the C-
terminus to a GAGAGA linker, the 
biotin ligase BirA* (BioID), an HA 
epitope tag, and the transmembrane 
domain of monoamine oxidase as a 
mitochondrial targeting sequence. 
pcDNA3.1+ 
JB68 RhoAQ63L-BirA*-HA-MAO 
 
JB55 RhoAT19N-BirA*-HA-MAO 
 
JB86 RhebWT-BirA*-HA-MAO 
 
JB87 RhebQ64L-BirA*-HA-MAO 
 
JB88 RhebS20N-BirA*-HA-MAO 
 
JB95 nRasG12D-BirA*-HA-MAO 
 
JB96 nRasT17N-BirA*-HA-MAO 
 
JB97 RalBG23V-BirA*-HA-MAO 
 
JB98 RalBS29A-BirA*-HA-MAO 
 
JB27 
/JJS345 BirA*-HA-MAO 
 
 
BirA* (BioID) fused at its C-terminus to 
a GAGAGA linker, an HA epitope tag, 
and the transmembrane domain of 
monoamine oxidase as a 
mitochondrial targeting sequence. 
Used as a negative control for MitoIDs 
proximity labelling assays. 
 
 
pcDNA3.1+ (John 
Shin) 
JB31 Rab1AQ70L-BioID2-HA-MAO 
  
Wildtype (WT), GTP-locked (QL), or 
GDP-locked (SN/TN) protein fused at 
the C-terminus to a GAGAGA linker, 
the biotin ligase BioID2, an HA epitope 
tag, and the transmembrane domain 
of monoamine oxidase as a 
mitochondrial targeting sequence. 
pcDNA3.1+ 
JB32 Rab1AS25N-BioID2-HA-MAO 
  
JB152 Rab1BQ67L-BioID2-HA-MAO 
 
JB153 Rab1BS22N-BioID2-HA-MAO 
 
JB34 Rab6AQ72L-BioID2-HA-MAO 
  
JB35 Rab6AT27N-BioID2-HA-MAO 
  
JB37 Rab11AQ69L-BioID2-HA-MAO 
  
JB38 Rab11AS25N-BioID2-HA-MAO 
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JB158 Rab1AQ70L-TurboID-HA-MAO 
 
Wildtype (WT), GTP-locked (QL), or 
GDP-locked (SN/TN) protein fused at 
the C-terminus to a GAGAGA linker, 
the biotin ligase TurboID, an HA 
epitope tag, and the transmembrane 
domain of monoamine oxidase as a 
mitochondrial targeting sequence. 
pcDNA3.1+ 
JB159 Rab1AS25N-TurboID-HA-MAO 
 
JB150 Rab1BQ67L-TurboID-HA-MAO 
 
JB151 Rab1BS22N-TurboID-HA-MAO 
 
JB104 Rab6AQ72L-TurboID-HA-MAO 
 
JB105 Rab6AS27N-TurboID-HA-MAO 
 
JB106 Rab11AQ69L- 
TurboID-HA-MAO 
JB107 Rab11AS25N- 
TurboID-HA-MAO 
JB44 Rab1AQ70L-GST 
  GTP-locked (QL) or GDP-locked (SN) 
protein fused at the C-terminus to a 
GAGA linker and a GST tag. Used for 
the baculovirus expression system 
(MultiBac) in insect cells.  
  
pAceBac1 (Geneva 
Biotech)  
JB45 Rab1AS25N-GST 
  
JB148 Rab1BQ67L-GST 
 
JB149 Rab1BS22N-GST 
 
JB154 GST-Tev-Rab1AQ70L 
 GTP-locked (QL) or GDP-locked (SN) 
protein, N-terminally taged with a GST 
tag, a Tev cleavage site, and a GAGA 
linker. Used for the baculovirus 
expression system (MultiBac) in insect 
cells. 
JB155 GST-Tev-Rab1AS25N 
 
JB156 GST-Tev-Rab1BQ67L 
 
JB157 GST-Tev-Rab1BS22N 
 
JB63 Rab1AQ70L(C26S,C126S)-BirA*-
HA-MAO 
  
GTP-locked (QL), or GDP-locked (SN) 
Rab1A protein with C26S and C126S 
mutations, C-terminally fused to a 
GAGAGA linker, BirA* (BioID), an HA 
epitope tag, and the transmembrane 
domain of monoamine oxidase (MAO) 
as a mitochondrial re-localisation tag. 
  
pOPTG (Olga 
Perisic) 
JB65 Rab1AS25N(C26S,C126S)-BirA*-
HA-MAO 
  
JB78 GST-Tev-Rab1AQL 
(C26S,C126S)  
  
 
GTP-locked (QL) and GDP-locked (SN) 
Rab1A protein with C26S and C126S 
mutations, N-terminally tagged with a 
GST tag, a Tev cleavage sequence, and 
a GAGA linker. 
  
JB79 GST-Tev-Rab1ASN 
(C26S,C126S)  
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JB144 HA-Rab1AQ70L 
 
GTP-locked (QL) and GDP-locked (SN) 
protein, N-terminally tagged with an 
HA epitope 
pcDNA3.1+ 
 
JB145 HA-Rab1AS25N 
 
JB146 HA-Rab1BQ67L 
 
JB147 HA-Rab1BS22N 
 
JB230 HA-Rab5AQ79L 
 
JB231 HA-Rab5AS34N 
 
JB180 mCherry2-Rab1AQ70L 
 
GTP-locked (QL) and GDP-locked (SN) 
Rab1A and Rab1B, N-terminally 
tagged with red fluorescent protein 
mCherry2 and a GAGA linker. 
JB181 mCherry2-Rab1AS25N 
 
JB182 mCherry2-Rab1BQ67L 
 
JB183 mCherry2-Rab1BS22N 
 
JB199 mCherry2-Rab1AQ70L-MAO 
 
GTP-locked (QL) and GDP-locked (SN) 
Rab proteins, N-terminally tagged with 
red fluorescent protein mCherry2 and 
C-terminally tagged with the 
transmembrane domain of 
monoamine oxidase (MAO) to re-
localise to the mitochondrial outer 
membrane.  
JB200 mCherry2-Rab1AS25N-MAO 
 
JB201 mCherry2-Rab1BQ67L-MAO 
 
JB202 mCherry2-Rab1BS22N-MAO 
 
JB203 mCherry2-Rab5AQ79L-MAO 
 
JB204 mCherry2-Rab5AS34N-MAO 
 
JB128 Rabaptin5-FLAG 
  
Rabaptin5 C-terminally tagged with a 
FLAG epitope  
JB132 FLAG-CALCOCO1 
  
Effector proteins and their fragments, 
N-terminally tagged with the FLAG 
epitope. 
JB215 FLAG-Clec16A 
  
JB137 FLAG-PPP1R37 
 
JB220 FLAG-PPP1R37 (1-448) 
 
JB221 FLAG-PPP1R37 (449-end) 
 
pQ51 FLAG-HPS3 
 
 
pcDNA3.1+ (Alison 
Gillingham) 
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pM51 FLAG-TRAPPC10 
 Effector proteins and their fragments, N-terminally tagged with the FLAG 
epitope. 
pcDNA3.1+ (Alison 
Gillingham) pI51 FLAG-SH3BP5L 
 
JB170 Myc-PPP1R37 
  
Effector proteins N-terminally tagged 
with the Myc epitope pcDNA3.1+ 
JB171 Myc-CALCOCO1 
  
JB214 Myc-Clec16A 
  
N/A 
 
GFP-PX (PI3P) 
 
 
N-terminally GFP-tagged PX-domain pcDNA3.1+ (Yohei Ohashi) 
pQ49 GFP-FLAG-TBCK 
 Effector proteins (TBCK, STAMBPL1, 
ARFGEF3) and PI3P binding domain 
(PX), N-terminally tagged with the 
green fluorescence protein GFP and 
the FLAG epitope 
pcDNA3.1+ (Alison 
Gillingham) 
pN49 GFP-FLAG-STAMBPL1 
 
pO49 GFP-FLAG-ARFGEF3 
 
pV51 His6-NDE1 
 
 
NDE1 N-terminally tagged with 
polyhistidine 
pYO1296 mCherry-Rab5AQ79L 
 
 
GTP-locked Rab5A N-terminally tagged 
with red fluorescent protein mCherry 
eGFP-C1 (Yohei 
Ohashi) 
pYO1280 
 
VPS34-eGFP 
 
 
VPS34 C-terminally tagged with green 
fluorescent protein eGFP 
pYO1300 
 
VPS34(REIE>AAAA)-eGFP 
 
 
 
 
VPS34, mutated to have its 199-REIE-
202 replaced with Alanines, C-
terminally tagged with green 
fluorescent protein eGFP 
pYO1101 BECN and ATG14L 
 
 
Bicistronic vector containing BECN and 
ATG14L, both untagged 
pCAG (Yohei 
Ohashi) pYO1031 BECN and UVRAG 
 
 
Bicistronic vector containing BECN and 
UVRAG, both untagged 
pYO350 VPS15 
 
 
Untagged VPS15 pcDNA4/TO 
(Yohei Ohashi) 
N/A eGFP-LC3B 
 
 
LC3B, N-terminally tagged with green 
fluorescent protein GFP 
(Thomas Mund, 
MRC LMB) 
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I.II Cell lines 
 
I.II.I Mammalian cell lines  
Unique Identifier Description Origin 
HeLa Human cell line derived from cervical adenocarcinoma 
ATCC 
 
HEK293T 
 
Human cell line derived from 
embryonic kidney 
U2OS 
Human cell line derived from 
osteosarcoma 
 
mCherry-Parkin (HeLa) 
Human cell line derived from 
cervical adenocarcinoma with 
constitutively expressed Parkin 
(tagged N-terminally with red 
fluorescent protein mCherry) 
(Lazarou et al., 2015) 
 
 
I.II.II Bacterial cell lines 
 
 
Unique Identifier Supplier Genotype Used for 
α-Select Silver 
Efficiency 
Bio-line 
(BIO-85027) 
F- deoR endA1 recA1 
relA1 gyrA96 hsdR17(rk- , 
mk+) supE44 thi-1 phoA 
Δ(lacZYA argF)U169 
Φ80lacZΔM15λ- DNA transformation 
and expression 
 
NEB 5-alpha 
competent E. coli New England Biolabs 
fhuA2 Δ(argF-lacZ)U169 
phoA glnV44 Φ80 
Δ(lacZ)M15 gyrA96 recA1 
relA1 endA1 thi-1 hsdR17 
BL21-CodonPlus(DE3)-
RIL competent cells 
Agilent Technologies 
(230132) 
E. coli B F– ompT hsdS(rB- 
mB- ) dcm+ Tetr gal 
λ(DE3) endA Hte 
[argU ileY leuW Camr] 
Protein expression 
DH10EMBacY Geneva Biotech Request from Supplier Baculoviral expression 
 149 
I.III Antibodies 
 
I.III.I Primary antibodies 
 
Antigen Species Dilution Supplier (catalogue number) 
WB IF 
FLAG (M2) Mouse 1:5000 1:300 Sigma Life Science (F1804) 
HA  Rat  1:300 Roche (3F10) 
HA Mouse 1:250  In house (12CA5) 
Myc (9E10) Mouse  1:400 Santa Cruz  Biotechnology (sc-40) 
α-Tubulin Rat 1:250  In house (YL1/2) 
TGN46  Sheep  1:300 ABD serotec (AHP500G) 
Giantin  Goat  1:100 Santa Cruz Biotech (N-18/sc-46993) 
Golgin-84 Rabbit  1:300 Atlas Antibodies (HPA000992) 
GCC185  Rabbit  1:300 Atlas Antibodies (HPA035849) 
GCC88 Rabbit 1:1000 1:300 Sigma Life Science (HPA019369/HPA021323) 
ZFPL1 Rabbit  1:300 Sigma Life Science (HPA014909) 
COXIV (3E11) Rabbit  1:200 New England Biolabs (4850S) 
TOM20  Mouse  1:300 Santa Cruz Biotechnology (sc-17764) 
CI-MPR Mouse  1:300 Abcam (ab2733) 
OSBPL9 Rabbit 1:1000  Abcam (ab151691) 
TBCK Rabbit 1:500  Cambridge Bioscience (HPA039951) 
RELCH/KIAA1468 Rabbit 1:1000  Cambridge Bioscience (HPA040038) 
RELCH/KIAA1468 Rabbit 1:1000  Atlas Antibodies (HPA014570) 
ARFGEF3 Rabbit 1:1000  Thermo Fisher Scientific (PA5-57623) 
STAMBPL1  Rabbit 1:1000  Sigma Life Science (SAB4200146) 
GBF1  Mouse 1:1000  BD Transduction Laboratory (612116) 
NDE1 Rabbit 1:500  Life Technologies (711424) 
SIPA1L2  Rabbit 1:1000  Invitrogen (PA5-20848) 
ALS2 WB Rabbit 1:1000  Novus Bio (NBP2-14284) 
ARFGEF2  Mouse 1:1000  Santa Cruz Biotechnology (sc-398042) 
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Antigen Species Dilution Supplier (catalogue number) 
WB IF 
SH3BP5L  Rabbit 1:1000  Aviva Systems Biology (ARP71605-P050) 
VPS34  Rabbit 1:1000  Proteintech (12452-1-AP) 
VPS15 Rabbit 1:1000  Proteintech (17894-1-AP) 
UVRAG Rabbit 1:1000  Cell Signalling Technology (5320S) 
ATG14L Rabbit 1:1000  Cell Signalling Technology (5504S) 
Beclin-1 Rabbit 1:1000  Santa Cruz Biotechnology (sc-11427) 
NRBF2 Rabbit 1:1000  GeneTex (GTX54585) 
Rubicon Rabbit 1:1000  Abcam (ab92388) 
EEA1 Rabbit  1:300 Abcam (ab109110) 
EEA1 Mouse  1:300 BD Transduction Laboratories (610457) 
CALCOCO1  Rabbit 1:1000  Atlas Antibodies (HPA038313) 
Rabaptin5  Mouse 1:1000  BD Transduction Laboratories (610676) 
AKAP10  Rabbit 1:1000  Proteintech (12356-1-AP) 
GRIPAP1  Rabbit 1:1000  Proteintech (15806-1-AP) 
PPP1R37  Rabbit 1:1000  Atlas Antibodies (HPA041500) 
PPP1R37 Rabbit 1:1000  Thermo Scientific (PA5-59597) 
CLEC16A Goat 1:1000  Novus Bio (NBP1-36948) 
LC3B Rabbit  1:300 MBL (PM036) 
LC3A/B Mouse 1:1000  Santa Cruz Biotechnology (sc-398822) 
P62 Mouse  1:300 MBL (M162-3) 
P62 Mouse 1:1000  BD Transduction Laboratories (610832) 
Sec16A Rabbit  1:300 Atlas Antibodies (HPA005684) 
CD63 Mouse  1:250 BD Biosciences (740080) 
GFP Rabbit 1:1000  Sigma Life Science (SAB4301138) 
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I.III.II Secondary antibodies 
 
Antigen Species Dilution Supplier (catalogue number) 
Anti-Rabbit Alexa Fluor 488 Donkey 1:300 Thermo Fisher Scientific (A21206) 
Anti-Rabbit Alexa Fluor 555 Donkey 1:300 Thermo Fisher Scientific (A31572) 
Anti-Rabbit Alexa Fluor 647 Donkey 1:300 Thermo Fisher Scientific (A31573) 
Anti-Rabbit HRP Donkey 1:3000 GE Life Sciences (NA934V) 
Anti-Mouse Alexa Fluor 488 Donkey 1:300 Thermo Fisher Scientific (A21202) 
Anti-Mouse Alexa Fluor 555 Donkey 1:300 Thermo Fisher Scientific (A32773) 
Anti-Mouse Alexa Fluor 647 Donkey 1:300 Thermo Fisher Scientific (A31571) 
Anti-Mouse HRP Sheep 1:3000 GE Life Sciences (NA931V) 
Anti-Rat Alexa Fluor 488 Donkey 1:300 Thermo Fisher Scientific (A21208) 
Anti-Rat Alexa Fluor 555 Donkey 1:300 Abcam (ab150154) 
Anti-Rat Alexa Fluor 647 Goat 1:300 Thermo Fisher Scientific (A21247) 
Anti-Rat HRP Goat 1:3000 Abcam (ab205720) 
Anti-Goat Alexa Fluor 555 Donkey 1:300 Thermo Fiscer Scientific (A21436) 
Anti-Goat Alexa Fluor 647 Donkey 1:300 Thermo Fisher Scientific (A32849) 
Anti-Sheep Alexa Fluor 647 Donkey 1:300 Thermo Fisher Scientific (A21448) 
 
  
II. Methods 
 
II.I Molecular cloning 
 
II.I.I DNA manipulation 
DNA manipulations were performed using specified kits and carried out according to the manufacturer’s 
protocol. Plasmid DNA was prepared from bacterial liquid cultures using Qiagen plasmid kits and were 
eluted in TE buffer. Mammalian genomic DNA was purified from cultured cells using the Qiagen DNA 
extraction kit. DNA amplifications were performed using Phusion High-Fidelity DNA Polymerase (New 
England Biolabs) with GC buffer, an annealing time of 30 seconds and an extension time of 30s/kbp. DNA 
digestions were performed for 60 minutes at 37°C using New England Biolabs restriction enzymes and its 
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corresponding CutSmart buffer. DNA fragments were resolved by gel electrophoresis using a 1.2% agarose 
gel with SYBR Safe DNA gel stain (Thermo Fisher Scientific). A 1kb+ DNA ladder was loaded together 
with DNA fragments, and the gels were visualised using a Safe Image Blue-Light Transilluminator (both 
Thermo Fisher Scientific). Excised bands were purified using the Qiagen gel extraction kit. DNA fragments 
were ligated using T4 DNA Ligase (New England Biolabs) for 60 minutes at room temperature.  
Gibson Assembly backbone and insert DNA were generated by performing PCR DNA amplifications using 
Gibson-appropriate primers. Gibson Assembly reactions were performed by mixing 3 μL backbone DNA, 
1 μL insert DNA and 7.5 μL Gibson Assembly master mix (New England Biolabs). The mixture was 
incubated for 1 hour at 50°C, and was either stored at 4°C or immediately used for bacterial transformation 
onto plates. 
 
II.I.II Cloning strategies 
Small GTPase chimeras for MitoID assays were generated by fusing the GTPases lacking the C-terminal 
cysteines to a GAGAGA linker, the promiscuous biotin ligase BirA*, another GAGAGA linker, the HA 
epitope, a GAGA linker, and the mitochondrial targeting sequence of monoamine oxidase (MAO). These 
chimeras were cloned into a pcDNA3.1+ vector and used for transiently transfecting mammalian cultured 
cells. 
FLAG-, HA-, Myc-, GFP-, His6-, and mCherry-tagged proteins were for transient expression in mammalian 
cultured cells for co-localisation and recruitment experiments by confocal microscopy or to serve as baits 
for affinity chromatography experiments. All fusion proteins contained a GAGA linker between the tag and 
the protein of interest, whether tagged on the N- or C-terminus, and were cloned into pcDNA3.1+. Small 
GTPases were tagged N-terminally whenever possible, with C-terminal tags only being used with 
mitochondrial re-localisation in combination with the removal of C-terminal cysteines, allowing for proper 
membrane incorporation. Effector proteins were tagged on either end, after which both chimeras were tested 
to allow for assay optimisation. All plasmids containing N- or C-terminally tagged proteins were supplied 
by Alison Gillingham or Lawrence Welch. 
GTP- and GDP-locked Rab1A and Rab1B were fused to GST on either their N- or C-terminus, and cloned 
into pAceBac1 vectors to allow baculoviral expression (see below). 
PPP1R37 truncations were created by PCR amplifying residues 1-448 and 449-691 of wildtype PPP1R37 
and cloning into pcDNA3.1+ containing an N-terminal FLAG tag (supplied by Lawrence Welch) through 
traditional restriction enzyme cloning. 
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II.I.III transformation and growth of bacteria 
Bacterial lines stored at -80°C were thawed on ice for 30 minutes and, after which 1-2 μL of plasmid DNA 
was added to 15 μL of bacterial cells. The mixture was incubated on ice for 30 minutes, heat shocked at 
42°C for 45 seconds and placed back on ice. SOB medium was added and the mixtures were incubated at 37°C 
to allow for antibiotic expression; 1 hour for BL21, α-select and DH5-alpha cells, and 4 hours for DH10EMBacY  
cells. Bacteria were then plated on 2xTY or LB agar plates with appropriate antibiotics and grown overnight at 
37°C. Resulting single colonies of BL21, α-select, and DH5-alpha cells were used for inoculation of liquid 
cultures of 2 mL 2xTY medium with appropriate antibiotics. DH10EMBacY colonies were screened for 
successful transposition by blue-white screening. 
 
 
II.II Mammalian cell biology 
 
II.II.I Cell culture, cryopreservation, transfection, and RNAi 
HeLa, HEK293T, and U2OS cells were cultured in Dulbecco’s Modified Eagle’s Medium with high 
glucose (DMEM GlutaMAX+, Thermo Fisher Scientific) and 10% supplemented fetal calf serum (FCS) at 
37°C and with 5% CO2. Cell lines were regularly tested to ensure that they were mycoplasma free, using 
the MycoAlert kit (Lonzo). Cells were passaged consistently to ensure healthy confluency, by washing with 
EDTA solution and incubating in trypsin solution at 37°C for 2-5 minutes (both MRC LMB media kitchen). 
Cells were resuspended in culture medium and replated for either maintaining a cell stock or for further 
experiments. Long term storage was achieved by pelleting resuspended cells for 5 minutes at 1000rpm and 
resuspending in freezing medium (10% DMSO, 50% FCS, 40% DMEM GlutaMAX+), after which they 
were stored in cryovials at -80°C.  
For immunofluorescence experiments, U2OS or HeLa cells were seeded in 6-well plates to achieve 60-80% 
confluency at the time of transfection. A total of 1 mg of DNA was mixed with 4 μL FuGENE 6 (Promega) 
or PEI (MRC LMB media kitchen) and 100 μL Opti-MEM media (Thermo Fisher). The mixture was 
incubated for 20 minutes and added to the cells for 24 hours. 24 hours prior to fixation, cells were 
trypsinated, resuspended, and seeded onto microscope slides. 
For MitoID and affinity chromatography experiments, HEK293T cells were seeded in T175 flasks in culture 
medium at 37°C with 5% CO2. 2 mL Opti-MEM medium was mixed with 75 μL FuGENE 6 or PEI and 25 
mg DNA. After gentle mixing and incubating at room temperature for 20 minutes, the mixtures were added 
to the flasks. 48 hours after transfection, cells require for affinity chromatography were resuspended by 
tapping of the flask and addition of ice cold PBS. Cells were pelleted by 5 minute centrifugation of 1000rpm 
at 4°C. Cells were kept on ice prior to immediate use, or snap frozen in liquid nitrogen and kept at -80°C 
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for long term storage. Cells required for MitoID assays were supplemented with a final concentration of 50 
mM biotin, 24 hours before use. 
HeLa cells stably expressing mCherry-Parkin were previous described by (Lazarou et al., 2015). 
For RNAi protein depletion, U2OS cells were seeded in 6-well plates to achieve 60-70% confluency at time 
of transfection. One hour prior to transfections, cells were gently washed and given fresh culture medium. 
30 nM siRNAs were diluted in 100 μL working solution of GenMute Transfection Buffer (SignaGen). After 
gentle mixing, 2.4 μL GenMute Reagent was added and the mixture was left to incubate at room temperature 
for 15 minutes. The mixture was added dropwise to cells and left to incubate for 5 days at 37°C with 5% 
CO2. 24 hours before fixation, cells were trypsinised, resuspended, and seeded on microscopy slides. 
 
II.II.II Autophagic induction and lysosomal inhibition 
For autophagic induction by starvation, cells were washed twice with EDTA and incubated for 4 hours with 
EBSS (Earle’s Balanced Salt Solution) medium at 37°C and 5% CO2. Autophagic induction by was 
performed by washing the cell culture medium off adhered cells and adding 100 mM Trehalose in fresh 
medium. Cells were incubated at 37°C and 5% CO2 for 24 hours prior to fixation or lysis. Lysosomal 
inhibition was achieved by adding 100 nM Bafilomycin-A1 to the autophagic induced cells 4 hours prior 
to fixation or lysis. Cells were either fixed on microscope slides and used for immunofluorescent staining, 
or lysed in 6-well plates using 2x Tris-glycine sample buffer (Invitrogen) with 5% β-mercaptoethanol. 
 
II.II.III Mitochondrial stress induction 
10 mM CCCP (carbonyl cyanide m-chlorophenylhydrazone) diluted in DMSO was added to HeLa cells 
stably expressing mCherry-Parkin (Lazarou et al., 2015). The cells were incubated for 3 hours at 37°C and 
with 5% CO2, after which they were immediately fixed and used for immunofluorescent staining. 
 
 
II.III Insect Cell Biology 
 
II.III.I Cell culture 
Sf9 cells were cultured and prepared for order by the MRC LMB Baculovirus Facility, and were incubated 
at 25°C at 140rpm. 
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II.III.II Baculoviral expression system 
Sf9 cells were seeded at a density of 106 cells/cm2 in Insect Xpress culture medium (Lonza) at 27°C and 
allowed to adhere for 10-15 minutes. Cells were transfected with 2 μg bacmid DNA using Fugene HD 
(Promega) according to manufacturer’s protocol. After incubating at 27°C for 3-5 days, the culture medium 
was aspirated and added to 50 mL suspended Sf9 cells at a density of 2x106 cells/mL in 250 mL Erlenmeyer 
flasks. After a further 3-5 days incubation at 27°C with 140rpm, culture medium containing the virus was 
used to inoculate 500 mL cultures to enhance the viral titer, after which the cells were pelleted at 2500g for 
10 minutes and snap frozen in liquid nitrogen.  Cell pellets were kept at -80°C until use for protein 
purification. 
 
 
II.IV Immunofluorescence microscopy 
Cells were seeded onto multisport coated slides (Hendley-Essex) in culture medium at 37°C with 5% CO2 
in a closed humid container. If cells were subjected to autophagic induction, lysosomal inhibition, or 
mitochondrial stress induction (as described above), this was performed 24 hours after seeding to allow cell 
adherence. Slides were moved to room temperature and cells were fixed in 4% PFA for 20 minutes. Cells 
were washed twice in PBS, permeabilised with 0.15% Triton-x100/PBS, washed 3x with PBS, and 
incubated in blocking buffer (20% FCS, 0.5% Tween-20, PBS) for 1 hour. Primary antibodies (see above) 
were diluted in blocking buffer and incubated on the cells for 1 hour at room temperature. Cells were 
washed 5x with 0.05% Tween in PBS after which secondary antibodies diluted in blocking buffer were 
added to the cells. After incubating for 1 hour at room temperature, cells were washed a further 5x in 0.05% 
Tween-20/PBS and once in PBS. PBS was fully aspirated and cells were mounted in Vectashield mounting 
media (Vector Laboratories), after which a coverslip was placed over the microscope slide and sealed by 
clear nail polish. Microscope slides were imaged using a Leica TCS SP8 confocal microscope using an 63x 
oil objective. 
 
 
II.V Biochemistry 
 
II.V.I Protein sample preparation 
Pelleted mammalian and insect cells were resuspended in lysis buffer consisting of 50 mM Tris HCl pH 
7.4, 150 mM NaCl, 1 mM EDTA, 0.5% Triton X-100, 1 mM PMSF (Sigma) and the cOmplete EDTA-free 
protease inhibitor cocktail (Roche) on ice. Cells were incubated for 20-30 minutes at 4°C with agitation. 
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Cells were pelleted by centrifugation at 32.000rpm for 10 minutes at 4°C, after which the supernatant was 
either immediately used for protein purification or ran on SDS-PAGE protein gels for resolution. 
 
II.V.II GST affinity chromatography of insect cell expressed Rab1A and Rab1B 
Glutathione sepharose 4B beads (GE Life Sciences) were washed with lysis buffer and pelletted by 
centrifugation at 100 x g for 1 minute. Beads were mixed with clarified Sf9 lysate from strains expressing 
GST-tagged fusion proteins and incubated with agitation at 4°C for 30 minutes. Next, beads were washed 
once with lysis buffer, once with high salt lysis buffer (lysis buffer with 500 mM NaCl) and another four 
times with lysis buffer. Mammalian cell lysates, either wildtype or transiently expressing FLAG-tagged 
proteins, were mixed with the beads coated with GST-tagged proteins and incubated for 1 hour with 
agitation at 4°C. Beads were washed 5 times with lysis buffer, after which interacting proteins were eluted 
by boiling the beads at 98°C for 5 minutes in 2x Tris-glycine sample buffer (Invitrogen) with 5% β-
mercaptoethanol.  
In case of studying direct binding, FLAG-tagged proteins were isolated by incubation with FLAG M2 
affinity resin (Sigma) for 1 hour at 4°C with agitation. Beads were washed 5x in lysis buffer and proteins 
were eluted in 100 mg/ml 3x FLAG peptide (Sigma) in 25 mM Tris-HCl pH 7.4, 250 mM NaCl, and 1 mM 
EDTA. Isolated FLAG-tagged proteins were mixed with GST-coated beads and continued as described 
above.  
 
II.V.III Affinity chromatography of E. coli expressed Rab2A, Rab5A, Rab6A, Rab9A, and Rab11A   
GTP- and GDP-locked Rab GTPases were expressed in E. coli strain BL21-GOLD (DE3; Agilent 
Technologies) as GST-fusion proteins. Bacteria were grown at 37°C to an OD600 of 0.7 and induced with 
100 mM IPTG overnight at 16°C with agitation. Cells were pelleted by centrifugation, dounce homogenised 
and sonicated in lysis buffer (50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 5 mM MgCl2, 1% Triton X-100, 5 
mM β-mercaptoethanol, plus 1 EDTA-free complete protease tablet/50 ml, 1 mM PMSF and either 100 
mM non-hydrolysable GTP analog (GppNHp, Sigma) or 100 mM GDP as appropriate). The lysates were 
clarified by centrifugation at 12,000g for 15 min and GST-Rab proteins were added to washed glutathione 
Sepharose beads (GE Healthcare) for 30 min at 4°C with agitation. After incubation, beads were washed 
extensively to remove unbound material. HEK293T cells from 5 T175 cm2 flasks were collected, washed 
and lysed in 10 mL lysis buffer (as described above). The lysate was divided equally and applied to 50 ml 
of GST-Rab coated beads with either 100 mM non-hydrolysable GTP (GppNHp) or 100 mM GDP added 
as appropriate. Beads were incubated, washed and proteins eluted in high salt buffer (lysis buffer with 500 
mM NaCl). Proteins were precipitated and analysed by immunoblotting with the indicated antibodies.  
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To assess the interaction between Rab9A and HPS3, 1 T175cm2 flask of HEK293T cells was transfected 
with FLAG-tagged HPS3 using Fugene 6 (Promega). After 24 hours of incubation, cells were lysed and 
incubated with beads coated with GST-Rab GTPases, and continued as described above. 
 
II.V.IV Affinity chromatography of GST-Rab2A and purified STAMBPL1 
1 T175 cm2 flask of HEK293T cells was transfected with GFP-FLAG-STAMBPL1 using Fugene 6 
(Promega). Cells were lysed as described above and GFP-FLAG-STAMBPL1 was isolated by incubation 
with FLAG M2 affinity resin (Sigma) for 1 hour at 4°C with agitation. Beads were washed 5x in lysis buffer 
and proteins were eluted in 100 mg/ml 3x FLAG peptide (Sigma) in 25 mM Tris-HCl pH 7.4, 250 mM 
NaCl, and 1 mM EDTA. Isolated GFP-FLAG-STAMBPL1 was added to glutathione Sepharose beads (GE 
Healthcare) coated in GST-Rab2A and incubated at 4°C for 2 hours with agitation. Beads were then washed 
in lysis buffer, before bound proteins were eluted in high salt buffer (25 mM Tris-HCL, pH7.4, 1.5 M NaCl, 
20 mM EDTA, 5 mM β-mercaptoethanol and 1 mM of the opposing nucleotide). Proteins were precipitated 
with chloroform/methanol, and resuspended in SDS sample buffer with 1 mM β-mercaptoethanol. 
 
II.V.V Affinity chromatography of GST-Rab2A and ARFGEF3 isolated from rat brain 
Rat brain was harvested rapidly and placed into ice-cold PBS. Following several washes in PBS, the brain 
was minced into small pieces and 50 mL of lysis buffer was added (20 mM Tris-HCl, pH8, 150 mM KCl, 
5 mM MgCl2,,1 mM PMSF, 1% (w/v) CHAPS, and 1 EDTA-free complete protease tablet/25 ml buffer). 
The material was dounce homogenised, solubilised by rotation at 4°C for 3 hours and centrifuged at 
100.000g for 60 min at 4°C. The supernatant was stored in aliquots at -80°C. For each affinity 
chromatography experiment, 5 mL of supernatant was applied to 50 mL of GST-Rab coated glutathione 
Sepharose beads. The beads were then incubated and processed as previously described, except 1% (w/v) 
CHAPS replaced Triton X-100 in the wash buffer. 
 
II.V.VI Affinity chromatography of GSWT-Rab9A with purified NDE1 
NDE1 was expressed BL21-GOLD E. coli as a fusion to a N-terminal His6 tag with a dihydrolipoyl 
acetyltransferase solubility tag and a TEV cleavage site between the His6 tag and the NDE1 insert. Lysates 
containing NDE1 were incubated with glutathione-Sepharose beads to pre-clear the sample prior to 
incubation with 50 ml GST-Rab coated beads for 2 hours at 4°C with rotation. Beads and protein complexes 
were washed 5x in lysis buffer, as previously described, and proteins were eluted in SDS sample buffer 
with 1 mM β-mercaptoethanol.  
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II.V.VII MitoID assays and streptavidin affinity chromatography 
The MitoID protocol was adapted from the BioID method (Roux et al., 2012). Briefly, HEK293T cells were 
grown in T175 flasks, and transfected using two flasks per bait (as described above). 24h after transfection, 
biotin was added to a final concentration of 50 μM, and further incubated at 37°C for 18-24 hours. Cells 
were pelleted by centrifugation for 5 mins at 1000rpm and at 4°C, washed once in ice cold PBS, and 
resuspended in lysis buffer (25 mM Tris pH 7.4, 150 mM NaCl, 1 mM EDTA, 1% (v/v) Triton X-100, 1 
mM PMSF, and 1cOmplete protease inhibitor tablet (Roche) per 50 mL buffer. One pellet containing 2x 
T175 cells was mixed with 1mL lysis buffer and incubated for 30 mins at 4°C with rotation. After 
centrifugation at 32.000rpm for 10 minutes at 4°C, the supernatants were added to 500 μL MyOne 
Streptavidin C1 Dynabead (Invitrogen) that had be pre-washed twice in lysis buffer. The beads were 
incubated at 4°C overnight and the next morning were washed twice with Wash Buffer 1 (2% SDS, 
cOmplete inhibitors), three times in Wash Buffer 2 (1% (v/v) Triton X-100, 0.1% (w/v) deoxycholate, 500 
mM NaCl, 1 mM EDTA, 50 mM HEPES, cOmplete inhibitors, pH 7.5), and three times in Wash Buffer 3 
(50 mM Tris pH 7.4, 50 mM NaCl, cOmplete inhibitors). Finally, beads were incubated in 75 μL SDS 
sample buffer containing 3 mM biotin and heated for 3 minutes at 98°C, after which 1 mM β-
mercaptoethanol was added to the samples. Samples were either used immediately or snap frozen and stored 
at -20°C. All MitoID experiments were performed as biological triplicates for each GTPase bait; 
transfection and affinity chromatography assays were performed and processed separately. 
 
II.V.VIII Resolution of protein samples 
Protein samples were incubated for 3 minutes at 90°C prior to loading onto Novex 4-20% Tris-Glycine 
Mini Gels (Thermo Fisher Scientific). After 1 hour at 175V, proteins were either stained by incubating 
InstantBlue Coomassie stain for 1 hour at room temperature, or transferred onto 0.45 μm nitrocellulose 
paper using 255 mA. Transferred Western blots were blocked in 5% milk in 0.01% Tween-20/PBS for 1 
hour at room temperature with agitation. Blots were incubated with primary antibodies diluted in blocking 
buffer for 1 hour at room temperature of overnight at 4°C, after which blots were washed 4x for 5 minutes 
in 0.01% Tween-20/PBS. Next, blots were incubated with HRP-conjugated secondary antibodies diluted in 
blocking buffer for 1 hour at room temperature, after which blots were washed as described above and once 
in PBS. Proteins were detected by incubating in ECL detection agent (Amersham) for 3 minutes at room 
temperature prior to exposure to X-ray films (Photon Imaging Systems). The films were developed using a 
JP-33 film processor (JPI Healthcare Solutions). Alternatively, Western blots were scanned by the 
Amersham Typhoon Biomolecular Imager (GE Life Sciences). 
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II.V.IX GUV assays, cryo-EM, HDX-MS 
All GUV assays, cryo-Electron Microscopy, and Hydrogen-Deuterium Exchange experiments were 
performed by the Williams group (MRC LMB, UK). Detailed descriptions of the protocols and reagents 
used are stated in (Tremel et al., 2021) 
 
 
II.VI Mass spectrometry 
Protein samples obtained from affinity chromatography and proximity biotinylation were loaded on 4-20% 
Tris-Glycine SDS-PAGE gels and run for 1-2 centimetres. Gels were stained with Coomassie InstantBlue, 
after which each gel lane was cut into eight pieces and placed in a 96-well plate. The 96-well plates were 
handed to the MRC LMB Mass Spectrometry Facility, where the gels were destained with 50% v/v 
acetonitrile and 50 mM ammonium bicarbonate, reduced with 10 mM DTT, and alkylated with 55 mM 
iodoacetamide. Proteins were digested with 6 ng/μL trypsin (Promega) by overnight incubation at 37°C, 
after which peptides were extracted in 2% v/v formic acid and 2% v/v acetonitrile, and analysed by nano-
scale capillary LC-MS/MS (Ultimate U3000 HPLC, Thermo Scientific Dionex) at a flow of ~ 300 nL/min. 
Peptides were trapped (C18 Acclaim PepMap100 5 μm, 100 μm x 20 mm nanoViper) and separated (C18 
Acclaim PepMap 100 3 μm, 75 μm x 250 mm nanoViper), after which they were eluted with an acetonitrile 
gradient. The analytical column outlet was interfaced via a nano-flow electrospray ionisation source with a 
linear ion trap mass spectrometer (Orbitrap Velos, Thermo Scientific). A resolution of 30.000 for the full 
MS spectrum was used to perform data dependent analysis, followed by ten MS/MS spectra in the linear 
ion trap. MS spectra were collected over a m/z range of 300-2000, after which MS/MS scans were collected 
using a threshold energy of 35 for collision-induced dissociation. LC-MS/MS data were searched against 
the UniProt KB database using Mascot (Matrix Science), with a precursor tolerance of 5 ppm and a fragment 
ion mass tolerance of 0.8 Da. The gene RABGAP1L has two entries, RBG1L_HUMAN and 
RBG10_HUMAN, and so the latter was removed. Variable modifications for oxidised methionine, 
carbamidomethyl cysteine, pyroglutamic acid, and phosphorylated serine, threonine and tyrosine were 
included.  
 
 
II.VII Data analysis 
 
II.VII.I Analysis of confocal micrographs 
Confocal micrographs taken on either a laser scanning or spinning disc confocal microscope were processed 
and analysed using Fiji/ImageJ.  
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II.VII.II Bubble plot generation 
LC-MS/MS data were validated using the Scaffold Programme (Proteome Software Inc). To score the 
significance of interactors, total spectral counts were converted into WD-scores according to the 
CompPASS method (Sowa et al., 2009). WD-scores of all tested small GTPases using Bir* were processed 
in Microsoft Excel, generating so-called bubble plots which visualise the size of the WD-score via the area 
of the bubbles. When only one or several GTPases are shown in a bubble plot, the WD-scores of the entire 
comparative dataset were taken, ensuring correct scores. The only exception is for the data described in 
Chapter 4; when visualising the data of BioID2/TurboID or phospho-mimetic mutants, WD-scores were 
calculated solely on the GTPases visible in the bubble plots. 
 
II.VII.III Volcano plot generation 
Volcano plots were generated as described in (Gillingham et al., 2019). Briefly, LC-MS/MS data were 
processed in MaxQuant and analysed on the Perseus platform. Two sample Student’s t-tests were performed 
in which GTP-locked GTPases were compared against the entire set of GDP-locked baits, with the number 
of randomisations set at 250. Analysis was performed by Mark Skehel and Alison Gillingham, and volcano 
plots were generated by Sean Munro (MRC LMB, UK).  
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Supplementary material 
Table 1. GTP- and GDP-locked mutations for all tested GTPases. Nucleotide-locked point mutations were made, either by using known 
functional mutants based on previous research or by mutating the equivalent residues in lesser studied GTPases. 
 
 
GTPase GTP-locked GDP-locked 
Rab1A Q70L S25N 
Rab1B Q67L S22N 
Rab2A Q65L S20N 
Rab5A Q79L S34N 
Rab6A Q72L T27N 
Rab7A Q67L T22N 
Rab8A Q67L T22N 
Rab9A Q66L S21N 
Rab10 Q68L T23N 
Rab11A Q69L S25N 
Rab11B Q70L S25N 
Rab18 Q67L S22N 
Rab19B Q76L T31N 
Rab21 Q78L T33N 
Rab29 Q67L/A16V T21N 
Rab30B Q68L T23N 
Rab33B Q92L T47N 
Rab39B Q68L S22N 
Rab43 Q77L T32N 
Cdc42 G12V T17N 
Rac1 Q60L T17N 
RalB G23V S29A 
Rheb Q64L S20N 
RhoA Q63L T19N 
N-Ras Q60L T17N 
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Supplementary Figure 2.1. Expression levels of GTPase-BirA*-HA-MAO chimeras. Immunoblots of whole cell lysate of HEK293T cells 
expressing mitochondrially-tagged GTPase chimeras, stained for HA (chimera) and α-tubulin (expression level control). Untrans.: untransfected, 
wildtype HEK293T lysate. The HA antibody has a non-specific background band (also found in untransfected cell lysate), marked with an asterisk 
(*). 
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Supplementary Figure 2.2. Representative micrographs of mitochondrially localised GTPase chimeras. Confocal images of HeLa cells 
expressing mitochondrial GTPase chimeras (as indicated) and stained for HA (internal chimera epitope tag), COXIV (mitochondrial marker) and 
giantin (Golgi marker). 
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Supplementary Figure 3.1. Analysis of GTP-locked Rab6A, Rab7A, Rab8A, and Rab10  MitoID experiments. (Α-D)  Bubble-volcano plots 
showing GTP-locked Rab6A (A), Rab7A (B), Rab8A (C), and Rab10 (D) plotted against all tested GDP-locked GTPases. Circle area corresponds 
to WD-score. Data analysed by Alison Gillingham, plots generated by Sean Munro. 
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Supplementary Figure 3.2. Analysis of GTP-locked Rab18, Rab19B, Rab21, and Rab29 MitoID experiments. (Α-E)  Bubble-volcano plots 
showing GTP-locked Rab18 (A), Rab19B (B), Rab21 (C), Rab29A (Q67L) (D), and Rab29 (A16V) (E) plotted against all tested GDP-locked 
GTPases. Circle area corresponds to WD-score. Data analysed by Alison Gillingham, plots generated by Sean Munro. 
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Supplementary Figure 3.3. Analysis of GTP-locked Rab30, Rab33B, Rab39B, and Rab43 MitoID experiments. (Α-D)  Bubble-volcano plots 
showing GDP-locked Rab30 (A), Rab33B (B), Rab39B (C), and Rab43 (D) plotted against all tested GDP-locked GTPases. Circle area corresponds 
to WD-score. Data analysed by Alison Gillingham, plots generated by Sean Munro. 
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Supplementary figure 3.4. Analysis of GDP-locked Rab6A, Rab7A, Rab8A, and Rab10 MitoID experiments. (Α-D)  Bubble-volcano plots 
showing GDP-locked Rab6A (A), Rab7A (B), Rab8A (C), and Rab10 (D) plotted against all tested GDP-locked GTPases. Circle area corresponds 
to WD-score. Data analysed by Alison Gillingham, plots generated by Sean Munro. 
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Supplementary figure 3.5. Analysis of GDP-locked Rab18, Rab19B, Rab21 and Rab29 MitoID experiments. (Α-D)  Bubble-volcano plots 
showing GDP-locked Rab18 (A), Rab19B (B), Rab21 (C) and Rab29 (D) plotted against all tested GDP-locked GTPases. Circle area corresponds 
to WD-score. Data analysed by Alison Gillingham, plots generated by Sean Munro. 
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Supplementary figure 3.6. Analysis of GDP-locked Rab30B, Rab33B, Rab39B, Rab43, RalB, and Rheb MitoID experiments. (Α-F)  Bubble-
volcano plots showing GDP-locked Rab30B (A), Rab33B (B), Rab39B (C), Rab43 (D), RalB (E), and Rheb (F)  plotted against all tested GDP-
locked GTPases. Circle area corresponds to WD-score. Data analysed by Alison Gillingham, plots generated by Sean Munro. 
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